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Bioinformatics is rapidly advancing through the "post-genomic" era following the sequencing
of the human genome. In preparation for studying the inner workings behind genes, proteins
and even smaller biological elements, several subdivisions of bioinformatics have developed.
The subdivision of proteomics, concerning the structure and function of proteins, has been
aided by the mass spectrometry data source. Biouid or tissue samples are rapidly assayed for
their protein composition. The resulting mass spectra are analyzed using machine learning
techniques to discover reliable patterns which discriminate samples from two populations,
for example, healthy or diseased, or treatment responders versus non-responders. However,
this data source is imperfect and faces several challenges: unwanted variability arising from
the data collection process, obtaining a robust discriminative model that generalizes well to
future data, and validating a predictive pattern statistically and biologically.
This thesis presents several techniques which attempt to intelligently deal with the prob-
lems facing each stage of the analytical process. First, an automatic preprocessing method
selection system is demonstrated. This system learns from data and selects a combination
of preprocessing methods which is most appropriate for the task at hand. This reduces the
noise aecting potential predictive patterns. Our results suggest that this method can help
adapt to data from dierent technologies, improving downstream predictive performance.
Next, the issues of feature selection and predictive modeling are revisited with respect to the
unique challenges posed by proteomic prole data. Approaches to model selection through
kernel learning are also investigated. Key insights are obtained for designing the feature
iv
selection and predictive modeling portion of the analytical framework. Finally, methods for
interpreting the results of predictive modeling are demonstrated. These methods are used
to assure the user of various desirable properties: validation of the strength of a predictive
model, validation of reproducible signal across multiple data generation sessions and gener-
alizability of predictive models to future data. A method for labeling prole features with
biological identities is also presented, which aids in the interpretation of the data. Overall,
these novel techniques give the protein proling community additional support and leverage
to aid the predictive capability of the technology.
v
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GLOSSARY
AUC
Area under the Receiver Operating Characteristic Curve, a performance metric used to
evaluate the decision-making ability of a predictor.
Biomarker
A naturally occurring biological component, such as a gene, protein or molecule, which
indicates or characterizes normal biological processes. The presence or absence of a
biomarker can also indicate a pathological process.
Dalton (Da, kiloDalton kDa)
The unit of measurement approximately equivalent to the weight of a proton or neutron.
A molecule appearing at mass-to-charge ratio m=z generally weighs m Daltons.
MALDI-TOF-MS
Matrix-Absorbing Laser Desorption/Ionization Time-of-Flight Mass Spectrometry, a type
of mass spectrometer technology.
Method
In general, I use the word Method to describe a technique used to accomplish a single
task.
MS
Mass Spectrometer / Mass Spectrometry. See Section 2.3 for a detailed explanation.
Pathway
A set of genes which interact and depend on each other to achieve a biological function.
A disturbance in part of the pathway, such as a mutated gene, may cause a disruption
of the resulting biological function.
xviii
Procedure
In general, I use the word Procedure as a course of action consisting of individual Methods
which are applied sequentially to a dataset.
Prole
A record in a dataset for a single sample which explains the molecular composition of
that sample at the protein level.
QA/QC
Quality-Assurance / Quality Control data. The biouid sample which generates these
proles comes from a common, pooled source. These data are intended to be used as
references to check the consistency of the output of the mass spectrometer.
Raw
Refers to the state of data as it arrives from the mass spectrometer.
SELDI-TOF-MS
Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry, a type
of mass spectrometer technology.
Surrogate Biomarker
An element of the data which suggests the presence of a biomarker (see Biomarker above).
Knowledge of the biological nature of the biomarker is usually incomplete.
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1.0 INTRODUCTION
Bioinformatics is rapidly advancing through the "post-genomic" era following the sequencing
of the human genome. In preparation for studying the inner workings behind genes, several
subdivisions of bioinformatics have developed. Each subdivision concentrates on a specic
level of biological granularity: genomics covers the DNA sequence and mutation of genes,
transcriptomics to study the expression of these genes, proteomics to characterize the pro-
teins produced by these genes and metabolomics to study the economy of cells. Each of these
subdivisions is supported by multiple similar technologies which allow for the rapid assess-
ment of thousands of biochemical or genetic experiments, or assays. This process is generally
referred to as high-throughput screening and their results are known as high-throughput data.
The popularity of high-throughput screening began with DNA microarrays. This tech-
nology is still currently used to perform gene expression assays, which measure how active
genes are behaving under certain conditions. In an eort to nd genes responsible for a
particular condition, a researcher would take biological samples from several individuals ex-
hibiting this condition, the cases, and several individuals who do not, the controls. Producing
the high-throughput data for each sample, the researcher can locate genes which exhibit a
robust dierence between cases and controls; this result is called a biomarker. A biomarker
can potentially serve to indicate a number of things: presence of disease, susceptibility of a
condition, responsiveness to treatment or relationship among individuals.
Finding a gene biomarker does not necessarily pinpoint the cause of a condition, as is the
case with many diseases. A gene is only the blueprint for proteins, which are responsible for
constituting and controlling cells. The ultimate cause of a condition may be attributed to
an abnormal level or state of a protein, which could be expected to be normal from simply
looking at the expression level of it's producing gene. This can occur for a number of rea-
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sons. Although a gene may be highly expressed, it does not mean that its associated protein
product is produced correctly or at all. Furthermore, a single expressed gene may encode
more than one protein. The decision about which protein is used, and how these proteins'
functions may be changed, take place outside of the realm of gene expression. Therefore, a
natural next step in the investigation for biomarkers was to expand high-throughput screen-
ing beyond genomics to proteomics.
Several methodologies for performing proteomic high-throughput screens exist, and are
typically based on mass spectrometry technology. This type of technology is suitable for
analyzing complex mixtures of proteins, such as those obtained from biouids, e.g. blood,
urine and saliva. Since these sample sources are more easily obtainable than organ tissue
samples, it increases the opportunity for data collection and production. The resulting data,
termed proteomic proles, quantify how much, and depending on the technology, what type
of proteins are present in the sample.
The proteome changes from cell to cell, and even from time to time, and the resulting
complexity of proteomic prole data is naturally high. Generally, no limit is placed on the
number of types of proteins that can be quantied by the instrument. A typical proteomic
prole contains tens of thousands of measurements, or features, and the most sensitive tech-
nologies will produce proles with hundreds of thousands of features. Each feature has the
potential to be a biomarker, but many challenges stand in the way before a good claim can
be made.
Lessons learned from microarray screening also apply to proteomics. The rst is that no
technology is perfect - stochastic noise permeates all high-throughput technologies through
multiple ways. Changes in sample collection and processing, physical limitations of the
sensitivity of the detecting machinery and natural variation in the biology of the samples
contribute to errors and uncertainty in the data. Beyond this, thousands of features await
analysis for their potential identication as biomarkers. Many of these features can be spuri-
ously correlated with the dierence between case and control samples. Perhaps only certain
combinations of features can be reliable biomarkers, but many combinations exist, and it
is infeasible to investigate all of them. Determining the ability of these biomarkers to dis-
criminate future unseen samples as case or control is yet another issue. Finally, interpreting
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the quality of biomarkers and their relevance to the discriminating condition in question is
a necessary step in moving a discovery-minded analysis forward.
1.1 CONTRIBUTIONS OF THE THESIS
Much research in bioinformatics has been devoted to developing methods to address each of
these issues. Although many ideas translate across the types of high-throughput screening
techniques, every data type has its own unique quirks and caveats. The objective of this
work is to develop a framework for analysis of high-throughput mass spectrometry data. The
components of this framework are briey outlined below with descriptions of the methods
which contribute to those components.
 Preprocessing
Preprocessing consists of a range of methods used to make high-throughput data eas-
ier to analyze. The goal is to minimize the amount of perceived imperfections in the
data. These imperfections can be anything from missing or nonsensical values to unwar-
ranted stochastic variation, systematic or otherwise. These imperfections can obscure
useful information, or may cause downstream analyses to mistakenly identify spurious
biomarkers. Preprocessing methods are employed to resolve the problems caused by these
imperfections, with the expectation that most of the true biological information remains
unaected. I demonstrate new methods for removing noise in a modular fashion, while
conserving valuable information.
1. Metrics for the evaluation of individual preprocessing stages are proposed. Standard
preprocessing in mass spectrometry typically only evaluates preprocessing holisti-
cally, after all stages have been completed. I investigate whether stagewise evaluation
through these metrics will improve preprocessing as a whole.
2. I evaluate preprocessing methods with the goal of preserving the discriminative infor-
mation between case and control proles as much as possible. Standard preprocess-
ing techniques do not account for this. These methods will use the above-mentioned
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metrics to improve further on preprocessing methods.
 Feature Selection and Predictive Modeling
These are two intertwined topics which enable a computer to predict a disease state from
the mass spectrometry prole data. The former involves methods which select or con-
struct features from the proteomic proles which appear to have diagnostic information.
These features are then fed into a predictive model, which must be given training data
to learn the relationship between the selected features and the actual disease state of the
sample. The predictive model must be able to discover a robust relationship from the
selected features, and furthermore, the features given as input must not be spuriously as-
sociated with the disease state. Thus, the combination of the methods used for selecting
features and model is critical. I evaluate whether certain methods are better at auto-
matically determining good combinations of feature selection and predictive modeling
techniques.
1. A variety of feature selection techniques are compared. This dissertation document
discusses these feature selection techniques and explains why certain feature selection
techniques are preferable to others.
2. A decorrelating feature selection procedure is presented. This feature selection tech-
nique takes advantage of the naturally highly correlated data by restricting feature
selection to potentially more informative features. In preliminary studies, this tech-
nique has performed comparably to other popular feature selection techniques.
3. The Support Vector Machine (SVM) has performed admirably in preliminary stud-
ies, even with the basic linear kernel. I compare the SVM approach to additional
kernel selection techniques. One alternative to the linear kernel is to learn a kernel,
which is accomplished through linear combinations of existing basis kernels. Another
alternative is to select a kernel from among many, based on statistical characteristics
of the dataset at hand.
4. I compare these kernel-learning approaches with a customized kernel for mass spec-
trum protein prole data. This kernel uses prior knowledge about gene and protein
interactions to extract pathway information within the proles. I investigate the ex-
tent to which any of these approaches have favorable qualities which are important
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for mass spectrometry data analysis.
 Interpretive Analysis
These are approaches for evaluating and interpreting the results of predictive models.
Two major issues exist which discourage the acceptance of predictive models for routine
use: (1) the lack of statistical reproducibility of the predictive model's performance in
light of multiple sources of noise, and (2) uncertainty about the underlying biological
reasons responsible for the predictive model's performance. I present novel methods for
addressing these concerns and assisting the interpretation of preceding results.
1. I introduce a method for assessing the signicance of predictive modeling perfor-
mance. This is a nonparametric method based on the permutation test, and allows
the analyst to determine the strength of a predictive model's result.
2. I introduce a set of methods for measuring reproducibility across separate data pro-
duction sessions. This is particularly useful in determining whether a positive result
from an analysis of mass spectrometry data can be repeated. These methods can
also strengthen the condence that the study design is robust against many types of
noise resulting in dierences in sample collection and data production.
3. I introduce a method for labeling of features in mass spectrometry proles with
protein identiers. This is a necessary task when dealing with many types of mass
spectrometric protein proles. This is especially true in the case of Time-of-Flight
Mass Spectrometry data, the predominant data type used in this thesis (See section
2.3 for further clarication).
4. I introduce methods for deriving biological interpretations from interesting patterns
in mass spectrometry prole data. This is motivated by the wish to represent proles
as aggregate features which represent the biological functions ongoing in the sample.
While a similar framework for analysis may be assembled from existing pieces and meth-
ods, my framework builds upon knowledge and methods rened by analyses of multiple
datasets, each with dierent characteristics and requirements. Thus, the methods intro-
duced here are either new or are novel variations of existing methods. Their eectiveness
will be demonstrated on datasets pertaining to a variety of conditions. For certain areas,
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I provide guidelines and insight about eective analytical techniques for existing methods.
Overall, the hypothesis to be tested by this research is that the framework proposed here
improves the analysis of mass spectrometry proteomic proling data, in terms of automating
the analytical process, improving predictive modeling performance and enabling more intuitive
and useful interpretation of results. The research reported here will be primarily useful to
the bioinformatics community, and particularly those who use mass spectrometry proteomic
technologies for disease prediction, risk assessment and treatment prediction. Validation
methods incorporating prior information will be of interest to systems biology and transla-
tional researchers, who routinely seek patterns of dierential biological activity as it relates
to the condition of an organism.
Figure 1 is a simple depiction of the relationships between steps of analysis for proteomic
proling data. The methods in this thesis were developed with this analytical workow
in mind. Each of the steps are described in sequence throughout this document. Chapter
2 is devoted to describing the state-of-the-art techniques in mass spectrometry proteomic
proling. The data collection and production process is described in detail, to give the
reader an appreciation for the nature of the data source. The types and limits of information
contained in the data are also described. A list of available mass spectrometry datasets from
a variety of disease conditions is presented. In addition, I also present a mass spectrometry
simulator for the generation of articial datasets. The simulator is an iterative improvement
from a previously developed physical model of mass spectrometry [1] These datasets are
used in the development and evaluation of the methods presented in later chapters. Finally,
Section 2.5 describes mathematical notation relevant to the following chapters.
Chapter 3 is devoted to Preprocessing. The methods described in this chapter present
heuristics that are useful for comparing and evaluating how well preprocessing techniques
work. These heuristics are used to develop novel preprocessing steps which take into account
the dierences between case and control proles, and adjust the proles in a way that
preserves these dierences as much as possible.
Chapter 4 deals with the search for biomarkers. This process is governed by two inter-
twined topics, feature selection and predictive modeling. This chapter describes the basic
methods for each step, and then introduces new methods which take advantage of observ-
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Figure 1: A owchart demonstrating the relationship between steps of analysis of proteomic
prole data.
able correlations in the data. Accounting for correlations allows exibility and robustness in
predictive modeling. An approach to automatic model selection is also investigated through
approaches which try to learn the kernel of a Support Vector Machine. Additional ap-
proaches to model selection are also evaluated and should provide a basis for guidelines for
model selection.
Chapter 5 discusses approaches for evaluating and interpreting the results of predictive
models. As mentioned above, methods are presented to deal with the statistical and biolog-
ical uncertainty inherent in mass spectrometry protein proling data. Though a great deal
of uncertainty surrounds the data source at any level, the presented methods work around
this problem in order to elucidate information and bolster condence in predictive models.
This work also proposes a method which could relate elements of protein prole data to
expression of biological pathways in the sample.
Chapters 3, 4 and 5 follow a similar structure (see the Table of Contents for an overview
at a glance). Each chapter begins with a background section to motivate the chapter and
describe the relevant challenges. This section gives enough information to understand the
concepts developed in the methods section. The related work section describes the exist-
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ing state-of-the-art research involved in the respective topic. The methods section details
research advancements made by this thesis. Results evaluating the eectiveness of these
described methods are given at the end of every chapter.
The thesis concludes with Chapter 6, which summarizes the thesis work and sheds light
on future applications and extensions of the techniques presented in this thesis.
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2.0 DATA
Proteomics is dened as the study of the structure and function of proteins. At a high level,
one way of studying the function of proteins is to determine which are present or absent only
in a group of patients with a common disease state. Mass Spectrometry (MS) is an analytical
technique used to determine the elemental composition of a substance. In proteomic research,
this substance is typically a sample biouid consisting of, for example, blood, tissue cell
lysate, urine or saliva. Many of these sample types can be obtained noninvasively, which
facilitates a potential clinical screening process. A mass spectrometer is one of many devices
which can be used to interrogate these samples to determine its constituents. A human
biouid sample is a complex mixture of proteins and other molecules. To identify and
quantify each component of the mixture with certainty, any analytical technique would need
to tediously separate each molecule in the sample and count it. Technologies such as gel
electrophoresis, western blotting or liquid chromatography can separate proteins, but each
technique has their limitations. The advantage of mass spectrometry is that a complex
mixture can be analyzed with or without separation, and even small amounts of molecules
will be measured. The time and cost of the analysis is also relatively low compared to other
analytical techniques, which require non-reusable reagents, columns or lms, larger amounts
of sample and a signicant amount of time for necessary chemical reactions to take place.
The process by which mass spectrometry works is described briey and depicted in gure
2. The complex mixture sample is placed on an analytical surface. This surface may have
properties which may emphasize the analysis of a particular class of proteins. The surface
and attached sample are exposed to an energy source (for example, a laser beam). The
surface transfers the energy source to the sample, causing individual molecules in the sample
to become ionized and y away from the surface. During this ight time, the ions (charged
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molecules) are controlled and directed toward a detector plate. A more detailed description
of the factors involved in the ionization process is given in the following section, which
illustrates the complexity of the data production process.
2.1 BIOCHEMICAL ISSUES AFFECTING THE DATA GENERATION
PROCESS
Many biochemical processes contribute to the types of peptides or proteins measured by the
mass spectrometer. In particular, reparation of the analytical surface plays a critical role in
the resulting data. The analytical surface captures molecules in the sample for analysis. For
example, in Matrix-Enhanced Laser Desorption/Ionization (MALDI) mass spectrometry, the
analytical surface is formed by a mixture of the biouid sample and a \matrix" chemical,
which crystallizes around the sample and allows laser energy to be transferred directly to
molecules in the sample. The earliest and most popular method for preparing the surface
is the \dried droplet" method [2]. Other methods were subsequently developed in attempts
to smoothly and evenly distribute matrix-sample crystallization across the analytical sur-
face. An investigation into the advantages of these alternative surface preparation methods
revealed that two factors have the majority of the inuence in the crystallization: a careful
choice of the matrix chemical, as well as the amount of time allowed for the cocrystallization
to occur [3].
If important molecules in the sample do not crystalize with the matrix, their presence
will not be detected by the mass spectrometer, and they will be excluded from the data.
Thus, it is important that molecules of interest are present in the matrix-sample crystals.
The above investigations also established guidelines for matrix preparation when targeting
particular types of molecules. For example, peptides greater than 3 kDa in mass crystalize
better when the matrix solution includes formic acid and has a pH less than 1:8. Smaller
peptides are better analyzed when the matrix solution includes no added acid [3]. Matrix
solutions can be created to cover a more complete range of peptide masses, but it comes at
a cost of losing potential information where a more optimized protocol is established.
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If a matrix-sample crystal is hit by the laser, we must hope that the molecules in the
sample become properly ionized. Only ions will y away from the analytical surface and
become measured by the mass spectrometer. Ideally, a peptide molecule will be measured
intact and singly-charged. Too much energy can cause a peptide to fragment, breaking it
into smaller peptides. Too much electric charge can cause the peptide to be measured at
dierent areas of a protein prole. The electrical charge of the ion plays diering roles in
various mass spectrometers. Depending on the amount of ionizing energy used, molecules
will acquire or lose one or more electrons. Since the ions are repelled by their charge from
the analytical surface by a constant eld, adding additional charges will increase the ight
speed of the ion proportionally. A doubly-charged ion will y twice as fast as with a single
charge. The ion mass and charge are combined to form the mass-to-charge ratio, or m/z
ratio. Creating an analytical procedure which controls the amount of expected charge on a
peptide would help to stabilize the analysis. Ideally, if every peptide is only singly-charged,
then a peptide will be measured by the spectrometer by its mass alone. If a doubly-charged
peptide is obtained, it will also be measured at half its mass.
Unfortunately, the ionization process in mass spectrometry is dicult to explain with
a simple physical mechanism [4]. Ionization depends on the laser wavelength, pulse energy
and pulse length, which can change from lab to lab. In addition, the relationship between
these parameters and the varying sample preparation methods has yet to be extensively
studied. Finally, certain classes of peptide molecules are more likely to ionize than others.
In certain types of mass spectrometry experiments, the rate of successfully ionized molecules
to neutral molecules can be as low as 1 out of 10000 [4]. These factors combine to make a
very complex picture of what is ordinarily a small and underappreciated step in the data
production and analysis of protein proling data. However, it is important to discuss, as it
shows the complexity of the data source and the need for analytical techniques which can
deal with the inevitable imperfections in the data.
Prior knowledge about the chemistry of the sample and the types of molecules expected
can help to guide the data production process. Primarily, the acidity or basicity of the desired
molecules seems to be the most important factor inuencing ionization. Matrix chemicals
with appropriate proton anities or gas-phase basicities can be selected in order to encourage
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stable ionization behavior, and guidelines have been established in order to support these
behaviors [4]. Furthermore, new matrix chemicals can be designed if the available chemicals
are not appropriate for ionizing the desired peptide molecules. Overall, there are many
characteristics which play a part in the ionization process. The most important thing is to
ensure that as many ions as possible can be generated. Careful design of the matrix chemical,
combined with careful selection of the spectrometer's laser settings, can help to ensure more
consistent and useful data production [4].
2.2 DATA USED FOR THIS THESIS
This thesis is primarily concerned with Time-of-Flight Mass Spectrometry (TOF-MS), which
is one method the mass spectrometer uses to calculate which ions are reaching the detector.
The detector plate records a series of collision events, which consist of the electrical charge
and time of impact of ions ying into the detector. The time of impact since the start of the
analysis is important. Heavier, more massive molecules will y slower than their smaller,
less massive counterparts. From the length of the ions' ight path, the mass spectrometer
calculates the mass of the colliding ion. The resulting data from a mass spectrometer is a
list of m/z ratios and the number of ions detected with that ratio.
A proteomic prole is a data record produced by a mass spectrometer from a biouid
sample. Proteomic proles can be visualized in a number of ways; a common view is displayed
in gure 3. M/z ratio is presented along the x-axis, and the y-axis measures the relative
intensity of ions present at a particular m/z ratio. Relative intensities are used instead of
ion counts, due to a physical limitation on the number of ions the detector plate can sense
simultaneously. There is a maximum value which the detector can sense, and all other values
recorded by the machine must be normalized to this value. Figure 3 gives the illusion of a
continuous line, but in reality, the measurements are individuals, and the distance between
observed m/z ratios can vary. However, the continuous-line interpretation will facilitate
many aspects of the data analysis, as will be seen in Chapter 3. From this point forward, a
m/z ratio and its associated relative intensity will be interchangeably referred to as a feature
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of the proteomic prole. These types of proles typically consist of tens of thousands of
features.
Mass spectrometry is an imperfect technology. It should be clear that many interpre-
tation errors can take place. For example, a molecule may be represented by two separate
features when ionized with a single and double charge. Two (or more) molecules could po-
tentially have the same m/z ratio, causing their intensities to overlap. And amongst these
uncertainties, it should be noted that very little information about the biological nature of
the features is generated by the mass spectrometer. Arguably, this is the largest problem
facing interpretation of MS proteomic prole data. Cutting-edge technology is being de-
veloped for the elucidation of identities of protein and peptide molecules. Briey, ions in
the ight path are subjected to another energy source, causing the molecule to be reduced
to fragments. The fragments are then measured by the detector plate, and the resulting
fragmentation pattern is compared to databases of known protein fragmentation patterns.
Matches can often be found,however, even these methods are far from perfect. While it is
possible that MS technology will improve in the future to identify all proteins, techniques
can still be developed for the technology that works well now, and these techniques can be
designed to incorporate additional information as the supporting technology evolves.
2.3 AVAILABLE BIOLOGICAL DATA
For the purposes of this thesis, I have assembled a collection of proteomic prole datasets
for analysis. The majority of this data was produced by a Surface-Enhanced Laser Desorp-
tion/Ionization (SELDI) TOF mass spectrometer. Compared to other mass spectrometry
techniques, SELDI uses a specialized analytical surface which can have particular anities
for certain protein types. Proteins that do not bind to the surface are washed o before
ionization. This reduces the number of dierent protein types that can enter the mass spec-
trometer, and can reduce the complexity of the resulting data. The particular SELDI-TOF
model used is the Ciphergen PBS-II SELDI-TOF mass spectrometer (Ciphergen Biosystems,
Fremont, CA, USA). The available Matrix-Assisted Laser Desorption/Ionization (MALDI)
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TOF data is produced by either a Voyager-Elite mass spectrometer (Applied Biosystems,
Foster City, CA, USA) or Bruker Clin-Prot II mass spectrometer (Bruker Daltonics, Billerica,
MA, USA).
Most datasets were produced either by the University of Pittsburgh Cancer Institute
(UPCI, Pittsburgh, PA, USA) or the University of Pittsburgh Medical Center (UPMC,
Pittsburgh, PA, USA). These datasets were produced with careful, strictly-controlled study
designs in order to reduce the potential for bias and confounding. Each dataset contains data
from samples of diseased (case) and healthy (control) individuals. Cases and controls were
processed by the laboratory on the same machine. When samples could not be processed
simultaneously, the order in which samples are processed by the laboratory is randomized
to reduce the possibility of spurious temporally-created biomarkers. To reduce the eect
of confounding between the two sample groups, the case and control samples are matched
by variables such as age, gender and smoking history when applicable. This means that
each case sample is matched with a control sample from an individual with similar clinical
characteristics.
Several disease conditions are demonstrated in the various datasets. Table 1 lists the
datasets as well as the disease condition, number of cases and controls, year produced and
originating laboratory. The disease conditions cover both diseases which are similar (Ovarian,
Prostate, Melanoma, Pancreatic and Lung Cancers) and dissimilar (hepatitis C, kidney
necrosis, diabetes and dental caries). With the diversity of conditions studied, it will be
possible to perform robust comparisons between methods, to ensure that they are not too
strongly biased to one class of diseases.
2.3.1 Important dataset notes
Several datasets have special properties which allow the evaluation of certain experiments.
2.3.1.1 Prostate cancer dataset The prostate cancer dataset [5] was produced by re-
searchers at the National Cancer Institute (NCI, Bethesda, MD, USA) Clinical Proteomics
Program in 2002. This dataset suered from unintended mistakes as a consequence of the
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proteomic proling research eld being in its nascent and explosive stage. The case and con-
trol samples were processed on separate days. This had the unintended eect of introducing
a biased signal artifact which essentially labeled the case and control samples perfectly [6].
While results from this dataset should not indicate great success at predicting prostate can-
cer, it is still a useful tool in order to demonstrate the eectiveness of certain methods in
the face of overwhelming bias. The authors claim that this data was never intended to re-
ect the success of a potential screening platform. However, the aws in this and another
study [7] cast a pall of doubt upon the protein proling technology [8]. Despite the rough
beginning, protocols became more developed and technologies such as those presented in
this work began to develop, in order to support the promise of this technology.
2.3.1.2 Vanderbilt/UPCI Lung SPORE datasets This source of data reects a large
set of samples processed at dierent locations, under dierent technologies. A larger set of
lung cancer patients' serum samples were collected by the Vanderbilt University Medical
Center Clinics (Nashville, TN, USA), the Nashville VA Medical Center (Nashville, TN,
USA) and the UPCI. These samples were initially investigated at Vanderbilt University [9]
under the MALDI technology, and then the same samples were shipped to the UPCI to be
processed under SELDI IMAC (Immobilized Metal Ion Chromatography) and WCX (Weak
Cation eXchange) technologies. The intersection of these three datasets were a set of 134
case and 104 control proles. These 3 datasets give us a unique look into how a sample can
be expressed across dierent MS platforms as well as dierent locations and dierent times.
2.3.1.3 UPCI Lung Cancer II dataset This dataset featured four data production
\sessions" in which a subset of the samples were repeatedly reprocessed after spending time
in a freezer. This was done in an eort to determine whether sample degradation would play a
large role in observing clinically relevant patterns. In most cases, table entries corresponding
to this dataset reference the initial data production session, which contained the largest set
of samples out of the four sessions. In Chapter 5, all four sessions are analyzed in greater
detail in the context of a reproducibility study.
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2.4 SYNTHETIC DATA
In addition to the biological data summarized above, the ability to simulate data sets is
also available. The simulator is based on a physical model of the TOF-MS process [1], and
is able to simulate data from any TOF-MS system. While the simulator model proposed
in [1] is thorough in parameterizing many aspects of the TOF-MS system, I believe there
are errors in the model, so I derived new sets of equations to convert masses to times-of-
ight. A detailed description of the simulator is given in Appendix From the above section,
one can see that the mass spectrometer is constructed with three main components: the
energy source, the ight chamber and detector plate. The simulator parameterizes each
of these components in order to match the conguration of any TOF-MS system. For the
purposes of simulation, these parameters are chosen to match those of the Ciphergen PBS-II
SELDI-TOF-MS system. The amount of noise in the MS components can also be adjusted
to demonstrate the eect of inaccuracy in the instrument on the amount of proteins in the
simulated sample. Full details of the simulator and its parameters are given in Appendix A.
In biological data, we are always uncertain of the types and amounts of molecules that
are present in the sample. A major advantage of simulating data is that the constituents in
the sample can be controlled. Thus the simulated data can be used as a tool to study the
eects of noise on individual measurements, and develop realistic expectations of how well
the MS instrumentation can represent mixtures of molecules in the data. The eects of noise
are described in greater detail in Chapter 3. The choice of peptides to be included in the
simulated sample is arbitrary, and can t the need of the task when a particular reference
point is needed.
Mixtures of proteins and peptides can be added to the simulated sample if they are
present as entries in the UniProt database [10]. The UniProt peptide identiers are in
turn used to retrieve amino acid sequences for these proteins. The expected mass of the
peptide is computed as the sum of the average isotopic masses of the amino acids in the
given sequence, in addition to the average isotopic mass of a single water molecule. Post-
translational modications can also aect the peptide's sequence, and these are taken into
account when calculating the peptide mass. Signal peptides from complete protein sequences
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are removed, and when documented in the UniProt entry, the mass of a post-translational
modifying molecule is added to the peptide's expected mass. The relative abundances of each
peptide in the simulated mixture is provided. Thus, the abundances and expected masses
of the peptides can be used to study the ability of the mass spectrometer to detect an
appropriate amount of peptide at the correct m/z ratio. Additionally, multiple simulations
can be produced to study eects of noise on the MS system's ability to reproduce proles.
In this thesis, simulated data is used in Section 5.4.3.1 to demonstrate the eectiveness of a
peak-labeling system.
2.5 MATHEMATICAL NOTATION
The following notation and terminology is useful for understanding the technical details of
this thesis.
1. A dataset D is a collection of n proteomic proles, indexed by the variable i.
2. Each proteomic prole X has d features, indexed by the variable j. It is associated with
a class label, Y ,which is either 0 (healthy//control) or 1 (diseased//case). The positive
(or case) class is marked as X+ and the negative (or control) class is marked as X .
3. The jth feature in the ith prole fij occurs at m/z position xij and has intensity yij.
4. The average intensity of the jth feature is written as j. The standard deviation of the
jth feature is written as j. Superscripts of + or - indicate means or standard deviations
within a single class.
5. The average prole, consisting of all features 1   d averaged over all proles is referred
to as , and can be computed across all positive (+) or negative (+) proles.
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Analytical surfaces + Sample
Flight Chamber
Detector
Energy Source
MS Profile Data
ions
Figure 2: A simple diagram of the mass spectrometry data production process. A biouid
sample is deposited on an analytical surface. The sample is ionized by an energy source,
causing protein ions to y through a ight chamber. Lighter, smaller molecules y faster
than heavier molecules through the ight chamber. When they hit a detector plate at the end
of the chamber, the mass spectrometer records the amount of detected ions. By measuring
the time taken to y through the tube, the masses of the ions are calculated and a "peak"
feature at the appropriate m/z value is created in the data.
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Figure 3: An example of a proteomic prole produced by SELDI-TOF mass spectrometry.
The x-axis indicates the mass-to-charge ratio of molecules present in a sample for pancreatic
cancer. The y-axis reects the relative intensity, or abundance, of those types of molecules.
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3.0 PREPROCESSING
Preprocessing refers to a range of methods used to make high-throughput data easier to
analyze. Since each high-throughput technology diers in its method of data acquisition,
the techniques required dier between applications. The goal in any case is to minimize the
amount of perceived imperfections in the data. These imperfections can be anything from
missing or nonsensical values to unwarranted stochastic variation, systematic or otherwise.
Figure 4 illustrates four MS proles from the same sample source, but produced at four
dierent times. Changes are apparent in the intensity and shape of the MS signal, which
should ideally appear exactly the same across all four replicates. Downstream analysis
techniques could identify these imperfections in a way which would discriminate between
proles which should otherwise be identical. Preprocessing methods are employed to resolve
the problems caused by these imperfections, with the expectation that most of the true
biological information remains unaected. These methods are applied separately in stages
to address the dierent types of imperfections occurring in the data. The next section briey
explains the most popular preprocessing stages and the errors that they attempt to correct.
3.1 BACKGROUND
3.1.1 Stages of Preprocessing
Calibration refers to the process of ensuring that the quantity measured by an assay is
truly reected by its feature value. In a microarray experiment, this refers to translating
feature values into estimates of mRNA transcript abundance in the sample. In TOF-MS
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data, calibration can refer to mapping an observed time-of-ight value to an appropriate
m/z value, or to the more specic process of alignment. In any application, calibration helps
to ensure that the reported value is not misrepresented. Alignment is more particular to
proteomics, where peak features similar in shape across separate proles may be shifted to
dierent locations along the m/z axis. Figure 5 displays two proles from QA/QC serum
which require calibration. Their shape is nearly identical, but the peak positions appear
to be shifted linearly on the x-axis. The solid line could be shifted to the left to make the
shapes overlap neatly. Alignment can be used to bring these proles into agreement.
Variance stabilization is a process used to decouple the dependance of a feature variable's
variance on its mean. In many applications, features with the largest values exhibit the
greatest variance. Thus, a strongly expressed assay may incur more random noise than
a weaker one, detracting from its informational value. By applying a variance-stabilizing
transformation (such as taking the log or cube-root of the feature values), the features tend to
have a more constant variance, independent of the value of the feature. This makes adjusting
for systematic noise more convenient, as the relationship of the noise process becomes similar
across features. In any application, the aim is to reduce the eect of a multiplicative bias in
the feature values.
Baseline correction helps to ensure that all feature values are recorded with respect to
a baseline of 0 (or other suitable constant) to clearly distinguish values as being measured
features versus 'default' values produced by the data collection equipment. In TOF-MS
data, this is easily seen in an unpreprocessed prole, which seems to have a constant, nonzero
baseline. Figure 6 displays an example of such a phenomenon in a SELDI-TOF-MS prole. In
microarray data, this is referred to as background adjustment, and accomplishes the removal
of detectable signal occurring due to reasons other than the correct transcripts binding to the
probe surfaces. In any application, baseline correction assures that the scale of comparison
for values has a common starting point by removing an additive bias. Common methods
simply subtract a constant from every feature value. More involved methods may t a
function to the existing baseline and subtract this function to achieve a "at" baseline. The
result of the process is similar to that seen in the right panel of Figure 6.
Normalization adjusts all feature values to conform to the same scale. This process
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has varying levels of granularity. Microarray users typically refer to normalization as the
process that reduces variance between experiments in dierent datasets. In TOF-MS data,
it typically refers to removing bias from an individual prole by rescaling all feature values
within that prole. Figure 7 displays two proles from QA/QC serum which should be
identical. However, a dierence in either the level of sample or strength of the equipment
causes one prole to appear more intense than the other. Normalization would rescale the
data in both proles, so that they would appear to be on the same scale. A common approach
is to normalize all features to a [0 1] range. In TOF-MS, proles can be rescaled based on the
total sum of feature values across the prole (total ion current, or TIC, normalization). In
any application, normalization attempts to mold the data to a conformed range of variance.
Smoothing serves to eliminate a high frequency noise component in the signal. There are
multiple ways that this noise can be removed. A simple solution, moving average, involves
replacing the feature with an average of its neighboring features. Figure 8 displays an
example of moving-average smoothing on a SELDI-TOF prole. The signal in the left panel
carries a frequent, jagged landscape. By smoothing the signal, this variation is averaged over
a small area of points along the m/z axis. The result is a smoother signal with less variation.
A more intricate approach might use a kernel to give close features a particular shape. In
TOF-MS proles, an ideal peak might have a Gaussian shape, and therefore tting close
values to a Gaussian kernel might be best. Additional methods might employ a signal-to-
noise lter to remove the high-frequency random component. More recent work has used
wavelets to model a complex mixture of signals as a composition of simpler, smooth signals.
Regardless of the method used, it is never clear where to draw the line between random noise
and true biological information. A smoothing operation must be able to remove variance,
but not so aggressively that the features become fuzzy and redundant.
3.1.2 The order of preprocessing stages
Most applications do not require preprocessing methods that fall outside of these steps.
However, the selection and order of steps used is dependant on the type and quality of
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data. In the case of TOF-MS data, performing alignment before calibrating peaks along the
m/z axis is ideal. Although variance stabilization, normalization and smoothing all reduce
variation, they have specialized roles which might make them more eective in particular
orders. For example, variance stabilization can be seen as a type of normalization, which
removes a multiplicative bias on feature values. This must be done before the additive bias is
removed through baseline correction. Afterwards, additional rescaling through normalization
may take place, as not every rescaling operation will reduce the dependence of feature values'
variance on their means. Smoothing could be applied at any time to improve the consistency
of data. However, performing it too late may cause interesting variation to be obscured and
averaged out. Any preprocessing step entails removal and addition of information. Thus,
any preprocessing step carries a risk, and should be kept to a minimal level of aggressiveness
to preserve as much interesting information as possible. In order to adjust the harshness of
each preprocessing step, they are usually controlled by a choice of parameters (such as the
size of a moving-average window), or functions (such as an exponential function for modeling
a shifted baseline).
3.1.3 Related Work
The list of literature on high-throughput data preprocessing is substantial. It is typical
that each lab generating data will have their own preferred method, usually in addition to
at least one other 'default' method suggested by the lab equipment manufacturer. Despite
the dierences, the individual steps remain similar. The majority of dierences are brought
about by how the steps are tuned to t the quirks of the studied data. The following is a
summary of the most popular methods used for preprocessing data. Each technique will be
used later on as part of a comparative framework for evaluating preprocessing methods.
3.1.3.1 Preprocessing Techniques Preprocessing has been applied to data from many
elds, and should not be surprising that many techniques stem from simple methods. High-
throughput data is intended to demonstrate a signal, but suers from much noise. Methods
in signal renement have been simply transplanted from their native domains and applied to
24
high-throughput data. Signal-to-noise ltering, originating in electrical engineering applica-
tions, has been rened for the purposes of smoothing and variance stabilization. The latter
is commonly performed through either a fractional-power transformation [11] or more com-
monly, log transformation [12,13]. Applying the latter transformation will articially inate
variance of very low feature values, as well as necessitating truncation of negative values.
A generalized log-transform was later developed to address these problems by parameter-
izing the logarithmic transformation for individual assays [14]. Going one step further,
assay-specic variance-stabilizing transformations can be created by learning an appropri-
ate transformation function [15]. This function is derived by characterizing the relationship
between the mean and variance of a feature's values. This enables a wider variety of trans-
formation functions to be used. Another key advantage is that the method allows for the
incorporation of multiple replicates without needing to perform a linear normalization (av-
eraging) across feature replicates.
Smoothing techniques are relatively simple in nature and application. Many high-
throughput data analyses use local statistics to conform a feature's value to its immedi-
ate neighbors. These include simple approaches such as moving average [13], median and
geometric mean lters [16]. Techniques used to smooth time-series data have also been
applied to proteomic proles, due in part to their similarity in visualization. The Savitsky-
Golay lter [17,18] is considered a very popular choice for smoothing MS data. More recent
methods have been developed based on the Fourier transformation [19] and wavelet trans-
formations [20,21]. These transformations break the proteomic signal into a combination of
signals, with the intent to separate noise from the true signal. Wavelet transformations can
produce multiple wavelet basis functions, which have the advantage of adapting to dierences
in scale and local signal structure.
Baseline correction methods generally assume that signal is constructed from a linear
combination of a noise signal, true signal and baseline (zero) signal. The true signal is aected
by systematic noise as a result of the imperfect machinery used to measure a feature's value.
In the case of microarray data, this pertains to two separate eects; nonspecic binding of
genes to an inappropriate probe articially inates or deates expression values for those
genes. Furthermore, the optical scanner imparts noise to the value of a probe's reading. The
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original solution involved measuring mismatch probes, which are designed with a small defect,
to measure the amount of non-specic binding. The background adjustment is done by
subtracting this amount from the reading of the true-match probe. Although this ignored the
amount of noise introduced by the scanner, later models were able to separate contributions
of scanner and nonspecic binding noise. Anities between gene targets and probes were
estimated based on their nucleotide structure, which permitted models for estimating the
nonspecic binding. Additional noise is modeled as a separate additive component, modeled
through a distribution learned from data [22].
Baseline correction methods for proteomic spectra developed with a similar history. Early
techniques concentrated on detecting 'peak' features and subtracting them from the raw
signal to determine the shifted baseline [19, 23]. In these methods, the baseline is drawn
piecewise by nding a local minimum or median (to reduce noise) within a sliding window
of variable size. Alternative methods separated the peak-nding task from computing the
baseline, either by smoothing out the peaks [24], or by ignoring them altogether, using only
the local minima while ensuring a monotonically decreasing baseline [25]. The latter is a
simple and popular method, because it allows the decomposition of noise and true signal at
a later stage. A recent technique ts an exponential function to local medians which remain
below a smoothed version of the raw signal [24]. This can help to eliminate some of the
noise. However, remaining noise above the baseline may become more dicult to charac-
terize and remove. An "orthogonal background subtraction" method was developed [16] by
characterizing noise through Principal Component Analysis [26]. The top two components
were used to estimate noise contributions in an area of signal which was known to consist
only of baseline. These learned components were then used to remove the baseline from the
entire prole.
Normalization techniques are not particularly abundant in the literature, as their purpose
is simple: to enhance the appearance that data come from the same scale. The method
outlined in [27] rescales all values to the [0 1] range. Similarly, the 10th and 90th percentiles
of proles have been mapped to 0 and 1, with linear interpolation between [28]. Quantile
normalization [29] is a method which rescales data so that feature values in individual data
records come from the same distribution. This method was developed for microarray analysis,
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but has since been used for normalizing proteomic spectra [30]. Nevertheless, the most
common method of normalizing proteomic data tends to be the total ion current (TIC)
correction [19,25], which normalizes all feature values of a spectra by the sum of intensities
within a region of the spectra. This region can be as wide as the entire spectrum, but is
typically restricted to a region which appears to have a strong signal-to-noise ratio. A similar
method is global mean normalization [31], which assures the average feature intensity is the
same across all proles.
Alignment of proteomic spectra is commonly performed to ease comparison of features
within and across datasets. The dynamic time-warping algorithm [32] was initially used
to measure and increase the similarity between two proteomic signals over time-of-ight.
However, the large size of proteomic proles ( 10000 positions) is often prohibitive for the
memory and computational requirements of the underlying dynamic programming mecha-
nism. Restricting the maximum distance of edits between signals [33] alleviates this problem
somewhat. As an alternative, the dynamic programming approaches can be done away with
completely by using parametric and nonparametric methods [33,34]. These methods restrict
the warping function to a low-order polynomial. The parameters of the polynomial are t
via regression so that an appropriate distance metric between the aligned signals is mini-
mized. To save computational costs, a method has been developed [35] to split the signal
into segments which are dealt with separately, but also forced to agree when merging them
at the end. One drawback of these approaches is that they require a \template" prole to
which other proles are aligned. To avoid biasing the alignment with a poor choice of a
template prole, a probabilistic model was developed [36] to perform multiple alignments
simultaneously with a hidden Markov model (HMM). The template becomes a sequence of
states, each of which reect a distinct feature in the prole. This is learned from the training
data in a way that maximizes the probability that the HMM can produce the training data
from the template state sequence. Afterwards, a prole is aligned to the template by its
probability of which state each feature is in.
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3.2 METHODS
As no technology can be absolutely perfect, high-throughput data requires preprocessing to
assure that the eects of internal and external noise are mitigated. Preprocessing necessarily
aects the downstream analysis of high-throughput data [37]. Predictive models learned
on dierently preprocessed data may be substantially dierent in terms of which features
are used for diagnosis. This in turn aects the interpretation and validation of interesting
models. This may suggest that preprocessing methods consistently emphasize the same
features. However, preprocessing cannot correct for all variations in laboratory protocols
which may be responsible for dierent sets of informative features. Thus, preprocessing
methods must do their best to maintain any dierences between classes, if they exist, so
that analysis routines can examine all reasonable possibilities. Concurrently, they must also
deal with the inherent stochasticity of the data collection process by benignly removing noise.
Thus, proles belonging to the same class must remain as similar as possible, to reduce the
chances of spurious features arising in the feature selection phase.
This dissertation intends to develop heuristics and methodology for the evaluation of pre-
processing techniques. No means exists to objectively compare sets of preprocessing methods
for mass spectrometry data. The generic heuristics given here are applicable to any type of
MS data, and the methodology stresses an important aspect which is often overlooked in the
development of many preprocessing methods. This aspect is that the global task of achieving
good prediction must be balanced against the localized removal of noise. The evaluation of
these techniques are demonstrated on real biological data. The following sections describe
a methodology for automatically evaluating and applying preprocessing techniques which
seem to best improve discriminative information while removing targeted sources of noise.
These methods are then compared for their eect on downstream performance.
3.2.1 Evaluating Preprocessing Steps
The sections below introduce the Standard Automatic Preprocessing procedure, henceforth
abbreviated as SAP. This procedure attempts to maximize the discriminative signal remain-
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ing after a preprocessing method at a tradeo with how well noise is removed from the
signal. At each stage of the preprocessing, we use two kinds of heuristics to determine a
preprocessing method's performance at retaining discriminative signal and removing noise.
A third parameter acts as a security measure against methods which may cause these scores
to be circumvented.
In general, we are interested in the task of using proteomic proles to predict disease.
This classication task is central to any analysis of protein proling data. Preprocessing
consists of many stages, with each stage targeting a specic source of noise. Sometimes,
these sources of noise are more easily dened and their eects quantied. Other sources of
noise are hard to describe accurately and are more dicult to quantify. In this case, it is
increasingly important to focus on the original predictive task to assist us in determining
how well a noise source has been dealt with.
The Discriminative Estimate (DE) score is a global metric which stays constant through-
out all stages of the preprocessing. The goal of this heuristic is to measure how easily the
case and control proles can be discriminated after a preprocessing method has been applied.
We can calculate the DE score through many means. In the experiments below, I use the
10-fold cross-validated AUC of a support vector machine, evaluated on the internally split
training data. Other possible ways to calculate the DE score include the following options:
 Summing the univariate scores of the top n discriminative features, where n is an index
into features sorted by their Fisher score in descending order
DE =
nX
i=1

(+)
i   ( )i (i)
(
(+)
i )
2 + (
( )
i )
2
(3.1)
 Measuring the ratio between average Euclidean distance of proles within class to the
average Euclidean distance of proles between classes (as in equation 3.2 below).
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The following subsections present methodology for evaluating the best technique at every
stage of the preprocessing routine. However, each stage may have a dierent criteria to
evaluate the goodness of that particular stage's contribution to the complete preprocessing
routine. I call these local criteria stagewisescores. There may be tradeos between local
stagewise scores and the global DE score, which is intended to reect the goodness of
the entire preprocessing routine, rather than each individual step. Therefore, in order to
choose the best preprocessing method at any stage, I create so-called Stagewise Performance
curves (Henceforth referred to as SP-curves) akin to ROC curves. For each preprocessing
stage, multiple preprocessing methods will be evaluated using a stage-specic criterion. This
criterion is computed along with the resulting eect on the data's DE score. A curve is
generated from the points, so that the x-axis represents the quantity 1-DE, and the y-axis
represents the stage-specic criterion, which is rescaled to the range [0 1]. The "optimal"
method is chosen as the one whose scores are closest to the point (0,1). This gives a similar
interpretation to ROC curves, in which a "perfect" classication system's ROC curve will
reach the point (0,1). This selection system has the eect of equally weighting the DE score
and the stagewise score. However, a higher-quality stagewise score may be weighted higher
than the DE score, and for poorly dened stagewise scores, the DE score could likewise be
favored.
The sections below briey describe the type of noise each preprocessing step tries to
address, and suggests a stagewise score for each stage. Some stagewise scores are very neatly
dened, such as the Heteroscedacity Retention score for variance stabilization. Other stages,
such as baseline correction, may have more diculty accurately quantifying the success of
the baseline removal with the signal-to-noise ratio score. In this case, the global DE score
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will serve as an assistant to an imperfect local score. Section 3.1.3 includes a discussion of
all methods which are analyzed at each stage of preprocessing.
3.2.2 Variance Stabilization and Heteroscedacity
Heteroscedacity is dened as a relationship between the mean and variance of features.
This phenomenon can be observed by plotting the mean of feature intensities versus their
standard deviation. Ideally, we would like to see a constant amount of variance across all
intensities; thus the ideal plot would appear as a thin, horizontal cloud. A rough approach
to quantifying heteroscedasticity can use linear regression to t a line to points dened by
these standard deviations and means. The slope of the tted line indicates the degree to
which the heteroscedasticity remains in the data after the transformation. A atter slope is
better. Furthermore, the sum of the residuals indicates to what degree the line approximates
the cloud. A smaller sum would indicate that the variance-stabilizing transformation was
able to alleviate more of the heteroscedasticity. Although both the slope and residual errors
are important, it is not clear at what point the residual errors begin to matter more than
the slope. Figure 9 displays an example on the pancreatic cancer dataset. Although the
slope increases slightly, the residual error from a linear regression t improves greatly. This
is despite a slight increase in the slope from the raw data, which appears to be due mostly to
the poor choice of linear regression to t a quadratic relationship between mean and standard
deviation. In practice, the dierence between residual sums, combined with the small slope,
is probably enough to consider this transformation benecial to the data.
The Heteroscedacity Retention score (HR, equation 3.3) uses both the slope and sum
of residuals in evaluating the goodness of a variance stabilization procedure. The sum of
residuals is the dominant term in the equation. As the slope varies, additional penalties to
the score are added, up to a maximum of each residual. When the slope is exactly 0, no
penalty is incurred. A larger HR score indicates that the variance stabilization procedure
retains more heteroscedacity (is poorer). To evaluate a variance stabilization procedure, the
HR score is calculated after applying the procedure to the training set. The HR score is
then used in the SP curve to decide which variance stabilization method performs the best.
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HR =
dX
j=1
(Rj +Rj  (mreg)) , where
Rj = jjmregxj + breg   yjjj , where
mreg and breg are from linear regression on x and y
(3.3)
3.2.3 Baseline removal, smoothing and the Signal-to-noise ratio
Baseline removal and smoothing are two techniques for removing systematic sources of noise.
Baseline removal deals with constant background noise, while smoothing deals with a stochas-
tic uctuation between or within measurements. In the proteomic data, a baseline sub-
traction procedure restores the minimum of the measurements closer to 0. A smoothing
technique relieves the data of high-frequency noise which may appear as separate peaks or
valleys. Since these procedures remove information from the signal, the question is, how
much noise is removed in comparison to true signal?
The signal-to-noise ratio (typically calculated as the ratio of amount of true signal to
the amount of noise) seems to be a tting metric for answering this question. Since the
noise sources are dierent, interpreting how the signal is constructed can become a dierent
task. A baseline shift is an additive noise which has its own variation. This should be
considered separately from the noise which is targeted by smoothing techniques, and comes
from other sources of variation inuencing the signal (natural biological variation, chemical
or mechanical noise). In the case of baseline removal, we can dene the Baseline Signal-to-
Noise Ratio score (bSNR) as 1
d
Pd
j=1(vj   bj)=(vj   bj), where vj is the mean intensity
of feature j before baseline correction, bj is the mean intensity of the baseline at feature
j, and vj and bj refer to the standard deviations of the feature and baseline intensities,
respectively. In the case of smoothing, since we only need to worry about the variance
experienced after the baseline is considered, we can drop the bj terms and calculate the
Smoothing Signal-to-Noise ratio score sSNR simply as 1
d
Pd
j=1 j=j. Both scores estimate
the average signal-to-noise ratio resulting from a preprocessing method. These scores are
used to determine the SP curves for baseline correction and smoothing, respectively.
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The standard application of baseline correction and smoothing methods are analogous
to that of variance stabilization. For either stage, a set of methods is obtained. Each one is
applied to the training data at an appropriate time in the preprocessing sequence. The bSNR
score is obtained by using the chosen baseline removal method to calculate the baselines of
the proles. Likewise the sSNR score is computed using the resulting smoothed proles
from a smoothing method. Methods which have an acceptable PR score are retained for the
computation of their stage's SP curve.
3.2.4 Alignment and the coecient of variation
Alignment methods for proteomic proling often dier in the metrics used to evaluate the
quality of the alignment. In general, an alignment is considered successful if the variation
in features which should be identical is minimized. Therefore, methods have attempted
to characterize this variation in many ways, for example, by measuring the percentage of
variance captured by the rst two principal components of a PCA decomposition, or by
counting the percentage of proles in which a peak is detected. A hybrid between these
approaches is using the coecient of variation, computed as j j. This is a measure of the
dispersion of the variable, and should be smaller for measurements which should be identical.
Since many of the features in a proteomic prole will most likely not be discriminative, the
variation in most of the features should be minimized. Measuring the average coecient of
variation (ACoV= 1
d
Pd
j=1 j j) is a simple and eective metric for comparing the vastly
dierent alignment methods discussed above. After an alignment method is applied to
the training data, the ACoV score is computed. Since the ACoV score uses the mean
and standard deviation across the entire training data set, a single score for the method is
achieved. Methods with an acceptable PR score are used to compute the SP curve. The
mean aligned prole is used as a template, when needed, to align proles from testing data.
Occasionally, a poorly-designed method can enter the competition between other valid
methods. This method may allow the DE score to articially inate. For example, the
Moving-median smoothing routine available during the smoothing stage often performed
very well on the training data, but results on the test data were poor. Since smoothing occurs
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after baseline correction, many values are brought to 0 or close to 0. This means that the
median at many points in the prole will be 0 or very small. The moving median smoother
eectively erases much of the signal and smooths out several peaks if the sliding window
parameter is chosen poorly. The only part of the prole that remains similar is the start
of the prole (from 0 to roughly 3 kDa). This region in a MS proteomic prole is typically
referred to as the \junk" region, since many biological artifacts arise from the vaporization of
the analytical surface. These can include matrix molecules that are used to hold the biouid
on the analytical surface, portions of broken proteins or other contamination. Nevertheless,
this region contains thousands of features and can possess spuriously discriminative features.
If the rest of the prole has been smoothed to 0, the classier evaluating the DE score will
be forced to choose one of these spuriously discriminative features. However, the classier
cannot make a guarantee about the reliability of the feature appearing in the junk region
of future test cases. In this case, the SP-curve will choose a poor method, and the SAP
preprocessing will suer. This means the choice of the DE score must also be made carefully,
in order to try to weight robust preprocessing methods more heavily. In an eort to require
methods behave reasonably in their treatment of the data, I enforce the condition that
only methods which retain a number of \peak" features in the prole are considered for
application. This constrains the overall signal shape as a result of the preprocessing. A peak
detection routine is used to calculate positions of local maxima in the prole. These peak
features are often subselected in later stages of analysis as a rst pass of feature selection,
since they often vary the most, and therefore have a greater chance to be discriminative. If
a preprocessing routine does not retain at least P% of the peaks in the data, the method
is not allowed to be chosen as a preprocessing step. The Peak Retention score (PR) is an
indicator function which is 1 when the percentage of peaks retained is > P , and 0 otherwise.
In our experiments, P = 50%.
All of the above methods were implemented in MATLAB. The computational time de-
pends largely on the number of proles in the dataset, since many preprocessing routines
operate in a vectorized manner over the feature space, but work on individual proles at a
time. Since the automatic preprocessing procedure evaluates all preprocessing methods, the
worst-case complexity is dependant on the most resource-intensive method.
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3.3 EXPERIMENTS AND RESULTS
These experiments are intended to evaluate and compare the above methodologies for prepro-
cessing and demonstrate the eectiveness of automatic selection of preprocessing methods.
A owchart for these experiments is depicted in Figure 11. Briey, a comparison is made be-
tween three dierent preprocessing methodologies: no preprocessing (referred to as \Raw"),
the \baseline" preprocessing procedure discussed in section 3.3.1 and the \Standard Auto-
matic Preprocessing" method, where the SP curves are used to select methods, but no class
information is used during the individual preprocessing stages. The raw dataset is divided
into training and testing datasets. The Standard Automatic Preprocessing (SAP) procedure
uses only the training data until the 'best' preprocessing methods are known, and then these
are applied to the testing set.
A predetermined predictive model is trained using the preprocessed training data, and
classies the proles in the preprocessed testing set. The predictive model used in all exper-
iments for this section is a Support Vector Machine (SVM) with a linear kernel and `1-norm
penalized regularization. This model was chosen primarily because of its simplicity. Addi-
tional details about this model are given in 4.2.10. This model is learned from the training
set and applied to the testing set, and the resulting performance (in terms of Area under
the ROC curve, or AUC) is recorded and reported in the experiments below. The AUC
performance is averaged over 40 training/testing data splits. These splits are identical for
each of the three evaluated preprocessing procedures. I begin by describing the results of
applying the baseline and SAP procedures relative to performance on raw data.
3.3.1 Baseline Preprocessing
During the development of my research, a baseline preprocessing procedure was devel-
oped [25, 38, 39]. The baseline preprocessing procedure was originally designed to remove
what was perceived at the time as the "major" noise artifacts; the baseline shift and the
high-frequency noise running along the entire signal. This procedure was empirically de-
veloped primarily through visualization of the data before and after preprocessing. Sat-
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isfactory elimination of the noise artifacts on multiple datasets, coupled with satisfactory
downstream classication performance, suggested that this procedure was robust. The base-
line preprocessing procedure (not to be confused with baseline correction, the second stage
of preprocessing) is performed as follows:
 Variance stabilization - Cube-root transformation
 Baseline correction - Our baseline correction procedure uses a sliding window of 200
time-points to dene local minima. These points are then linearly interpolated to dene
the baseline. The area underneath the baseline is then subtracted from the uncorrected
signal.
 Normalization - Total Ion Current (TIC) normalization from 1500 to 20000 Daltons.
This constant is calculated individually for each prole.
 Smoothing - We use Gaussian-kernel smoothing to remove random noise in the signal.
The kernel aects 12 time-points at once.
 Alignment - Before alignment takes place, a mean reference prole is computed by av-
eraging all proles within a dataset. Proles are aligned individually to this reference
prole via dynamic programming within an area of 200 time-points.
In order to demonstrate the ability of the baseline preprocessing procedure alone, I also
evaluated classier performance with respect to the unprocessed, raw data. Thus, the pre-
dictive model was trained on raw data, and evaluated on the raw testing data proles. Table
2 displays the average area under ROC curves (AUC) for the predictive models evaluated
on the raw and baseline-preprocessed data.
Two important notions stand out from these results. The rst is that many of the
datasets possess a signal in the raw data which enables correct classication beyond ran-
domly guessing (random guessing would give AUC = 0.5). In the case of the prostate cancer
dataset, we know this is due to a spurious discriminative signal introduced during data
production [6]. The same eect may be present in other datasets, but this is dicult to
determine. On the other hand, it is encouraging to see signal from the raw data, as it would
be overly pessimistic to assume the mass spectrometer could not reveal true biological dier-
ences in the samples. Regardless of the authenticity of the signal, it is unclear whether the
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baseline preprocessing procedure is robust enough to consistently improve the performance
of downstream predictive models. Four out of the 14 datasets experience an average draw-
back from learning with baseline-preprocessed data. Of those datasets that do experience
an advantage, this advantage is greater than 0.03 AUC in only 2 cases. The prostate cancer
dataset deserves an exception, as the baseline procedure eectively attacks the spuriously
discriminative signal. As a result, the performance drops greatly (-0.11 AUC).
In some cases, the baseline preprocessing procedure results in a poorer average AUC
than possible with the raw data. This suggests that most raw data contains a "usable"
discriminative signal before any preprocessing takes place. The source of this discriminative
signal can be genuine biological information, or it can signify bias introduced in the data
production from lack of randomization between case and control sample processing, as was
the case in the prostate cancer dataset [6]. Regardless of the authenticity of the signal, it is
clear that our baseline preprocessing procedure is not suited to preprocessing the majority
of data. In almost all cases, the average AUC of resulting predictive models is lower than
those provided with the raw data.
The advantages imparted by the baseline procedure are small in all cases except the
Hepatitis and Vanderbilt Lung Maldi dataset. The addition of an additional 1% of AUC, as
well as largely overlapping condence bounds suggests that the baseline procedure may not
have much inuence on the development of predictive models. Regardless of the baseline
procedure's performance, we can see that it will not guarantee a positive advantage over using
the raw data, and we may still seek improvement through other preprocessing procedures.
3.3.2 Scored Standard Automatic Preprocessing
We assume raw protein proles have inherent discriminability, and the noise upon these
sources dier per dataset. The Standard Automatic Preprocessing (SAP) method attempts
to adjust to noise sources by choosing preprocessing methods at each stage which best
improve the discriminability of the data. Table 3 displays the average AUC achieved by
predictive models on the baseline-preprocessed and SAP-preprocessed data. The rightmost
column indicates the "advantage" of using the SAP procedure over the baseline procedure.
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This advantage is surprisingly negative for all except four datasets (COPD, ILD, Prostate
Cancer and Vanderbilt Lung MALDI, where the advantage is 0). Interestingly, three of these
datasets incur a disadvantage from using the baseline procedure as seen in Table 2, and the
advantage given to COPD by SAP is greater than the advantage given to COPD by the
baseline procedure. This suggests that the SAP procedure can indeed improve over xed
preprocessing procedures which are not robust enough for every dataset.
Unfortunately, for the rest of the datasets, the advantage from using SAP is negative, but
small (less than 0.05% AUC). For those datasets where SAP imparts a large disadvantage to
the predictive model, we might be concerned whether data production bias was present in
the raw data despite careful data production protocols. A small disadvantage may simply be
due to the limited pool of methods available to the SAP procedure. A larger pool of available
methods with alternatives for parameter settings may enable SAP to perform better than the
baseline procedure. These methods could be created on the y by performing a grid-search
over the parameter space, and allowing the results of that search to be used in the SP-curve
selection process explained in Section 3.3.1.
3.3.3 Discussion
The SAP procedure was meant to be an intelligent method for dealing with the uncertainty
of whether a static preprocessing procedure was proper for any mass spectrometry protein
proling dataset. Thus it was surprising to see that the baseline routine, created primarily
through experimental evaluation on the pancreatic cancer datasets, often outperformed SAP.
However, performance of the two methods is very close. There are many ways to explain
this behavior. The rst is that our local stagewise scores for each stage may not be very
strong. The heteroscedacity score for variance stabilization is a well-dened metric which
targets and quanties a noise in our signal. However, signal-to-noise ratio based metrics
such as those for baseline correction and smoothing are more general and need more of an
assist from the global DE score. The second reason why SAP may have underperformed
was due to the small pools of methods available. With few candidates for every stage, and
each stage including the method used in the baseline procedure, it is easy for SAP to select
38
part or all of the baseline procedure's methods. On a good note, this reinforces the strength
of our choices for the baseline preprocessing procedure we developed prior to SAP. Finally,
the raw data often possesses a usable discriminative signal by itself. This suggests that data
production bias may already be evident before any preprocessing begins. It is possible that
the baseline routine is actually failing to remove some or all of this production bias. SAP
is more aggressive in targeting the noise sources, and may remove more of these production
biases, but at the cost of not outperforming the baseline method in terms of predictive model
performance.
The following section discusses the performance of SAP with respect to the baseline
procedure in more detail.
3.3.3.1 Value of Individual Preprocessing Stages I re-evaluated the baseline and
SAP procedures by individual stage. This means that for each stage, only that stage of
preprocessing is performed, and the rest are skipped. The resulting data is then given to the
predictive model for training and evaluation. SAP in this case will only make a decision for
the method that will perform that stage.
Table 4 displays the AUC advantage contributed by each stage of baseline preprocessing
alone. No individual stage by itself stands out as the major contributor for every datsaet.
Instead, each dataset seems to be most favored by a dierent stage of preprocessing. In
general, variance stabilization (by cube-root transformation) seems to be the most harmless.
Table 5 displays the AUC advantage contributed by applying the method learned by SAP
for each stage. Similarities between this table and Table 4 would indicate that SAP tried
to choose the same method as baseline. This occurs most often with intensity correction, as
SAP frequently chose to use the baseline procedure's TIC-normalization routine. In other
stages, there was more variance in the methods selected by SAP. For those datasets where
SAP outperformed baseline (COPD, ILD, Prostate Cancer, Vanderbilt MALDI), there are
patterns for the selection of methods which may be indicative of the behavior of SAP.
Sometimes, a competing method provides a good t and it is chosen consistently. For
example, SAP repeatedly chose the generalized logarithm variance stabilization procedure for
the ILD dataset. The result was an improvement in the variance stabilization stage. For the
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COPD and Pancreatic Cancer II datasets, SAP alternated between performing no baseline
correction 50% of the time, and performing the monotone-baseline correction procedure the
other 50%. In the case of COPD, there was an average improvement, but the Pancreatic
Cancer II dataset suered from the mixture. It's possible that we got lucky with the mixture
with the COPD data, but the large drop in advantage for the Pancreatic Cancer dataset and
frequent choice to perform no baseline correction indicates that there was a poor selection
of baseline correction routines available for that dataset.
Interestingly, for only the two MALDI datasets (Diabetes and Vanderbilt Lung MALDI)
SAP chose to use the Log-transformation variance stabilization routine, and the average
advantage of applying this transformation improves over the baseline's performance for this
stage. This may suggest that the Log-transformation is better suited to data from the
MALDI technology. Provided a wide array of preprocessing methods and a variety of data
types, SAP may be able to establish xed preprocessing routines per data production tech-
nologies.
The large drops in advantage for the smoothing stage should not be alarming. Those
datasets which seem to suer end up having the Moving-median smoothing routine chosen
for them. This routine is simply not a good method. Since the median is used as the
replacement value within the sliding window, a large number of features are reset to what
the local baseline appears to be. The remaining features which stand out are likely to be
from the aforementioned \junk" region, which exhibits high variance. It becomes possible
to discriminate proles in the training set by chance (and also possibly because baseline
correction wasn't performed beforehand, the baseline shift between classes may be obvious).
However, these features are not guaranteed to be robust for future data, and the error rate
on the test set increases. For the other datasets, SAP chooses among the other smoothing
methods, and this has a more positive eect. The lack of baseline preprocessing makes a
dierence. For the Vanderbilt Lung WCX dataset, SAP chooses the moving median routine
if no baseline correction occurs, and as shown in Table 5, there is a large performance
dropo. However, when smoothed within the context of the entire preprocessing pipeline,
SAP chooses a mixture of the Savitzky-Golay smoothing method, the Fourier-transform
smoothing method and No smoothing. The results as shown in Table 3 indicate that, in
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fact, SAP can choose a capable method. Nevertheless, this underscores the importance of
the teamwork and order between preprocessing stages.
3.3.3.2 Eect of additional training data on preprocessing procedures I investi-
gated how preprocessing procedures behaved as a result of learning from more or less training
data. Of course, the baseline procedure doesn't \learn" anything, as its preprocessing meth-
ods are xed. However, in the previous subsection, it was apparent that changes in the
training data can cause a dierent selection of methods for SAP. This is evidenced by the
selection of a mixture of methods to perform stages of preprocessing over the 40 separate
train/test splits.
For the three \Vanderbilt Lung SPORE" datasets, I repeated the experiments from this
chapter using random subsamples of the training data, starting at 20%, and increasing by
steps to 35%, 50%, 65% and 80% of the training set. Figures 12, 13 and 14 display a plot of
each preprocessing method's average performance (in terms of AUC and their 95% condence
intervals) as a function of the available training data percentage. In the interest of time,
these experiments were measured over only the rst 10 out of 40 train/test splits. The test
set size remains constant (30% of original data), while the training set (70% of original data)
underwent subselection for each of the thresholds. The remaining data removed from the
training set is not used in any way. It can be seen that SAP performs close to the baseline
routine in terms of performance.
The procedures' performance trends upward as the training set size increases. This is
the expected behavior, since increasing the training set size increases the heterogeneity of
the training data. This in turn improves the robustness of the predictive model, resulting in
better predictive performance.
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Figure 4: MS proles for a single sample across 4 dierent sessions. Changes are apparent
in relative intensities of peaks.
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Figure 5: An example of misalignment or mass inaccuracy. Two proles from QA/QC
serum are shown. The signals are shifted so severely, the same feature (peak shape) in the
two signals correspond to dierent m/z positions.
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Figure 6: An example of baseline correction. Left panel: a prole with a baseline drift.
Right panel: the corrected prole. The additive component in the signal is removed and the
baseline is shifted to the zero intensity level.
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Figure 7: An example of intensity variation.
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Figure 8: An example of smoothing
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Figure 9: The eect of variance stabilization on heteroscedacity.
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Figure 10: Flowchart for evaluation of variance stabilization techniques.
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Table 2: Classier performance on raw versus baseline-preprocessed data.
Dataset Raw AUC Baseline AUC Advantage
COPD 0.5088  0.2510 0.5179  0.2319 0.0091
Hepatitis C 0.5933  0.2098 0.7120  0.1713 0.1187
ILD 0.5593  0.2610 0.5108  0.2591 -0.0485
Diabetes 0.6078  0.2340 0.6311  0.2190 0.0233
Melanoma I 0.5997  0.1767 0.5875  0.1916 -0.0122
Breast Cancer 0.5113  0.1487 0.5140  0.1366 0.0027
Pancreatic Cancer I 0.8963  0.0632 0.9050  0.0538 0.0088
Pancreatic Cancer II 0.8450  0.0833 0.8501  0.0726 0.0050
Prostate Cancer 0.9718  0.0163 0.8679  0.0571 -0.1039
Scleroderma 0.7164  0.1135 0.7216  0.1199 0.0052
UPCI Lung Cancer 0.7589  0.0737 0.7803  0.0713 0.0214
Vanderbilt Lung IMAC 0.8976  0.0419 0.9007  0.0454 0.0031
Vanderbilt Lung WCX 0.8584  0.0520 0.8858  0.0470 0.0274
Vanderbilt MALDI 0.8773  0.0504 0.8291  0.0617 -0.0481
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Table 3: Classier performance on baseline versus automatically preprocessed data
Dataset Baseline AUC SAP AUC Advantage
COPD 0.5179  0.2319 0.5460  0.2366 0.0281
Hepatitis C 0.7120  0.1713 0.6657  0.1911 -0.0463
ILD 0.5108  0.2591 0.5759  0.2441 0.0650
Diabetes 0.6311  0.2190 0.6025  0.2698 -0.0287
Melanoma I 0.5875  0.1916 0.5384  0.1961 -0.0491
Breast Cancer 0.5140  0.1366 0.4894  0.1481 -0.0246
Pancreatic Cancer I 0.9050  0.0538 0.8978  0.0663 -0.0072
Pancreatic Cancer II 0.8501  0.0726 0.8047  0.0836 -0.0454
Prostate Cancer 0.8679  0.0571 0.8695  0.0565 0.0015
Scleroderma 0.7216  0.1199 0.6630  0.1144 -0.0586
UPCI Lung Cancer 0.7803  0.0713 0.7307  0.0792 -0.0496
Vanderbilt Lung IMAC 0.9007  0.0454 0.8535  0.0573 -0.0472
Vanderbilt Lung WCX 0.8858  0.0470 0.8735  0.0475 -0.0123
Vanderbilt MALDI 0.8291  0.0617 0.8291  0.0679 0.0000
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Figure 12: Performance versus varied train set size, Vanderbilt Lung SPORE IMAC data
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Figure 13: Performance versus varied train set size, Vanderbilt Lung SPORE WCX data
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Figure 14: Performance versus varied train set size, Vanderbilt Lung SPORE MALDI data
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4.0 BIOMARKER DISCOVERY AND PREDICTIVE MODELING
4.1 BACKGROUND
High-throughput data technologies such as microarray and MS proling are producing large
quantities of genomic and proteomic data relevant for our understanding of the behavior
and function of an organism. This often includes the study of characteristics of disease
and its dynamics. Thousands of genes are measured in a typical microarray assay; tens
of thousands of measurements comprise a mass spectrometry proteomic prole. The high{
dimensional nature of the data demands the development of special data analysis procedures
that are able to adequately handle such data. Once these data are properly preprocessed, the
central question of this process becomes the identication of those features (measurements,
attributes) that are most relevant for characterizing the system and its behavior. We study
this problem in the context of classication tasks where our goal is to build a model that
lets us discriminate well among classes of samples, such as samples from people with and
without a certain disease. Discovering the features and building a model that uses them
are two intertwined processes. Neither task is straightforward, and both tasks have caveats
which must be addressed.
4.1.1 Feature selection
Feature selection is a process that aims to identify a smaller set of features from a large
number of features. Reducing the number of features is often done with the goal of simplifying
the process of discriminating between classes (groups) in the data. If the number of feature
candidates is small and the number of samples in the data set is large, feature selection is
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only rarely an issue. However, high-throughput data suers from the curse of dimensionality.
Data such as MS proles are naturally high-dimensional, with the number of features being
in the hundred-thousands, and the number of samples in a dataset often being less than
a hundred. By learning a model from data with so many features and so few samples, the
estimates of parameters of the model are unreliable and may cause overtting, a phenomenon
in which each datum is t so rigidly that the model lacks exibility for future data. To avoid
overtting, feature selection is applied to balance the number of features in proportion to
the number of samples.
Feature selection can be a one-shot process, but it can also include search problems
where multiple sets of features are evaluated and compared. However, high-throughput data
is naturally high-dimensional, with the number of features being in the hundred-thousands.
This makes the number of possible feature subsets prohibitively large to explore exhaustively.
Thus, ecient feature selection methods are typically sought. These features must also be
strongly correlated with the class membership (in this case, the disease state). At the same
time, the feature selection method must be correct in retrieving valid features.
Feature selection methods are typically divided into three main groups: lter, wrapper
and embedded methods. Filter methods rank each feature according to some univariate met-
ric, and only the highest ranking features are used; the remaining features are eliminated.
Wrapper algorithms [40] search for the best subset of features. These methods use a pre-
dictive model during the selection process to evaluate feature combinations. The wrapper
algorithm treats a classication algorithm as a black box, so any classication method can
be combined with the wrapper. Standard optimization techniques (hill climbing, simulated
annealing or genetic algorithms) can be used.
Embedded methods search among dierent feature subsets, but unlike wrappers, the
process is tied closely to a certain classication model and takes advantage of the model's
characteristics and structure. In addition to feature selection approaches, in which a subset
of original features is searched, the dimensionality problem can be often resolved via feature
construction. The process of feature construction builds a new set of features by combining
multiple existing features with the expectation that their restructured form improves our
chance to discriminate among the classes as compared to the original feature space.
58
4.1.2 Predictive modeling
Inextricably linked to the process of feature selection, predictive modeling refers to the uti-
lization of selected features for the classication of data points. A predictive model is any
mathematical function which maps data inputs to the class prediction. These models fall
into dierent types of their own, depending on how they use features to arrive at the clas-
sication. Each model type oers distinct advantages and disadvantages, which therefore
makes the choice of model important. Afterwards, the model must be validated to ensure
that its predictions truly reect the task at hand.
The primary objective of MS proteomic prole data analysis is to build a predictive model
that is able to determine the target condition (case or control) for a given patient's prole.
The predictive classication model is built from a set of SELDI-TOF- MS proles (samples)
assembled during the study. Each sample in the dataset is associated with a class label
determining the target patient condition (case or control) we would like to automatically
recognize. More formally, let D be a set of data pairs f< X1; Y1 >;< X2; Y2 >; : : : ; <
Xn; Xn >g, whereXi denotes inputs and Yi their designated outputs. In the case of proteomic
proles, Xi corresponds to prole readings (a vector of m/z intensity values) and Yi to the
class label: case or control (cancer or non-cancer). The objective is to build a predictive
model f : X ! Y that maps inputs (proles) to outputs (labels) such that the mapping
achieves high accuracy on future unseen proles. The classication (prediction) refers to the
process of applying the learned model f : X ! Y to proles and assigning the output label
for them.
4.1.3 Evaluation of Classier Methods
Our objective is to obtain models that achieve accurate predictions on future proles. Since
these examples are unobtainable, the ability of a classier model f to generalize to such
data is analyzed by splitting the available data into two subsets: a training set and a test
set. The training set consists of prole samples used to pick the features and learn the
model. The test set consists of prole samples withheld from the learning stage that are
used to approximate the ability of the classier to correctly predict future, yet to be seen,
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data. The complete performance picture is given by the confusion matrix that represents the
percentages of true positive (TP), true negative (TN), false positive (FP) and false negative
(FN) results. Secondary measures can be derived from the confusion matrix and include the
following:
Error rate (E) : FP + FN
Sensitivity (SN) : TP=(TP + FN)
Specicity (SP ) : TN=(TN + FP )
Positive predictive value (PPV ) : TP=(TP + FP )
Negative predictive value (NPV ) : TN=(TN + FN)
These performance measures can be computed for both the training set and test set.
Test set results are more important since they testify about how the classier generalizes to
future data. However, the dierences in training and testing performance statistics are still
important and carry useful information. For example, a large separation between training
and test errors is a sign of high variance of the estimates of the model parameters and
indicates potential overtting of the model.
The evaluation measures discussed above are appropriate indicators of a learning models
performance under a 0-1 loss function that reects the situation in which type 1 and type
2 errors (FP and FN) carry approximately the same weight. In the case where one type of
error should be weighted more heavily, a binary classier's performance can be captured and
examined independent of the loss function in terms of the receiver operating characteristic
(ROC). The separation of the two classes with dierent proportions of misclassication error
types is measured and summarized using the Area Under the ROC Curve (AUC) score [41].
A number of pitfalls apply to the evaluation of predictive models. The rst cautions
against a perfect predictive model. Because of the intrinsic stochasticity in MS prole data,
it may be impossible to obtain a model with zero expected error. Noise may simply obscure
or remove important diagnostic information in features. A perfect model cannot be expected
in this type of environment. Following this, even if we see a small error, we must be assured
that the training and testing set were not chosen to particularly demonstrate this small
error. Evaluation measures must be averaged over several, random data splits to reduce
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the chance of biasing the evaluation with a lucky training/testing set split. Cross-validation
techniques such as random subsampling, n-fold and leave-one-out validation can be applied
to average evaluation measures over multiple data splits. And nally, the choice of which
model to apply to a test set must be made solely on their performance on data in the
training set. If we consider a single test set, a collection of predictive models will generate
varying performance statistics. This denes a distribution of the performance statistic which
is conditioned on the test set. Choosing the model that corresponds to the best value of
this distribution is biased, since in most practical settings, the test data comes from the
future (for example, a new patient comes into the hospital and is proled). Since our test set
changes, our distribution of performance is no longer guaranteed to be identical, and thus
the best{performing model may not classify the future data well. Splitting the training set
further into an internal validation set can allow for estimation of generalization performance.
This process can be repeated multiple times and the results averaged in order to obtain a
good estimate of generalization performance.
4.2 RELATED WORK
4.2.1 Filter Methods
Filter methods perform feature selection in two steps. In the rst step, the lter method
assesses each feature individually for its potential in discriminating among classes in the
data. In the second step, features falling beyond some thresholding criterion are eliminated,
and the smaller set of remaining features is used. This score{and{lter approach has been
used in many recent publications, due to its relative simplicity. Scoring methods generally
focus on measuring the dierences between distributions of features. The resulting score is
intended to reect the quality of each feature in terms of its discriminative power. Many
scoring criteria exist. For example, in the Fisher score [42],
V (i) =
(+)(i)  ( )(i)
2(+)(i) + 
2
( )(i)
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the quality of each feature is expressed in terms of the dierence among the empirical means
of two distributions, normalized by the sum of their variances. Table 6 displays examples
of scoring criteria used in bioinformatics literature. Note that some of the scores can be
applied directly to continuous quantities, while others require discretization. Scores can be
limited to two classes, like the Fisher score, while others, such as the mutual information
score, can be used in the presence of 3 or more classes. For the remainder of this chapter,
we will assume our scoring metrics deal with binary decisions, where the data either belong
to a positive (+) or negative (-) group.
Table 6: Examples of Univariate Scoring Criteria for Filter Methods
Criterion References
Fisher Score [43,44]
SAM Scoring Criterion [45,46]
Student t{test [47,48]
Mutual Information [49]
2 (Chi Square) [50,51]
AUC [52]
J{measure [53]
J5 Score [54]
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4.2.2 Univariate feature selection
Dierential scores allow us to individually rank all feature candidates. However, it is still not
clear how many features should be ltered out. The task is easy if we always seek a xed set of
k features. In such a case, the top k features are selected with respect to the ordering imposed
by ranking features by their score. However, the quality of these features may vary widely, so
selecting the features based solely on the order may cause some poor features to be included
in the set. An alternative method is to choose features by introducing the threshold on the
value of the score. Unfortunately, not every scoring criterion has an interpretable meaning,
so it is unclear how to select an appropriate threshold. One solution is to transform a scoring
metric to a p-value. Regardless of whether the score is parametric (Fisher score, t-test) or
nonparametric (wilcoxon rank-sum test), any score can be transformed into p-values through
a permutation test (see section 5.1.1) For example, if the p{value threshold is 0.05 then there
is a 5% chance the feature is not dierentially expressed at the threshold value. Such a setting
allows us to control the chance of false positive selections. These are features which appear
discriminative by chance.
4.2.3 Multivariate feature set selection and controlling false positives
A natural step after doing univariate feature selection is to consider what combinations of
features can work well. The high{throughput nature of biological data sources necessitates
that many features (genes or MS{prole peaks) be tested and evaluated simultaneously.
Unfortunately, this increases the chance that false positives are selected. To illustrate this,
assume we measure the expression of 10,000 independent genes and none of them are dier-
entially expressed. Despite the fact that there is no dierential expression, we might expect
100 features to have their p{value smaller than 0.01. An individual feature with p{value 0.01
may appear good in isolation, but may become a suspect if it is selected from thousands
of tested features. In such a case, the p{value of the combined set of the top 100 features
selected out of 10,000 is quite dierent. Thus, adjustment of the p{value when performing
multiple tests in parallel is necessary.
The Bonferroni correction adjusts the p{value for each individual test by dividing the
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target p{value for all ndings by the number of ndings. This assures that the probability
of falsely rejecting any null hypotheses is less than or equal to the target p. The limitation
of the Bonferroni correction is that it operates under the assumption of independence and
as a result it is becomes too conservative if features are correlated. Two alternatives to the
Bonferroni correction are oered by: (1) the Family{wise Error Rate method (FWER, [55])
and (2) methods for controlling the False Discovery Rate (FDR, [45, 56]. FWER takes
into account the dependence structure among features, which often translates to higher
power. [56] suggest to control FDR instead of the p{value. The FDR is dened as the mean
of the number of false rejections divided by the total number of rejections. The Signicance
Analysis of Microarrays (SAM) method [46] is used as an estimate of the FDR. Depending
on the chosen threshold value for the test statistic T , it estimates the expected proportion
of false positives on the feature list using a permutation scheme.
4.2.3.1 Multivariate lters In the experiments below, a set of four multivariate lters
are evaluated.
 Leave-one-out AUC Drop Score (LOO-AUC)
This score is calculated by evaluating a predictive model Mall on a complete set of
features. One at a time, feature i is removed from the model and retrained. The AUC of
the retrained model Mi is evaluated over 10-fold cross-validation. The score for feature
i is given as:
LOO-AUCi = AUC(Mall)  AUC(Mi) (4.1)
 Random Forest Importance Score (RF-Import)
This score uses Random Forests [57] to calculate the importance score for each feature.
The importance score for feature i is given as:
RF-Importi =
# times feature i is selected as a splitting feature in a tree
total # trees in forest
(4.2)
where the selection of a splitting feature is done to optimize the Gini gain of a particular
tree [58].
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 `1-regularization Score (`1-Reg)
This score uses the `1-regularized Elastic Net [59] to calculate the average regularization
coecient of each feature. The Elastic Net attempts to solve a linear regression problem
in the following general form:
min
2Rd
1
2N
NX
i=1
(yi   0   xTi )2 + P() (4.3)
where
P() =
dX
j=1

1
2
(1  )2j + jjj

(4.4)
is the elastic-net penalty, which involves the `1-norm. The penalty is weighted by 
over an optimization process. As this penalty changes over the schedule L of 1   L ,
weights for features in l become more sparse, until only the most important features have
the largest weight. For a sequence L = 1;    ; L and associated regression coecients
 = 1;    ;L learned during the course of training an Elastic Net, the `1-regularization
score is given as:
`1-Regi =
LX
l=1
ll;i (4.5)
 Adaptive Lasso `1-regularization score (Ad-Lasso)
The adaptive lasso [60] is a technique which builds upon lasso regression [61] and is
a similar approach to the Elastic Net. However, during the optimization of 4.3, we
will instead weight each feature of x proportionally to its regression coecients from
an ordinary-least-squares regression (Although, since OLS has trouble with data having
high correlation, I use ridge regression instead). The Adaptive Lasso score is given as:
Ad-Lassoi = min

kky  
X
j = 1dxiwijkk2 + 
dX
j=1
jjj (4.6)
where wi = 1=^i, ^ is obtained from ridge regression of X on Y .
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4.2.4 Wrapper Methods
Wrapper methods [40] search for the best feature subset in combination with a xed classi-
cation method. The goodness of a feature subset is determined using internal{validation
methods, such as, k{fold or leave{one-out cross{validation [62]. Since the number of all
combinations is exponential in the number of features, the eciency of the search meth-
ods is often critical for its practical acceptance. Dierent heuristic optimization frameworks
have been applied to search for the best subset. These include: forward selection, backward
elimination [63], hill{climbing, beam search [64], and randomized algorithms such as genetic
algorithms [65] or simulated annealing [66]. In general, these methods explore the search
space (subsets of all features) starting with no features, all features, or a random selection
of features. For example, the forward selection approach builds a feature set by starting
from an empty feature set and incrementally adding the feature that improves the current
feature set the most. The procedure stops when no improvement in the feature set quality
is possible.
4.2.5 Embedded Methods
Embedded methods incorporate variable selection as part of the model building process. A
classic example of an embedded method is CART (Classication and Regression Tree, [67]).
CART searches the range of each individual feature to nd the split that optimally
divides the observed data into homogeneous groups (with respect to the outcome variable).
Beginning with the resulting subsets of the variable that produces the most homogeneous
split, each variable is again searched across its range to nd the next optimal split. This
process is continued within each resulting subset until all data are perfectly t by the resulting
tree, or the terminal nodes have a small sample size. The group constituting the majority of
the samples in each node determines the classication accuracy of the derived terminal nodes.
Misclassication error from internal cross{validation can be used to backprune the decision
tree and optimize its projected generalization performance on additional independent test
samples.
Regularization or shrinkage methods [61, 68] oer an alternative way to learn classi-
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cations for data sets with large number of features but small number of samples. These
methods trim the space of features directly during classication. In other words, regulariza-
tion eectively shuts down (or zeros the inuence of) unnecessary features. This is another
way to eectively deal with correlations in the data.
Regularization can be incorporated either into the error criterion or directly into the
model. Let w be a set of parameters dening a classication model (e.g., the weights of a
logistic regression model), and let Error(w;D) be an error function reecting the t of the
model to data (e.g., least{squares as likelihood{based error). A regularized error function is
then dened as:
ErrorReg(w;D) = Error(w;D) + jjwjj;
where  > 0 is a regularization constant, and jj:jj is either the L1 or L2 norm. Intuitively, the
regularization term penalizes the model for nonzero weights so the optimization of the new
error function drives all unnecessary parameters to 0. Automatic Relevance Determination
(ARD, [69, 70]) achieves regularization eects in a slightly dierent way. The relevance of
an individual feature is represented explicitly via model parameters and the values of these
parameters are learned through Bayesian methods. In both cases, the output of the learning
is a feature{restricted classication model, so features are selected in parallel with model
learning.
Regularization eects are at work also in one of the most popular classication frame-
works these days: the support vector machine (SVM) [71, 72]. The SVM denes a linear
decision boundary (hyperplane) that separates case and control examples. The boundary
maximizes the distance (also called margin) in between the two sample groups. The eects of
margin optimization are: unnecessary dimensions are penalized; only a small set of samples
(support vectors) are critical for the separation. Both of these help to ght the problem of
model overtting.
4.2.6 Feature construction
Better performance can be often achieved using features constructed from the original input
features. Building a new feature is an opportunity to incorporate domain specic knowledge
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into the process and hence to improve the quality of features. For example, we have already
seen that correlated features exist in proteomic data. Some of these sets of correlated features
may relate to proteins or peptides which have similar biological function, or are activated in
the same cellular signaling pathway. While incorporating this information is made dicult
due to the limited information in TOF-MS data, an assembly of correlated features may
still share a relationship. Machine learning methods exist which can construct new features
from existing ones, in order to represent inter-feature relationships more succinctly. These
methods include clustering, linear (ane) projections of the original feature space, as well
as more sophisticated space transformations such as wavelet transformation. These feature
construction approaches are briey reviewed below.
4.2.7 Clustering
Clustering groups data components (data points or features) according to their similarity.
Every data component is assigned to one of the groups (clusters); components falling into the
same cluster are assigned the same value in the new (reduced) representation. Clustering
is typically used to identify distinguished sample groups in data [73, 74]. In contrast to
supervised learning techniques that rely heavily on class label information, clustering is
unsupervised and the information about the target groups (classes) is not used. From the
dimensionality reduction perspective, the groups identied by clustering dene a new set of
features and their values.
Clustering methods rely on the anity matrix { a matrix of distances between data
components. The anity matrix can be built using one of the standard distance metrics
such as Euclidean, Mahalanobis, Minkowski, etc, but more complex distances based on, for
example, functional similarity of genes [75], are possible. Table 21 (see Appendix B) gives a
list of some standard distance metrics one may use in clustering.
Clustering methods such as k{means clustering [76, 77], and hierarchical agglomerative
clustering [78, 79]have been applied to group features in high-throughput data. When clus-
tering features, the dimensionality reduction is achieved by selecting a representative feature
(typically the feature that is closest to the cluster center, [80]), or by aggregating all features
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within the cluster via averaging to build a new (mean) feature. If we assume k dierent
feature clusters, the original feature space is reduced to a new k-dimensional space. An ex-
ample method of feature clustering is to cluster features based on intra{correlation, and use
the cluster center as a representative. Grouping together the most intra-correlated features
removes redundancy in the data and exposes more diverse features.
4.2.8 Principal Component and Linear Discriminant Analysis
Principal Component Analysis (PCA), [26] is a widely used method for reducing the dimen-
sionality of data. PCA nds projections of high dimensional data into a lower dimensional
subspace such that the variance retained in the projected data is maximized. Equivalently,
PCA gives uncorrelated linear projections of data while minimizing their least square re-
construction error. Additionally, PCA works fully unsupervised; class labels are ignored.
PCA can be extended to nonlinear projections using kernel methods [81]. Dimensionality
reduction methods similar to PCA that let us project high dimensional features into a lower
dimensional space include multidimensional scaling (MDS) [82] used often for data visual-
ization purposes or independent component analysis (ICA) [83]. The technique has been
used extensively for classication of proteomic [84] and microarray data [85,86], in addition
to many other highly dimensional data types.
Principal component analysis identies ane (linear) projections of data that maximize
the variance observed in data. The method operates in a fully unsupervised manner; no
knowledge of class labels is used to nd the principal projections. The question is whether
there is a way to identify linear projections of features such that they optimize the dis-
criminability among the two classes. These techniques, termed Discriminative projections
include Fisher's linear discriminant (FLD) [41], linear discriminant analysis [61] and more
complex methods like partial least squares (PLS) [87,88].
Take for example, the linear discriminant analysis model. The model assumes that cases
and controls are generated from two Gaussian distributions with means ( ), (+) and the
same covariance matrix . The parameters of the two distributions are estimated from data
using the maximum likelihood methods. The decision boundary that is dened by data
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points that give the same probability for both distributions is a line.
The linear projection is dened as:
w =  1(+    );
where  ; ~+ are the means of the two groups and  is the covariance for both groups,
where p(xjy)  N(;).
4.2.9 Wavelets
Wavelets are families of basis functions which are used as "building blocks" to approximate
more complex functions. Wavelets have been used to approximate the complex MS protein
prole data, since they appear as a superimposition of multiple wavy signals. The most
popular wavelet transformation for MS protein prole data is the Discrete Wavelet Transform
(DWT). In this wavelet model, the approximation for a curve c(t) is given by:
c(t) =
X
k
sJ;kJ;k(t) +
JX
j=1
X
k
dj;k j;k(t) (4.7)
The functions J;k(t) and  J;k(t) are called mother and father functions, respectively. In
the DWT method the mother and father wavelet functions are identical, so (t) =  (t) =
2 j=2(2 jt   k). The j and k parameters control how these basis wavelet functions are
translated and dilated. J controls the number of scales, and k 2 1; :::; Kj is the number
of coecients at scale j. A scale of j means that each wavelet coecient is spaced 2j time
units apart. The wavelet coecients sJ;k and dJ;k reect smooth and detailed behavior of the
function at scale j. The DWT calculates these components through a pyramid algorithm [89],
which transforms a datapoint into a vector of wavelet coecients. Since this is a linear
transformation, it can also be computed through matrix multiplication of a wavelet matrix
W , which is implicitly computed during the DWT. This makes it convenient to exchange
data points with wavelet coecient representations at will.
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4.2.10 Classier Models
Many classier models and learning approaches have been developed and are available for
these classication tasks. Their common property is that they represent the mapping be-
tween inputs and outputs. For example, classiers such as CART [67] (described briey in
section 4.2.5 and C4.5 [90] extract classication rules in terms of decision rules or trees. Some
methods, including logistic regression, [61] determine the output by a learning set of param-
eters used to weight individual inputs. Other examples include support vector machines
(SVM, [71,72,91], the naive Bayes classier [92, 93] and multilayer neural networks [94{96].
In general, classication models attempt to partition a high-dimensional space of prole
measurements (x), such that the case and control proles fall into distinct regions. Many
existing models, such as logistic regression or the SVM, achieve the partitioning by dening
a linear decision boundary: a hyperplane that separates a high-dimensional input space x
into two subspaces. Dierent models may use dierent optimization criteria.
For example, the SVM is a technique that computes a decision boundary between two
classes by restricting its attention only to the samples (support vectors) that are most critical
for separating the two groups. In our case, the decision boundary is a hyperplane that is
maximally distant from the support vectors on either side of the hyperplane. The hyperplane
is dened as:
wTx+ w0 = 0 (4.8)
with parameters w and w0, where w0 is the distance between the support vectors of each
class, and w is the normal to the hyperplane. The parameters of the model may be learned
through quadratic optimization with Lagrange parameters [72]. Then, the decision boundary
is given by:
w^Tx+ w0 =
X
i2SV
^iyi(x
T
i x) + w0 (4.9)
where i are Lagrange parameters obtained through the optimization process and yi repre-
sents the class label for xi with two possible values,  1 or 1. Note that only samples that
correspond to support vectors (SV) dene the hyperplane boundary, to which is normal.
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The decision made by the classier for a new input x is given by:
y^ = sign
"X
i2SV
iyi(x
T
i x) + w0
#
(4.10)
which corresponds to the side of the hyperplane on which the datapoint occurs, either
positive or negative. The choice of the separating hyperplane in the SVM algorithm incor-
porates regularization eects which makes it less susceptible to overtting [71].
4.2.11 Kernels
The dual problem formulation depends on the dot product (xi  xj). The dot product is a
measure of similarity between the two vectors xi and xj. The kernel trick [72] is used to
map input vectors of arbitrary structure to a (potentially) higher-dimensional feature space
through a replacement function called a kernel. The kernel function K(xi;xj) replaces (xi 
xj) with (xi)(xj) where the mapping function (xi) maps the vector xi to a new feature-
space. The "trick" is that the kernel function implicitly performs the mapping that would
be done by , which reduces the complexity incurred by complex  functions. Computing
the kernel function instead redenes distances between points in the mapped feature space.
The SVM draws a linear boundary in this new feature space, and upon returning to the
original space, this boundary becomes bent into a nonlinear decision boundary. Figure 15
depicts nonlinear decision boundaries generated by nonlinear kernels. Certain kernels, such
as a radial-basis kernel (bottom right), happen to suit this particular classication problem
better than the standard linear kernel (top left).
This example demonstrates that dierent kernels may be helpful for classifying certain
types of data. Special-purpose kernels have been constructed for many types of data, includ-
ing strings, trees [97] and graphs [98]. These kernels take advantage of structure in the data
to facilitate comparisons between data points. When such a kernel is unknown, one option
is to choose from a number of popular choices. Some work has been done in automatically
selecting the best kernel function from a list [99, 100]. The process works by extracting
general features (meta-data) about each dataset. The meta-data is comprised of statistical
,distance-based and distribution-based measures which measure various qualities about the
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Figure 15: Example of SVM with dierent kernels on the same dataset.
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data. A rule-learning approach is then taken to determine which qualities best reect the
applicability of a particular kernel. These rules are then applied to a test set in order to
decide an appropriate kernel function.
An alternative is to learn an appropriate kernel. Some more recent work involves learning
a kernel function [101, 102]. The basic approach involves learning a linear combination of
kernels. Multiple basis kernels are used to project features into individual feature spaces.
Weights for each kernel are used to optimize the margin as in the standard linear SVM
approach. These weights can also be optimized for agreement to an ideal kernel, but the
optimization method does not take misclassication error into performance, and can overt.
A quality-of-t metric was developed [103] to resolve this issue, which further enabled a
search over many kernels while penalizing complex kernels. The idea of a hyperkernel [103]
was created to enable searches over parameters which govern the kernels. This potentially
enables a kernel to be created from an innite amount of basis kernels, but these combinations
are always kept in check by a regularization quality.
The hyperkernel is enabled by a mathematical concept called the Reproducible Kernel
Hilbert Space (RKHS). A Hilbert Space is any arbitrary-dimensional space, such as Euclidean
space. However, we may want to consider spaces which are bigger or smaller, and where
the idea of a "point" can carry a dierent meaning. Briey, data points can be mapped
to individual kernel functions, for example, Gaussians with the datapoint as the centroid.
Thus, a 'point' in the space is really a continuous functional. Re-representing data points
in this way complicates the process of measuring distances between them in this space,
since the Gaussian functions are continuous. Instead of computing a distance, the RKHS
allows computation of dissimilarities between these re-representations. Through the kernel
trick, evaluating the dot product between these function re-representations ends up being
as simple as evaluating the original kernel function of the two points, hence "reproducible
kernel". A Hyper-RKHS (HRKHS) is a space where each point is its own RKHS. The
dierences between each point can be dierent parameterizations of the kernel functions,
and computing the kernel function between two points calculates the dissimilarity between
the involved RKHS spaces (namely, the dierence in their parameterization of their own
kernel function). Thus, similar datapoints are t with similarly parameterized kernels, and
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since the similarity metric is already computed, we need not worry about what happens in
relation to the nested RKH Spaces. The result is that the decision boundary is optimized
across all classes of kernels.
4.3 METHODS
High-throughput data naturally has many features, and it is important to distinguish those
which are informative from the rest. Predictive models built on these features should strive to
use the maximum amount of information made available. At the same time, the researcher
should not be forced to do a post-hoc selection of feature selection and predictive model
combinations - a certain level of condence should be seen that good combinations can be
arrived at automatically.
This dissertation intends to explore and analyze the aspects which make feature selection
techniques and predictive models better at dealing with high-throughput data, with partic-
ular emphasis on MS proteomic prole data. Often times, a feature selection technique is
employed for reasons that it simply improves the prediction error on a dataset, and does not
often give any insight as to why this improvement is experienced. Perhaps alternative meth-
ods with similar properties exist, which can perform equally as well. The hypothesis is that
feature selection techniques which deal explicitly with correlation perform signicantly better
(in terms of classication performance) than those methods which do not. The dierence
between correlation-aware techniques may be negligible. The evaluation of these techniques
is demonstrated on both biological and simulated data.
Using a correlation-aware feature selection process is only half a step of the analysis.
The other half comes from building a predictive model which is robust enough to deal with
multiple classication problems, such as dierent diseases, yet specic enough to incorporate
knowledge about the data type which may aid the classication. For example, classiers
which assume conditional independence between all features, such as Naive Bayes, may
perform poorly on datasets where many features are interdependent. The experiments in
section 4.4.1 show that indeed, this is the case. The SVM approach is known to work well in
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spite of highly correlated features [61, 104]. Thanks to the kernel trick, I can create varied
SVMs which are dierent predictive models, but still keep the advantage of the SVM against
correlated features. Varying the kernel may result in improved classication performance,
and providing a kernel which explicitly expresses valuable aspects of MS proles may be the
best option. The hypothesis is that a kernel designed specially for proteomic data can perform
equally as good as choosing among popular kernels, or learning a kernel. The hypothesis is
tested through evaluations on biological data.
4.3.1 Decorrelating Feature Selection
To keep the feature set small, the objective is to diversify the features as much as possible.
The selected features should be discriminative as well as independent from each other as
much as possible. The rationale is that two or more independent features will be able
to discriminate the two classes better than any of them individually. Each feature may
dierentiate dierent sets of data well, and independence between the features tend to reduce
the overlap of the sets. Similarly, highly dependent features tend to favor the same data and
thus are less likely to help when both are included in the panel. The extreme case is when
the two features are exact duplicates, in which case one feature can be eliminated. Figure
16 displays the phenomenon of correlated features in the pancreatic cancer dataset. Many
of the features are correlated with any other feature by .8 or more. Filtering out highly
correlated features therefore signicantly reduces the amount of work needed to search for
good, diverse features.
Correlation lters [25, 105] try to remove highly correlated features since these are less
likely to add new discriminative information [80]. Various elimination schemes are used
within these lters to reduce the chance of selected features being highly correlated. Typi-
cally, correlation lters are used in combination with other dierential scoring methods. For
example, features can be selected incrementally according to their p{value; the feature to be
added next is checked for correlation with previously selected features. If the new feature
exceeds some correlation threshold, it is eliminated [25].
The decorrelation lter method is designed to reduce the eect of correlations in selecting
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Figure 16: Correlation coecient matrix between features
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discriminative features. Multiple maximum-allowed correlation thresholds are used to create
queues for features. Features in each queue can only be correlated with feature selected
up to that stage by the MAC threshold. Since a correlated feature may still be able to
contribute to the analysis, highly correlated features might still be selected. However, the
overall diversity of the features should be improved.
Applying univariate analysis to each prole position allows us to rank the ability of each
position to discriminate between case and control proles. However, we are interested in
building classiers that utilize more than one feature and give the best possible classication
performance. One simple solution to this problem would be to pick the top candidates
determined by a univariate score. However, such a choice is not good for proteomic spectra
in which signals at many positions, are highly correlated. This is illustrated in Figure 17
(left) that shows the heat map of the top 15 Fisher score positions for the pancreatic dataset.
Note that all these positions appear to be good individual discriminants of case and control
samples. However, all of them look alike, come from the same neighborhood and their signals
are highly correlated (pairwise correlations are  0.97). Since such highly correlated signals
are less likely to improve the discriminability of case and control samples, one may consider
removing high correlates from the feature set. This goal can be achieved via correlation
ltering that combines the removal of high (absolute value) correlates in feature sets rank-
ordered using univariate scores. The strategy uses a maximum allowed correlation (MAC)
threshold and incrementally selects the highest ranked feature such that its (absolute value)
correlation with any of the previously selected features is below MAC. Figure 17 (right) shows
the heat map for the top 15 Fisher score positions for the pancreatic data after correlation
ltering with MAC=0.6. Prole positions dier widely giving us more opportunities to nd
good overall discriminants.
Experimenting with MAC thresholds on multiple cancer datasets (Pancreatic, Melanoma,
Prostate, Ovarian and Lung cancer data) we have found that enforcing MAC thresholds tends
to improve the quality of the feature set, but the best MAC value varies from dataset to
dataset and it is dierent also for dierent univariate criteria. Thus, instead of searching for
the best MAC we have developed a new feature selection procedure that combines the advan-
tages of univariate feature scoring and de-correlation. Figure 18 gives a visual representation
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Figure 17: Left Panel: Heatmap of the top 15 prole positions (features) selected by the
Fisher score, without correlation ltering. Right Panel: Heatmap of the top 15 Fisher
features with correlation ltering (MAC=0.6). The top and bottom rows are case and
control samples, respectively.
of the "parallel MAC" feature selection technique.
The parallel MAC feature selection procedure rst rank-orders features using a given
univariate dierential expression score and then builds a feature set incrementally by choosing
the best new feature from among multiple candidate features, each of them being the highest
univariate score candidate at some xed MAC level. The best feature is determined using a
internal cross-validation scoring (10-fold is the default) based on a simple classication model
such as a Nave Bayes or a linear Support Vector machine. Note that such an approach is
dierent from the classic greedy wrapper approach that must scan and evaluate all (~60,000)
possible candidate features. In contrast to this, the parallel MAC model scans and evaluates
only feature candidates that correspond to highest ranked candidates at dierent MAC levels
and the number of candidates com-pared depends on the number of MAC levels tracked. The
resolution of the method may be con-trolled by increasing or decreasing the number of MAC
thresholds.
This is one example of a method which directly interacts with the features to ensure that
correlations are limited. PCA and wavelet transformation, discussed above, also deal explic-
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Figure 18: Schema of the parallel MAC feature selection technique.
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itly with correlations by constructing features which tend to vary together. Certain feature
selection techniques either assume that all features are independent, as in univariate feature
selection strategies or embedded methods using classiers which ignore feature dependencies.
The fact of the matter is, discriminatory information must be found while dealing with the
overwhelming amount of correlation present in raw MS prole data. However, with limited
empirical knowledge about which features interact with each other, the complexity of feature
selection seems limited.
With this in mind, I investigate whether any feature selection technique which accounts
for correlations in the data can perform signicantly better than the popular techniques which
do not. Moreover, I investigated whether any technique taking advantage of correlations
is statistically indistinguishable from other correlation-aware methods. In this case, the
parallel MAC method would do just as well as PCA, wavelet transformations, or any other
decorrelating method at selecting discriminative features.
Feature selection techniques are divided into two groups - those that handle correlations
and those that do not. The techniques are taken from those discussed above throughout this
chapter. 40 splits of training and testing data are performed. On each split, all feature se-
lection techniques from either group are applied to the training data. The resulting features
are fed to a linear SVM. The choice of a linear SVM in this situation is to minimize the
complexity of the classier as much as possible. The classier is only used as a general eval-
uation technique for widely varied methods of feature selection. Later on, in the evaluation
of classiers, this process can be repeated to determine if either group of feature selection
techniques inuences the best way to decide which classier to use. The error rate of the
classier is used to evaluate the feature selection method. Two distributions of errors are
created - those resulting from feature selection ignoring correlates, and those resulting from
feature selection accounting for correlates.
The Mann-Whitney U-test [106] is a nonparametric test which estimates the likelihood
that two samples of data come from the same distribution. The null hypothesis in this case
is that the distributions of classication performances (errors) from the correlate-ignoring
and the correlate-aware groups are identical. The U-test determines the U -value (a p-value
analog) associated with the distance between the two distributions. The nonparametric
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nature of the test is necessary because the distributions of the errors are unknown and not
assumed to follow any predened distribution. A smaller U -value indicates that the null
hypothesis is less likely to be true. In this case, I am expecting to reject the null hypothesis;
this would suggest that the dierence between error distributions of the two feature selection
groups is more likely to be statistically signicant.
I am also interested in determining whether any of the correlate-aware feature selection
methods are statistically distinguishable from one another. For this, the Kruskal-Wallis non-
parametric one-way test [107] is used. It is essentially an extension of the Mann-Whitney
U-test to 3 or more groups. This test determines whether the medians of the groups (dis-
tributions of errors given by the individual correlate-aware feature selection methods) are
equal. In this case, the null hypothesis is that these distributions of errors are identical,
because they have equal medians and similarly scaled variances. I expect that it will be very
hard to reject this null hypothesis at a reasonable signicance level.
4.3.2 Kernel Comparison
The Support Vector Machine is a robust classier framework which can be adapted to many
types of data. However, several alternatives exist to the popular linear kernel which may
be more eective at classifying MS protein prole data. The questions are, does a suitable
kernel exist for MS protein prole data, and if so, can it be chosen automatically? The
following describes a comparative study to determine whether a suitable kernel for this data
can be discovered. Three separate approaches are presented.
4.3.3 Automatic Selection Among Predened Kernels
The rst approach is to learn rules about datasets which indicate the best classier to use.
This approach is similar to that taken in [99], where various statistical measures (henceforth
referred to as dataset characterization statistics) are used to characterize all datasets available
for training. The datasets are then classied using a handful of predened kernels. Datasets
are grouped based on which kernel performs best, and a rule-learning classier (CART or
C4.5) is used to generate relationships between the datasets' characterization statistics and
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the best performing kernel. The testing dataset's characterization statistics are calculated
and the learned rules are applied to determine the best kernel to use for classifying the
data. A list of characterization statistics is given in Appendix B, Table 23. Some popular
kernels are given below: The dth order polynomial kernel (Equation 4.11a), radial basis
kernel (Equation 4.11b), spline kernel (Equation 4.11c), multiquadratic kernel (Equation
4.11d) and Laplacian kernel (Equation 4.11e). Algorithm 1 describes the process formally.
K(Xi; Xj) = (hXTi Xji+ 1)d (4.11a)
K(Xi; Xj) = exp( jjXi  Xjjj
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The benet of this approach is that heterogenous data can be used to enhance learning
about the proper choice of kernels. Thus, with additional time and data, this approach has
the possibility of becoming stronger. However, if none of the predened kernels are able to
capture any salient relationships about features of the data, then this technique will struggle.
The remaining two approaches focus on constructing more appropriate kernels, in the case
that one is not readily available.
4.3.4 Learning a Customized Kernel
A second approach is to learn the kernel through Hyperkernels. The hyperkernel optimizes
a decision boundary of points over a class of kernels. However, the kernels selected from
the list above are not in the same class (that is, governed by the same set of parameters).
A suitable class of kernels would be, for example, several radial basis kernels with dierent
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values of . Still, in the previous approach, we made several distinct kernels available in the
hopes that their diversity would allow better classication of datasets. By sticking to a class
of kernels which are only radial basis functions, we take away a lot of the diversity. Instead,
we might consider the wealth of distance metrics already dened for clustering techniques in
table 21. In any kernel function which incorporates Euclidean distance (for example, those
in Equations 4.11b and 4.11d), we can perhaps substitute any of the clustering distance
metrics and therefore create a class of kernels limited only by the number of available distance
metrics. To construct a hyperkernel from this new class of metrics, a RKHS is represented
using a kernel function from this class. Optimizing the decision boundary in the hyperkernel
results in a decision boundary which is a linear combination of boundaries resulting from
the diverse distance metrics in the constituent RKH Spaces. Algorithm 2 summarizes the
evaluation procedure for evaluating a hyperkernel learned from the proteomic data.
4.3.5 Learning the Hyperkerneled SVM
The hyperkernel using linear combinations of kernels is dened as [103]:
k(xp; xq) =
mX
i;j=1
ij
nX
l=1
clkl(xi; xj)kl(xp; xq) (4.12)
where k 2 k1; :::; kn is a kernel function from the class of kernels considered. c 2 c1; :::; cn
are the weights for the linear combination of kernels. i;j are variables to be optimized to
minimize the Qreg (Regularized Quality of t) loss function dened in [103]:
Qreg = min

min

1
m
mX
i=1
max(0; 1  yif(xi)) + 
2
TK +
Q
2
Tk (4.13)
Minimizing Qreg in this formulation maximizes the hyperplane separating the training
data. This quantity can be optimized as an instance of semidenite programming (SDP, [103,
108]), which is an optimization technique that ensures that the optimized combinations of
matrices (in this case, the linear combinations of RKHS kernels) remain positive semidenite.
This is important since the hyperkernel should overall be positive semidenite to be a true
kernel. For a linear SVM using a soft margin loss function [72], the SDP is formulated as
follows, with notation following:
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where z = y + 1+    .
Some notation is briey presented. The training data Xtrain = x1; :::; xm and Ytrain =
y1; :::; ym consist of m examples.  and  are Lagrange multipliers.  and  are vectors of
Lagrange multipliers from the Wolfe dual of the SDP.  are hyperkernel coecients. t1 and
t2 are auxiliary variables for the SDP.
The pseudo-inverse of a matrix K is denoted Ky. The hyperkernel Gram matrix K is
dened by Kijpq = k((xi; xj); (xp; xq)). The kernel matrix K is given by K = reshape(K),
which reshapes an m2 by 1 vector K to a m by m matrix. Y = diag(y), is a matrix with y
on the diagonal and zeroes elsewhere. G() = Y KY . I is the identity matrix. 1 is a vector
of ones. y  z is the element-by-element multiplication operation.
The classication function for the optimized SVM is given by
f = sign(KG()y(y  z)  ) (4.15)
SDPs of the type represented in Equation 4.14 can be optimized using the MATLAB
tools SeDuMi [109] and YALMIP [110].
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4.3.6 Using a Proteomics-Specic Kernel
A third approach is to design a kernel which is well-suited to picking out the dierences
between MS protein proles. The natural idea is to take advantage of ideas learned from
feature selection. Certain techniques like wavelet decomposition and PCA can identify fea-
tures which seem to vary on the same levels. These features should probably be selected and
compressed into features which can be useful for a linear separation.
Overall, this task is more dicult than the previous one, because custom kernels typically
capture the features of the data which are anticipated to dierentiate dissimilar datapoints.
The string kernel, for example, computes similarity measures based on the amount of match-
ing substrings. The tree kernel also computes similarity based on the structure of the tree.
It is debatable what constitutes salient structural features of proteomic proles, but per-
haps the best thing to do is consider the data source from its originally intended biological
standpoint. MS prole data from diseased patients should display a deviation from the data
produced from healthy individuals. Many diseases manifest themselves through disregula-
tion of biological processes which stay within some bounds while an individual is considered
"normal" or "healthy". When these processes are disturbed by a disease condition, the devi-
ation eect can be seen, for example, as an increase in inammatory response proteins. Even
though this response is not very disease-specic, it certainly indicates that the individual is
experiencing from an adverse condition. Many of these deviating responses may be present
in the MS protein prole data, but they are hard to nd and quantify.
Dening what "normal" means is not a straightforward task. A control population can
vary over the course of study of a particular disease, and heterogenous case/control datasets
are bound to sample from dierent portions of the true "normal" distribution. In fact, many
controls for one study could be cases for another. As a result, this methodology is left
somewhat open-ended. Using all available data (even if it is heterogeneously generated with
respect to the target testing set) can be important for dening normalcy.
My approach for a proteomics-specic kernel involves grouping m/z positions into path-
ways, which individually attempt to summarize the status of biological regulatory mecha-
nisms in the prole. The kernel-mapping function maps a protein prole to a set of pathway
86
features, which indicate the level of disregulation of those pathways as viewed through the
prole. Thus, proles can be classied through the kernel by their arrangement based on
similarly-disregulated pathways. I refer to this approach as the "Pathway Kernel".
4.3.6.1 Dening the Pathway Kernel The advantage of this "Pathway Kernel" is
that it uses prior knowledge in the form of gene pathways to guide the learning process. The
method correlates these pathways either positively or negatively with previously unseen,
incoming data to subtype them into one class or another. Each dataset used in the learning
phase oers its own perspective on how proteomic spectra can be separated, but this method
allows some backtracking to see which pathways are responsible for those divisions.
The general methodology involves learning dierentially expressed patterns from het-
erogenous proteomic datasets. These patterns are tested for validity by a permutation test,
in a fashion similar to GSEA (Gene set enrichment analysis, [111]). GSEA was a technique
developed for microarray data which evaluated the strength of a multivariate feature set
versus other combinations of features. Combinations of features (genes) are selected either
at random or chosen by prior knowledge (i.e. genes related in a biological pathway). The
strength of the feature set in distinguishing between treatment / no treatment groups is
measured by an aggregate statistic over univariate t-test scores for the genes in the set. The
statistic is compared to a null hypothesis distribution, estimated by permuting treatment/
no treatment labels and rescoring the gene set. In a paper by Atul Butte's group [112], GSEA
was used to analyze pathway perturbations in microarray data. The pathway perturbations
(in terms of correlation with a case/control label) were signicantly useful in discriminating
among subtypes of disease. An improvement on GSEA developed by Tibshirani and Efron
(termed Gene Set Analysis, GSA [113]) was more general and robust, due to the fact that
the null hypothesis distribution was computed not only with respect to randomized sample
labels, but also the performance of random gene sets in the original data.
I wanted to evaluate the strength of pathways in the proteomic data, yet retain some
notion of biological relevance, which would make the results more interesting in the down-
stream analysis. Rather than search among all combinations of m/z values for pathways, I
wanted to nd a way to take in prior knowledge to drive the feature selection going into the
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pathway analysis. Harvard's Molecular Signature Database (MSigDB, [111]) is a database of
gene sets which have dened relationships, such as proximity on the chromosome, biologically
studied and curated interactions and genes with common gene ontology terms. I took these
5400 gene sets and estimated the m/z values where their produced proteins should appear in
a proteomic prole. Translation of gene identiers to protein prole features is done through
the following process. Gene identiers in MSigDB are given in the HUGO format specied by
the Human Gene Nomenclature Committee [114], which associates each gene identier with
a UniProt protein identier [10]. The UniProt identiers are in turn used to retrieve amino
acid sequences for the peptides associated with each gene. Using the amino acid sequences,
the nominal masses of these peptides are calculated by summing the monoisotopic masses
of their component amino acids, plus the weight of a water molecule. The resulting mass is
given a single charge and aligned to a feature in the prole. This process is repeated for all
genes in a MSigDB pathway. The gene sets dened by MSigDB become mapped to "pro-
tein sets" to be analyzed through the GSA technique. Pathways found to be signicantly
correlated by GSA are then retained and used to construct aggregate features from proles.
Proles are then reduced to a small set of aggregate pathway features which are used by
a standard kernel function, such as the linear kernel. The distance between points in this
space represents the similarity of how pathways are regulated between samples. Algorithm
3 outlines the procedure for computing and evaluating the pathway kernel.
4.4 EXPERIMENTS AND RESULTS
The output of the experiments in this chapter are intended to provide guidelines for the
choice of feature selection and classication models for MS prole data. I investigate whether
any feature selection method which is accounting for correlation is statistically equivalent.
Achieving a standard for feature selection is important to establish analytical protocols for
MS prole data. The kernel selection investigation is important because many researchers
only choose the model structure after seeing all methods' performances post hoc. Any clarity
resulting from these experiments will give new directions into how to select models (either
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automatically or by hand) based on clearly dened characteristics of data. Although feature
selection and classication are not new topics, the data type is novel and the opportunity
for novel insight in handling this data can be uncovered by the above described methods.
4.4.1 Feature Selection
The goal of feature selection is to nd a small group of discriminative features. Our features
in this data type may pertain to surrogate biomarkers which indicate the presence or absence
of a disease. Our set of selected features should ideally be diverse. Redundant features in our
selected set do not add additional information, and their selection implies the exclusion of
other, potentially useful features. Some predictive modeling methods, such as Naive Bayes
or logistic regression, are easily inuenced by closely correlated features and may result in
a poorly t model. Unfortunately, proteomic proling data is highly correlated by nature.
A charged particle is often preceded by and followed by its lighter and heavier isotopes,
respectively. This means that neighboring features on the x-axis have a high chance of being
dependent, and a visible correlation results.
To demonstrate this, I used the Vanderbilt Lung Spore IMAC data to calculate the abso-
lute value of the correlation between each unique feature pair in the dataset. This resulted in
302782 pairs and their correlation values, whose distribution is plotted in Figure 19. Approx-
imately 77% of the feature pairs are correlated above 0.8. Consider a hypothetical dataset
of the same size, where the features are independent of their neighbors. Such a dataset
may be generated by sampling randomly from a Gaussian distribution until the equivalent
number of features has been reached. The correlated structure of the true proteomic data
is lost. This is seen in Figure 20 as the distribution becomes centered around 0. In this
example, there is no mass in the distribution beyond correlation values of 0.5. Table 7 lists
the percentage of feature pairs which are correlated greater than 0.8 to illustrate that every
dataset demonstrates this bias. This experiment establishes the existence of an extreme bias
towards correlates in proteomic data, and with this in mind, we should seek feature selection
methods which avoid this bias.
In order to evaluate the ability of feature selection methods, I performed the following
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experiments on both raw and SAP datasets. The 40 train/test splits were identical to
those used in Chapter 3. First, I evaluated the performance of univariate lter methods,
which rank features based on their individual relation to the class label. Next, multivariate
feature lters were analyzed. Rather than evaluating the individual impact of features, the
multivariate ltering approaches take into account how well features collaborate with each
other to create a set which helps more together than the sum of its individual parts. Finally,
I investigated techniques which take advantage of correlation in the data. These techniques
either eliminate or construct new features based on their correlation, as well as reduce the
dimensionality of the data.
In all cases, the predictive model used was a linear Support Vector Machine (SVM) with
L2-norm regularization. The reason for choosing the L2-norm was because I intended to
select only a small set of features, and the less-aggressive form of regularization would allow
me to demonstrate the impact of having too many correlated features in the predictive model.
`1-norm regularization would perform additional feature selection and it would be dicult
to separate the eect of the predictive model on performance from the feature selection steps
used.
4.4.1.1 Demonstrating the eect of correlation on lter methods Univariate
methods are the simplest feature selection method, and often the least computationally
expensive. However, they can be inuenced by highly correlated components in the data,
and the fact that in high-dimensional, low-sample size data, some discriminative signals may
arise simply by chance.
Due to the nature of proteomic data, intensity values from neighboring positions on the
m/z axis are highly correlated. Thus, a large \peak" feature which appears discriminative
(either genuinely or by chance) will also spread its high univariate score with its neighbors.
This is a bad case in either scenario - either a good signal with lots of redundant features is
selected, but a predictive model t to them will not be robust, or a spurious signal with lots
of redundant features is selected, but a predictive model will overt to the false signal and
fail to classify future data correctly.
Table 8 lists the percentage of feature pairs selected by the univariate t-test ltering
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method which are highly correlated (magnitude of sample correlation above 0.8). This
relationship persists even after preprocessing, as can be seen in Table 9. In the situation
where future proles are generated which do not express this feature (say, for example, a
dierent subgroup of disease), the predictive model is poorly informed about where to look
for additional information, resulting in a greater rate of error.
Although some in the protein proling community \bin" local features together to form
an aggregate peak feature [115], I do not prefer this approach. It is dicult to know for
sure when separate features are indicating dierent molecules (in fact, ideally by the nature
of the data, each feature should be a dierent molecule). Discriminative features can also
lie along the sides of peaks or in the troughs between them, which makes evaluating peak
extraction dicult. I prefer to address the problem of high correlates in univariate lters
by employing a decorrelation lter. Tables 8 and 9 demonstrate the percentage of highly
correlated feature pairs and AUC from a t-test lter that was applied in conjunction with
correlation ltering. The maximum-allowed correlation (MAC) threshold was set to 0.6.
Note that the percentage of highly correlated feature pairs drops drastically, indicating that
the selected features are more diverse in the information that they carry. As a result, average
AUC of models trained on these features increases (fourth column). Note that sometimes,
noise in the raw data (and especially on harder datasets) causes a drop in AUC. This eect
disappears with preprocessing.
Also note that applying decorrelation is not guaranteed to improve the AUC, especially
if features must be selected randomly if remaining features are correlated too highly. In this
case, we may even select a feature which does not collaborate well with other features in the
set. This is where multivariate ltering approaches begin to play a role.
Multivariate ranking methods directly address the problem of selecting a panel of features
which performs well, although not necessarily by decorrelating them. Tables 8 and 9 show (in
column 5) the percentage of highly correlated feature pairs resulting from the RF-importance
multivariate lter. These percentages are not necessarily lower than t-test with decorrelation,
but are lower than from a plain univariate t-test lter. However, since these features are
selected in a way which makes their combination more useful, rather than focusing on their
individual ability, we see an average increase in AUC for models built using these features
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(column 6).
4.4.1.2 Comparison of univariate versus multivariate ltering For the sake of
being thorough, the following experiments were performed in order to compare univariate
and multivariate lter methods, which support, and are supported by,the above analysis.
A selection of univariate lter methods were evaluated on each dataset. The Fisher-like
score, Wilcoxon signed-rank score, SAM-score and t-test were applied, and the 20 highest-
scored features were subselected and passed to the predictive model. See Table 22 for the
denition of these scores. The choice of the scoring metrics was based on their frequency of
use in the protein proling research community. Most univariate scores can be computed in
a single vectorized operation. Certain scoring metrics (e.g. the t test score) are parametric
while others (e.g. the Wilcoxon score used here) are nonparametric. To account for the
disadvantage or advantage, I simply report the performance of the best-performing lter
method in each experiment. The leftmost column in Table 10 displays the best average
AUC obtained by the four performance models trained on the top 20 ltered features.
I evaluated four multivariate ranking approaches and reapplied them to the identical
train/test splits as the previous experiment, on raw data. These methods were the Random
Forest Importance lter, the Leave-One-Out AUC Drop lter, the `1-regularization lter
and the adaptive lasso regularization lter. The scores are dened in Section 4.2.3.1. The
performance of the best model out of the four multivariate lter methods is reported in
the center column of Table 10. The rightmost column indicates the advantage of the best
multivariate model over the best univariate model. The decisions are split, with about half
the data being at a disadvantage from multivariate ltering methods. The primary reason
for this is because we are working with the raw data, which contains discriminative features
by chance and are biologically unrelated to the disease state. For example, consider a dataset
where either cases or controls all suer from a baseline shift. Almost all features will appear
discriminative due to the baseline shift between classes. Non-neighboring features will be
considered by multivariate rankers, and since it is less likely that they will be correlated, they
will be added to the list of top features, on the basis of their ability to discriminate between
classes. However, because of the noise in the raw data, it makes it dicult for the predictive
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model to estimate the appropriate weights for these features, and the variance of the estimates
for the parameters of the model will increase. Rather than deal with a \single" parameter
(for the correlated feature chosen by univariate methods), a predictive model working with
multivariate features from raw data will struggle with the poorly estimated parameters for
multiple features. The result is a poorer model performance.
Table 11 displays the alternative to these experiments on SAP-preprocessed data. Here,
the noise has been removed from the data, and in general, improvements can be seen in the
performance of both univariate and multivariate models. Note however that the advantage to
multivariate models is more frequently positive. Table 12 displays the percentage of feature
pairs selected by each multivariate lter which are highly correlated. Compared to Table 14,
the amount of correlated feature pairs is greatly reduced. Three datasets still suer a perfor-
mance disadvantage. Multivariate ranking lters do not explicitly control for correlation; the
success of the multivariate lter largely depends on its ability to identify correlated features
and substitute them among one another. In fact, this is a dicult operation to achieve com-
putationally. The number of combinations of features in this extremely high-dimensional
setting is prohibitive to exhaustive evaluation. However, ecient techniques such as the
Parallel Decorrelation algorithm discussed in Section 4.3.1 exist which can simultaneously
reduce the feature space while simultaneously accounting for substitutability.
4.4.1.3 Correlation-based feature extraction and construction Rather than ex-
pect a multivariate lter to learn the substitutability of features, we can apply techniques
which account for and take advantage of their substitutability. I repeated the above ex-
periments, using 3 correlation-aware methods to select or construct features. The Parallel
Correlation, Top-K PCA Eigenvector reduction, and Wavelet Decomposition methods served
this purpose. In each case, the \top 20" features are taken: the parallel decorrelation lter
selects 20 features, the top-20 PCA eigenvectors are used for projecting the test data, and the
coecients from the rst 20 levels of wavelet decomposition are used. The best performing
models are reported in Table 13 for the raw data, and Table 14 for the SAP-preprocessed
data.
On dicult datasets like COPD and Diabetes, where few good features might exist, the
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noisy nature of the raw data makes itself apparent. Univariate lters will nd the good
feature and its immediate correlates. Good discriminative features which are uncorrelated
with this initial feature are hard to come by, and likewise the correlation-aware methods
suer. This is interesting, because we would expect these uncorrelated but discriminative
features (even if they are spurious) should exist just by random chance in the raw data.
While the disadvantages are mostly small, it's likely that these raw datasets contain noise
which correlates the most highly discriminative features (such as a baseline shift separating
classes). Being forced to select a nondiscriminative feature just because all the others are
correlation-substitutable can add noise to the model, decreasing performance.
4.4.2 Predictive Modeling
In order to evaluate the ability of predictive modeling methods, I performed the following
experiments on both raw and SAP-preprocessed datasets. The 40 train/test splits were iden-
tical to those used in all previous experiments. Dierent predictive models are evaluated by
changing the kernel function of an `1-norm SVM. The choice of the `1-norm is to enable ag-
gressive, decorrelating feature selection through the predictive model itself (without needing
to choose a method from Section 4.4.1).
Three dierent kernel learning approaches were evaluated, rst on the raw data. Table
15 displays the average AUC of the `1-norm SVM when learning either a Hyperkernel, a
Metadata-based kernel or the Pathway Kernel described in Section 4.3.6. Results using a
standard linear kernel can be obtained from Tables 2 and 3 in Chapter 3. As can be expected,
the kernel-learning approaches suer from the noisy raw data.
Table 16 displays the results of the previous experiment when applied to SAP-preprocessed
data. All three kernel-learning approaches almost always improve. The three cases where
performance does not improve occur on dierent datasets, under dierent methods (Hyper-
kernel on ILD, Metalearning on Hepatitis C and Prior Knowledge on the Vanderbilt Lung
WCX dataset). For many datasets, the eect of preprocessing gives a substantial advantage
to the kernel-learning methods. The stability of the performance estimates improves for the
Hyperkernel method, as evidenced by the smaller condence intervals and higher average
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AUC. The same cannot be said of the Metalearning or Prior Knowledge kernels, however.
The Pathway Kernel replaces the entire original prole data with new features. It is
interesting to see this method improve with the preprocessing, especially because the features
are almost totally unrelated to protein expression amounts by the time the SVM is applied.
However, it is not a good kernel choice for this type of data. The pathway kernel can
suer from many sources of noise due to its design. The conversion between Gene identier
and protein is one step wrought with error [116], and furthermore, the mapping of these
proteins onto prole locations is also problematic. Although the Pathway kernel method
improves with preprocessing, it does not appear that the method outperforms a classier
which guesses randomly. For data types which present more information about the features'
biological identities, perhaps the pathway kernel can be more useful. With TOF-MS data,
however, too much is lost in translation between the gene sets and protein features to take
advantage of this kind of prior knowledge.
The prior knowledge kernel has a direct biological interpretation. Helpful features reect
an overall overexpression or underexpression of a set of proteins in the prole. For the sake
of interest, I listed the top 20 pathways used as features for each dataset. This list is in
Appendix C, Table 24. The pathway names are taken from MSigDB [111], so the interested
reader is directed to the Molecular Signatures Database 1 to browse for further information
on pathways which do not have a readily interpretable name (for example, pathways in the
C4 set of MSigDB, which are given a nonbiological identier).
4.4.3 Discussion
It is dicult to make guarantees about what model will perform the best on any given
dataset. However, just because an assurance of a good model doesn't exist doesn't mean we
shouldn't try to achieve it. The above experiments point us in a favorable direction which
should motivate our choices for feature selection and predictive modeling.
1http://www.broadinstitute.org/gsea/msigdb/index.jsp
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4.4.3.1 Recommendations for feature selection First, our choice about feature se-
lection is largely made due to the desire to have a parsimonious explanation for a disease
pattern. Although univariate ltering methods are the extreme of sparseness, the nature
of proteomic data defeats their application. High correlations and substitutability among a
large percentage of the features hinder the robustness of predictive models based solely on
univariately ltered features. In general, their use is not recommended for the development
of a robust model.
Multivariate lters start to alleviate the issue of correlation among features. Still, search-
ing exhaustively through many combinations of features can be computationally expensive.
Additionally, multivariate lters are not explicitly aware of substitutable features, and are
not guaranteed to return a robust set of orthogonal features.
The feature selection techniques which are aware of correlations (PCA, wavelet decom-
position and the Parallel Decorrelation technique presented above) can deal with the substi-
tutability of features. Interpreting the resulting features can be dicult, but not impossible.
One thing we learned from our experiments is that performing feature selection often
produces a better performing model. Moreover, performing preprocessing adds an additional
advantage. Preprocessing with SAP leads to the results in Table 14. Even though we saw
in Section 3.3 that SAP is probably a suboptimal method, the advantage to correlation-
aware techniques is largely positive for all datasets. It becomes easier to nd uncorrelated
features which are discriminative, and this adds to the robustness of the model, improving
its performance.
I tested the signicance of the advantages granted by using certain techniques. Here,
"Advantages" are used to measure the dierence in model performance between the appli-
cation of a procedure and without the procedure applied (Advantage = Performance(after
feature selection ) - Performance(before feature selection)). Performance advantages must
be taken into context with the diculty of the dataset being classied. As datasets become
more easily classied, it gets harder to create additional advantage, simply because there is
little room for improvement. Likewise, a dicult task faces a large room for improvement,
and perhaps almost anything can cause a large jump in performance. By measuring per-
formance advantages, we somewhat limit the impact that easy or hard datasets have in the
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hypothesis testing analysis.
First, I tested whether the advantages from using any of the correlation-aware methods
were signicantly dierent from one another. Columns 1 and 4 from Table 17 show the per-
centage of times correlation-aware methods were not signicantly dierent from one another.
The signicance tests done in this table are by way of the Mann-Whitney U -test, a nonpara-
metric rank-sum signicance test for two populations. In this case, the populations consist of
performance advantages in AUC obtained over the 40 splits of training and testing data. On
half the datasets, none of the correlation-aware techniques are signicantly better than any
other. On the other half of the datasets, it's possible to select out signicantly better method
(p < 0:01). In the majority of cases where this occurs, it's due to the parallel decorrelation
method being signicantly better than the wavelet decomposition and PCA methods. The
statistical separation of the parallel decorrelation method increases after preprocessing with
SAP (Table 17, column 4).
Next, I tested whether the advantages from using correlation-aware methods were sig-
nicantly higher than the advantages from using univariate and multivariate lter methods.
These tests are also reected in the additional columns in Table 17. Again, the Mann-
Whitney test was used. On the raw, data, 6 of the datasets have no signicant dierence
between correlation-aware and multivariate methods half the time. On the other 8 datasets,
there are more often advantages to the correlation-aware approach. The percentage of times
that correlation-aware techniques are signicantly better decreases when the data is prepro-
cessed by SAP. Univariate methods are frequently signicantly poorer in the raw data - this
is just a consequence of the noise in the raw data. The separation between these methods
mostly remains in the SAP-processed data.
Third, I tested whether the advantages obtained by using any feature selection method
after applying SAP preprocessing were signicantly higher than advantages resulting from
applying the same methods to the raw data. Performance advantages from applying all
feature selection methods on SAP data were tested against performance advantages from
applying all feature selection methods on raw data, using the Kruskal-Wallis non-parametric
one-way test [107]. This is an extension of the Mann-Whitney test for 3 or more groups -
in this case, the advantages for all SAP methods are grouped together, and likewise with
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advantages from methods applied to the raw data. The Kruskal-Wallis test operates under
the null hypothesis that the samples come from populations such that choosing random
observations from both samples will only result in one observation being greater half the
time.
In the nal column of Table 17, the p-value resulting from the Kruskal=Wallis test is given
for each dataset. In only three of the datasets (COPD, Breast cancer and nearly ILD), the p-
value was less than 0.01. This suggests that, very frequently, performing feature selection on
SAP-preprocessed data is not likely to give you the same performance advantage as simply
performing feature selection on raw data and building a model. Rather, the advantage will
be greater with the SAP-processed data.
4.4.3.2 Recommendations for predictive model choice I analyzed dierent kernel
learning approaches to improve the SVM classier, and I wished to test whether any method
oers a consistent advantage over another. Evaluating the kernel-learning approaches was
an exploratory process. The decision about what model to use in the rst place because
of familiarity with the model, simplistic reasons, or personal preference. When we want to
consider whether better representations of the data exists in order to achieve a better classi-
cation, it becomes necessary to evaluate other models. For example, I once used the Pathway
Kernel to map proteomic proles into their pathway features, and then considered whether
a linear classier could separate the resulting transformed feature space. Unfortunately, the
feature space was perhaps more convoluted than before, but I wondered whether or not a
more advanced kernel method could separate the data in this feature space. The result would
be benecial for the sake of interpretation - heavily weighted features would have a direct
biological interpretation. To this end, this foray into kernel learning was developed.
From Tables 14 and 16, there are a few things to take note of. First, the Meta-learning
approach learned to only use the linear kernel on SAP data. This made the method not
much better than the results presented in Chapter 3 to evaluate the SAP method. On the
raw data, the noise in the proles causes the Meta-Learning kernel to switch between kernels
often, but the performance was not competitive with the other kernel-learning methods
(table not shown). After SAP preprocessing, the Meta-Learning approach realized that the
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best kernel was the linear kernel, and applied it continuously with only a few exceptions.
The COPD, Scleroderma and Melanoma datasets made use of the polynomial kernel and
multilayer-perceptron kernel twice each during 4 of the training and testing splits (but each
dataset on a dierent split, so these anomalies seem to be more about the individual datasets
than the train/test split). Moreover, many of the dataset metrics become useless under such
high dimensionality, and would not dierentiate many datasets after averaged over more
than a handful of features. In the end, it seems the Meta-learning approach relies more on
the internal cross-validation to choose a kernel, and is not appropriate for high-dimensional
data such as MS protein proling.
The Hyperkernel approach does not perform very well, given its complexity. Although it
produces predictive models which are better than random in some cases, the best univariate
lter approaches without decorrelation can outperform this method. The computational
complexity in terms of time and memory of solving the Semidenite Program is quadratic
in the number of proles, which is quite a large overhead considering other kernel methods
are linear in the number of proles.
Finally, the Pathway kernel is not a good option at this point in time. Due to the
problems involved in translating gene sets to protein location sets in the prole, the kernel
cannot provide a good re-representation of the data. This makes it dicult to use the kernel
to build a predictive model. However, if features could be labeled as proteins in the prole,
then the Pathway Kernel should be employed to take advantage of this information.
Table 18 displays the percentage of datasets on which a performance advantage of a
kernel-learning approach was statistically signicantly better than another. Four kernels are
evaluated: The hyperkernel, the meta-learning kernel, the pathway kernel and the linear
kernel selecting 20 features by way of the Parallel Decorrelation algorithm. Performance
advantages are calculated by subtracting the average AUC from the plain linear kernel
on SAP-processed data from the average AUC of the kernel-learning approach's predictive
model. These performance advantages undergo a Mann-Whitney U -test for signicance
at  = 0:5. Since we know the Meta-learning kernel approach is acting as a plain linear
SVM, we can interpret the results accordingly. The only reason why the linear kernel would
outperform the Parallel Decorrelation kernel would be due to the limit of the number of
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features. In the end, the linear kernel outperforms other kernels most often. Although
the parallel decorrelation-mapped kernel also performs well, it may be worth saving the
aggravation about how many features to pick, and simply go with a linear SVM kernel.
4.4.3.3 Using the decision-theoretic approach to recommend a predictive model
The analyses of dierent classication methods in terms of AUC statistics summarize how
well the models are able to discriminate among cases and controls for many dierent diag-
nostic thresholds. However, in practice we want to pick just one decision threshold.
One (simple) way to pick the decision threshold is to optimize the misclassication using
the zero-one cost function, where each misclassication contributes equally to the error score.
This is clearly suboptimal in many real-world cases where the cost of misdiagnosing a patient
with a disease when he is actually healthy is not equal to the cost of misdiagnosing a diseased
patient as healthy. To nd the optimal diagnostic threshold we can adopt a decision-theoretic
framework where each prediction/disease contingency is assigned a utility (or a cost). Then,
the optimal decision threshold is the one that optimizes the expected utility dened by these
contingencies.
Let p(y = ajx) be the probability the prole x is a, where a = fdisease; healthyg, and
let p(y = :ajx) = 1  p(y = ajx) denote the probability it is not a. Let u(a0; a) be a utility
function that assigns a real number to the true disease state a0 and the decision made a.
The utility is the negative of the corresponding mismatch cost.
The optimal decision a for x is then dened as:
a  (x) = argmax
a
P (y = ajx)u(a; a) + P (y = :ajx)u(:a; a):
The optimal decision can be rewritten in terms of a simple decision threshold on P (y =
diseasejx). Briey, we should choose \disease" if:
P (y = diseasejx) 
u(:disease;:disease)  u(:disease; disease)
u(:disease;:disease)  u(:disease; disease) + u(disease; disease)  u(disease;:disease)
(4.16)
otherwise the choice should be \healthy".
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The utility function u(a0; a) is typically elicited from an expert. However, the probability
model is not; it is learned from data. Some classication models and methods, such as Naive
Bayes, logistic regression or Linear Discriminant Analysis are probabilistic and attempt to
estimate P (yjx) directly. Others, such as the SVMs which were used extensively in our
previous investigations, do not have an immediate probabilistic interpretation. To build
a probabilistic model for the SVM, we can apply the probabilistic transformation model
introduced by Platt [117]. Let f(x) denote the value assigned to the prole x by the SVM
model trained with labels +1 corresponding to the disease and  1 to the control labels.
Then the probability P (y = diseasejx) is modeled as:
P (y = diseasejx) = 1
1 + exp( wf(x) + w0)
where w;w0 are parameters tted on the training data.
The probability model p(yjx), whether it is based on the Naive Bayes or an SVM, is an
estimate of the true model that is learnt from data. Its accuracy depends on the quality of
the learning algorithm and the number of examples available to learn it. Now, the question
is whether we can evaluate the goodness of the model and which metric we should judge
it by. One way to approach the task is to rely on the empirical likelihood measures based
on the test data. Briey, the probabilistic model M learned on the train data is applied
to every datapoint (x; y) in the test set and is used to calculate the predictive likelihood
P (yjx;M). The likelihood of M on the data is then calculated as Q(x;y)2Dtest p(yjx;M).
A log-likelihood metric
P
(x;y)2Dtest
logp(yjx;M) is more practical and prevents us from
reaching small values and resulting numerical operation problems.
Table 19 displays the predictive log-likelihood of our three kernel-learning approaches
as well as that of the linear kernel used to evaluate SAP in Chapter 19. A number closer
to 0 is better. Most of the time, the Hyperkernel-based SVM seems to produce the best-
calibrated model for converting SVM outputs to probabilities. It is interesting to note that
the Vanderbilt Lung datasets, which are generated from the same set of samples, all benet
the most from the pathway kernel-based SVM. In fact, the UPCI Lung Cancer dataset and
the Vanderbilt Lung IMAC dataset share a large subset of samples, so it is no coincidence
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that they share similar preferences for certain methods. Given these results, the hyperkernel-
based approach may have some merit when it is required to produce a probabilistic output.
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input : Raw training dataset D, set of kernels K = fK1;    ; Kpg
output: Selected kernel Ks
Estimate performance of each kernel via cross-validation.
for i 1to 10 do
Split D into training data Dtrain and validation data Dvalid by subsampling.
train-metrics(i) Calculated dataset characterization metrics for Dtrain
for j  1to p do
perf(j) performance of SVM with kernel Kj, trained on Dtrain and tested on
Dvalid
end
Save the index of the best performing kernel on this dataset.
sel-kern(i) index(max(perf))
end
Learn decision rules between data characterization metrics and best performing kernel.
rules  CART-learn(train-metrics,sel-kern)
Use learned rules to select best kernel on training data.
data-metrics  Calculated dataset characterization metrics for D
s CART-apply(rules,data-metrics)
Algorithm 1: Procedure for Evaluating Predened Kernel Selection
 Repeat over many splits of training and testing data
1. Split dataset Di into training data Dtrain and testing data Dtest
2. Dene the class of kernels K = k1; :::; kl
3. Optimize the hyperkernel using K, Dtrain and the SDP in Equation 4.14
4. Use an SVM to classify Dtest.
Algorithm 2: Procedure for Learning and Evaluating Custom Hyperkernel
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1. Repeat over many splits of training and testing data
1. Split dataset Di into training data D
train and testing data Dtest
2. Evaluate the GSA score of each pathway
3. For those k pathways which are found to be statistically signicant w.r.t
Dtrain by GSA
a) Compute the dierential expression of the features in those pathways.
This denes a set of values which are related to the dierences between the
classes in Dtrain.
b) Compute the correlation between these dierential expression values
and the intensities of features for the same pathway for each prole i 2 Dtest.
This results in a single value Pk for that pathway.
4. Let (Dtesti) = fP1; :::; Pkg
5. Use a linear kernel K = h(xi); ((xtesti )i)
6. Use an SVM to classify Dtest.
Algorithm 3: Procedure for learning the pathway kernel
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Figure 19: The distribution of absolute correlation values among all feature pairs for the
Vanderbilt Lung IMAC dataset. 77% of the feature pairs are correlated higher than 0.8,
demonstrating the correlation bias prevalent in proteomic MS data.
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Figure 20: The distribution of absolute correlation values for a hypothetical dataset gener-
ated by randomly sampling from a Gaussian distribution. The distribution is more heavily
tailed towards low values of correlation. 0% of the probability mass is correlated higher than
0.5.
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Table 7: Percentage of the distribution of feature pair absolute correlation value above 0.8.
For most datasets, more than two thirds of the features are highly correlated with each other.
For the Vanderbilt Maldi Lung dataset, 52% should not be striking, since this dataset has
roughly twice as many features as the other SELDI datasets.
Dataset Percentage of distribution mass above 0.8
COPD 77%
Hepatitis C 77%
ILD 77%
Diabetes 95%
Melanoma I 77%
Breast Cancer 77%
Pancreatic Cancer I 77%
Pancreatic Cancer II 77%
Prostate Cancer 96%
Scleroderma 77%
UPCI Lung Cancer 78%
Vanderbilt Lung IMAC 77%
Vanderbilt Lung WCX 77%
Vanderbilt MALDI 52%
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Table 10: Comparison of Univariate vs Multivariate Feature Selection on Raw Data
Dataset Best Univariate Best Multivariate Advantage
COPD 0.6270  0.2210 0.5638  0.2604 -0.0632
Hepatitis C 0.5484  0.2212 0.5368  0.2326 -0.0116
ILD 0.5549  0.2784 0.6027  0.2448 0.0477
Diabetes 0.5474  0.2313 0.5355  0.2662 -0.0119
Melanoma I 0.5825  0.1653 0.5208  0.1969 -0.0616
Breast Cancer 0.5698  0.1343 0.5559  0.1246 -0.0139
Pancreatic Cancer I 0.8310  0.0828 0.8939  0.0679 0.0629
Pancreatic Cancer II 0.7437  0.1086 0.8433  0.0779 0.0996
Prostate Cancer 0.9190  0.0291 0.9047  0.0330 -0.0143
Scleroderma 0.7479  0.1071 0.7298  0.1071 -0.0180
UPCI Lung Cancer 0.6411  0.0958 0.7964  0.0789 0.1553
Vanderbilt Lung IMAC 0.7686  0.0682 0.8518  0.0579 0.0832
Vanderbilt Lung WCX 0.8558  0.0611 0.8616  0.0528 0.0058
Vanderbilt MALDI 0.8107  0.0632 0.8512  0.0520 0.0405
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Table 11: Comparison of Univariate vs Multivariate Feature Selection on SAP Data
Dataset Best Univariate Best Multivariate Advantage
COPD 0.6386  0.2116 0.6670  0.1811 0.0284
Hepatitis C 0.6622  0.1538 0.6269  0.1680 -0.0353
ILD 0.6831  0.1905 0.6404  0.2174 -0.0427
Diabetes 0.6657  0.1997 0.6090  0.2158 -0.0567
Melanoma I 0.5804  0.1697 0.5844  0.1811 0.0040
Breast Cancer 0.5838  0.1337 0.6079  0.1364 0.0242
Pancreatic Cancer I 0.9009  0.0516 0.9349  0.0412 0.0340
Pancreatic Cancer II 0.9057  0.0510 0.9130  0.0525 0.0072
Prostate Cancer 0.8510  0.0578 0.9574  0.0214 0.1064
Scleroderma 0.5908  0.1392 0.6031  0.1416 0.0124
UPCI Lung Cancer 0.6917  0.0802 0.7304  0.0790 0.0387
Vanderbilt Lung IMAC 0.8083  0.0680 0.8790  0.0532 0.0708
Vanderbilt Lung WCX 0.8976  0.0475 0.9206  0.0373 0.0230
Vanderbilt MALDI 0.8044  0.0656 0.8469  0.0597 0.0425
111
Table 12: Percentage of feature pairs with jrj  0:8
Dataset LOO AUC Drop RF Importance L1 Regularization
COPD 0% 1% 0%
Hepatitis C 0% 8% 3%
ILD 61% 3% 21%
Diabetes 6% 1% 1%
Melanoma I 6% 9% 11%
Breast Cancer 0% 2% 1%
Pancreatic Cancer I 52% 17% 5%
Pancreatic Cancer II 33% 45% 9%
Prostate Cancer 4% 7% 2%
Scleroderma 18% 7% 3%
UPCI Lung Cancer 4% 15% 2%
Vanderbilt Lung IMAC 5% 25% 4%
Vanderbilt Lung WCX 6% 99% 11%
Vanderbilt MALDI 14% 9% 7%
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Table 13: Performance of Feature Decorrelating Methods on Raw Data
Dataset Best Univariate Best Feat.
Constructor
Advantage
COPD 0.6270  0.1979 0.5839  0.2316 -0.0432
Hepatitis C 0.5381  0.2026 0.6486  0.1855 0.1105
ILD 0.5502  0.2677 0.6035  0.2128 0.0533
Diabetes 0.5479  0.2570 0.5155  0.2731 -0.0324
Melanoma I 0.5777  0.1713 0.5797  0.1599 0.0021
Breast Cancer 0.5698  0.1225 0.5780  0.1331 0.0082
Pancreatic Cancer I 0.8304  0.0776 0.8923  0.0686 0.0620
Pancreatic Cancer II 0.7361  0.1097 0.8207  0.0897 0.0846
Prostate Cancer 0.9190  0.0291 0.9698  0.0188 0.0508
Scleroderma 0.7186  0.1066 0.7204  0.1120 0.0018
UPCI Lung Cancer 0.6411  0.0958 0.8368  0.0659 0.1957
Vanderbilt Lung IMAC 0.7686  0.0726 0.9089  0.0414 0.1402
Vanderbilt Lung WCX 0.8558  0.0579 0.9001  0.0453 0.0443
Vanderbilt MALDI 0.8107  0.0658 0.9143  0.0405 0.1036
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Table 14: Performance of Feature Decorrelating Methods on SAP-Preprocessed Data
Dataset Best Univariate Best Feat.
Constructor
Advantage
COPD 0.6233  0.2202 0.6478  0.2175 0.0245
Hepatitis C 0.6836  0.1564 0.7102  0.1398 0.0265
ILD 0.6572  0.1901 0.6627  0.2277 0.0055
Diabetes 0.6953  0.1869 0.7426  0.1571 0.0473
Melanoma I 0.5838  0.1876 0.5955  0.1893 0.0117
Breast Cancer 0.5806  0.1105 0.6067  0.1287 0.0261
Pancreatic Cancer I 0.9023  0.0505 0.9599  0.0238 0.0576
Pancreatic Cancer II 0.8979  0.0511 0.9311  0.0391 0.0333
Prostate Cancer 0.8510  0.0578 0.9691  0.0172 0.1181
Scleroderma 0.6112  0.1314 0.6889  0.1153 0.0777
UPCI Lung Cancer 0.6917  0.0799 0.8276  0.0639 0.1360
Vanderbilt Lung IMAC 0.7985  0.0668 0.9003  0.0429 0.1019
Vanderbilt Lung WCX 0.8976  0.0458 0.9520  0.0245 0.0545
Vanderbilt MALDI 0.8086  0.0628 0.9221  0.0379 0.1134
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Table 15: A comparison of predictive model performance (in terms of AUC) when using
various kernel learning methods on raw data. An `1-norm penalized SVM was used as the
base predictive model, while the kernel was learned through varying methods. The results
are shown as averages over 40 splits of training/testing data along with 95% condence
intervals.
Dataset Hyperkernel Metalearning Prior Knwlg
COPD 0.5025  0.2662 0.5473  0.1986 0.5365  0.1189
Hepatitis C 0.5666  0.2230 0.6299  0.1619 0.5728  0.1410
ILD 0.6550  0.2206 0.5505  0.2090 0.5538  0.2124
Diabetes 0.5557  0.2287 0.4783  0.2037 0.5172  0.1095
Melanoma I 0.5094  0.2055 0.5181  0.1177 0.5045  0.1513
Breast Cancer 0.5121  0.1303 0.5115  0.1298 0.5232  0.0853
Pancreatic Cancer I 0.5442  0.1405 0.7812  0.0632 0.5931  0.0449
Pancreatic Cancer II 0.5739  0.1373 0.7246  0.0840 0.5460  0.0851
Prostate Cancer 0.6243  0.0870 0.9405  0.0226 0.6571  0.0851
Scleroderma 0.5301  0.1342 0.6335  0.0666 0.5673  0.1295
UPCI Lung Cancer 0.5860  0.0947 0.5000  0.0000 0.5780  0.0643
Vanderbilt Lung IMAC 0.7419  0.0777 0.5201  0.0026 0.5907  0.0454
Vanderbilt Lung WCX 0.7764  0.0723 0.5448  0.0108 0.6764  0.0602
Vanderbilt MALDI 0.7140  0.0825 0.5527  0.0046 0.6038  0.0592
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Table 16: Performance of Kernel Learning Methods on SAP-preprocessed Data
Dataset Hyperkernel Metalearning Prior Knwlg
COPD 0.5640  0.2170 0.6247  0.1856 0.5651  0.2055
Hepatitis C 0.7608  0.1363 0.6542  0.1905 0.6719  0.1424
ILD 0.5549  0.0566 0.6984  0.1877 0.6380  0.2077
Diabetes 0.6372  0.1893 0.6473  0.2208 0.6008  0.1402
Melanoma I 0.5397  0.2003 0.5387  0.1957 0.5647  0.1587
Breast Cancer 0.5654  0.1227 0.5587  0.1373 0.5608  0.0945
Pancreatic Cancer I 0.6179  0.0906 0.9544  0.0324 0.6783  0.1002
Pancreatic Cancer II 0.5761  0.0856 0.9201  0.0473 0.6079  0.1036
Prostate Cancer 0.7017  0.0634 0.9369  0.0316 0.6913  0.0832
Scleroderma 0.6263  0.1297 0.6625  0.1520 0.6364  0.1203
UPCI Lung Cancer 0.6937  0.0897 0.7595  0.0725 0.5830  0.0799
Vanderbilt Lung IMAC 0.8070  0.0626 0.8684  0.0534 0.6174  0.0793
Vanderbilt Lung WCX 0.8753  0.0496 0.9360  0.0334 0.5877  0.0729
Vanderbilt MALDI 0.8233  0.0582 0.8758  0.0498 0.6765  0.0627
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Table 17: Percentages of insignicant (p >= 0:01 of Mann-Whitney U -test) comparisons
between feature selection methods. Key: CxC (Correlation-aware vs. Correlation-aware,
3 pairs); CxM (Correlation-aware versus Multivariate lter, 6 pairs); CxU (Correlation-
aware versus Univariate lter, 6 pairs). The tests are performed on the raw data (rst
three columns) as well as SAP-preprocessed data (last three columns); RxS (p-value for
Kruskal-Wallis test between advantages obtained on all feature selection methods on raw data
versus all feature selection method advantages on SAP data). A higher percentage means
that methods from the two groups more frequently oer a statistically similar performance
advantage
.
RAW SAP
Dataset CxC CxM CxU CxC CxM CxU RxS p
COPD 100% 50% 50% 100% 50% 50% 0.699
Hepatitis C 67% 17% 17% 100% 50% 50% 0.000
ILD 100% 50% 50% 100% 50% 50% 0.078
Diabetes 33% 17% 17% 100% 50% 50% 0.000
Melanoma I 100% 33% 50% 100% 50% 50% 0.000
Breast Cancer 100% 50% 33% 100% 50% 50% 0.387
Pancreatic Cancer I 100% 50% 0% 67% 50% 0% 0.000
Pancreatic Cancer II 100% 50% 33% 67% 33% 0% 0.000
Prostate Cancer 33% 50% 50% 33% 33% 0% 0.000
Scleroderma 100% 17% 50% 33% 50% 33% 0.000
UPCI Lung Cancer 33% 17% 0% 33% 17% 17% 0.000
Vanderbilt Lung IMAC 33% 0% 0% 100% 33% 0% 0.000
Vanderbilt Lung WCX 33% 0% 17% 100% 50% 0% 0.000
Vanderbilt MALDI 33% 17% 0% 33% 17% 0% 0.000
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Table 18: The percentages reect the proportion of datasets in which the row kernel-learning
method signicantly outperforms the column kernel-learning method. The Linear SVM with
Parallel Decorrelated features is also added for comparison. Signicance tests were done with
a Mann-Whitney U -test with  = 0:5. Interpret the Meta-Learning kernel as just a plain
linear kernel.
Hyperkernel Metalearning Pathway Parallel COR
Hyperkernel | 7% 35% 14%
Metalearning 57% | 50% 35%
Pathway 0% 0% | 7%
Parallel COR 28% 0% 50% |
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Table 19: Comparison of Log-likelihoods of probability models obtained from SVM classiers
on SAP-processed data using dierent kernels. Columns correspond to: HYP (Hyperkernel),
META (Meta-learning), PATH (Pathway Kernel) and the Linear kernel used in Chapter 3.
A greater number is better - the best result for each dataset is bolded.
Dataset HYP META PATH Linear
COPD -3.2400 -2.4017 -4.6944 -1.5809
Hepatitis C -8.8668 -15.0818 -6.3207 -5.1058
ILD -3.1548 -3.3564 -3.4733 -4.8469
Diabetes -2.0065 -2.5536 -4.3701 -4.3251
Melanoma I -4.2802 -4.2343 -10.9350 -7.0104
Breast Cancer -18.7682 -36.8485 -30.8202 -27.8166
Pancreatic Cancer I -7.1689 -13.0232 -8.2671 -37.4862
Pancreatic Cancer II -7.1665 -8.6821 -7.2155 -19.6421
Prostate Cancer -8.8602 -10.4713 -10.7550 -23.9234
Scleroderma -5.4823 -10.0400 -5.5808 -21.3438
UPCI Lung Cancer -15.7557 -23.3732 -14.8621 -29.7677
Vanderbilt Lung IMAC -21.9110 -29.1278 -14.7063 -37.0586
Vanderbilt Lung WCX -20.1528 -34.2703 -15.5185 -43.2553
Vanderbilt MALDI -14.9691 -23.0833 -14.1232 -30.5254
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5.0 INTERPRETATION
5.1 BACKGROUND
Following predictive modeling and classication of proteomic proles, any result must be
interpreted to some extent. The mass spectrometry (and in particular, the TOF-MS) data
source has two problems which can make interpretation of promising results dicult. The
rst problem is that the data source is inherently noisy. Although preprocessing alleviates
this problem to some extent, it's impossible to account for every source of variation in the
equipment and sample. The second problem is that the features in the data are dicult to
associate with biological concepts (henceforth referred to interchangeably as protein identi-
cation or protein labeling. This is due to the nature of how the data is generated with MS
equipment (and especially complicated with SELDI-TOF-MS technology) (See section 2.3
for a better understanding of why). Even with more complex equipment, labeling features
with biological identiers for proteins is dicult. Although the methodologies for protein
labeling can dier according to equipment, as long as one exists, it enables theorizing about
the data in dierent ways. With a large collection of data and the ability to label features,
it becomes possible to search for disease-specic and general biomarkers.
To address these problems, two classes of methods are considered for the interpretation
of the performance of predictive models. Statistical interpretation methods aim to alleviate
concerns about the caveats normally associated with predictive modeling, such as generaliza-
tion error between experiments and the reproducibility of results. Biological interpretation
approaches attempt to link biological relationships to the features or samples used by the
predictive model. First, the features should be attached to protein labels, so that any further
reasoning about the data and results will carry additional meaning. Then, additional rela-
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tionships can be made using prior knowledge and online databases which document protein
interactions. Uncertainty in the biological identities of features generally discourages this
type of analysis, but as MS proling technology improves, these interpretation techniques
will improve as they accommodate new information. For now, the hypothesis is that the
presence of these methods will enable more interesting conclusions about MS protein prole
analysis beyond the statistics presented for predictive model performance. These methods
should enable the analyst to reveal interesting concepts which have been hidden up until
now, due to the challenging nature of the data.
5.1.1 Statistical Interpretation Methods
To some degree the statistical validation of classier models is taken care of through cross-
validation. However we may be interested in additional statistical properties of the data
which extend beyond classier error. Rather than invent separate testing techniques for
each statistical property of interest, it would be desirable to use a general framework for
testing.
The permutation test [118] is such a framework, which can be used to interpret the
strength of any measurable statistical property T of a classier model or its data. Examples
of statistical properties aside from classier error include dierential expression scores of
features or inter-class correlation.
The permutation test is a nonparametric approach to hypothesis testing, which makes
it useful when the underlying distribution of T is unknown. Figure 21 illustrates the per-
mutation test. A distribution of T under a null hypothesis H0 is generated by randomly
permuting the class membership labels of the data. For each permutation, T is recalculated,
which results in an empirical estimation of the distribution of T under H0. The null hy-
pothesis typically reects the idea that no special relationship exists between T and the true
assignment of class labels to the data. For example, in the case of a model with excellent
testing error, we might consider H0 to represent the hypothesis that the model achieves
its testing error through chance, implying that the model's selected features are spuriously
correlated with the class label.
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Values in this distribution are compared to the value of T under the true class label
assignment. If this value outside the distribution by a signicant amount, the null hypothesis
is rejected. The level of signicance can be determined, for example, by p-value. The
parameter  describes the level of condence at which the null hypothesis was rejected.
5.1.2 Biological Interpretation Methods
The statistical validation of predictive models is useful for empirically determining the ap-
plicability of a predictive model. Determining the reasons why these models work beyond
the mathematical properties is a natural next question. Biological information is somehow
encoded into the proteomic proles, and if a predictive model is eective at using this infor-
mation to discriminate between cases and controls, it would be interesting to see how the
model achieves its decisions. Moreover, if a predictive model experiences errors, we might
be curious whether any biological relationship to these errors are present.
In the data available for this thesis, biological information is limited to the molecular
weights of molecules measured by the mass spectrometer. More recent technology exists
which can supplement MS prole data by annotating features with peptide identications.
With or without this advantage, it can be uncertain as to which proteins are being represented
in the MS proles. Although the protein identities can not be known for sure, we can make
educated guesses about the identities of features. In the future, if MS proteomic proling
improves to the point where all features are accurately identied, this identication step can
be skipped. However, biological interpretation techniques remain unchanged.
The Pathway Kernel from Section 4.3.6 was intended as an additional way to interpret
protein proling models. The features selected by an SVM using the Pathway Kernel would
correspond to separate biological systems of interactions inuencing the overall proteomic
prole. If the model ts the data well, we can then look at the components of the individual
processes to speculate why these components aect the outcome of a disease. Unfortunately,
converting the gene interaction pathways to locations in the protein proles proved dicult
with the SELDI and MALDI ToF-MS data sources.
To deal with uncertainty of the identity of features, discriminative features and patterns
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Figure 21: Example of the permutation test. The empirical distribution of the test statistic
T (shaded histogram) is estimated by permuting class labels of data. If the test statistic
obtained under the true class labels (red cross) falls outside of this distribution by a signicant
amount, the value of the test statistic is less likely to occur by chance.
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are often termed "surrogate" biomarkers. These surrogate biomarkers function in discrimi-
nating diseased and healthy samples despite their abstract nature. It is possible that other
abstractions can exist, which could be more easily related to biological concepts and possibly
more eective for classication. This thesis intends to investigate ways of abstracting the
information in proteomic proles in order to determine whether interesting biological rela-
tionships can be discovered. This is done primarily through latent variable models, a set of
statistical models which relate output variables to a smaller set of "hidden" variables. These
latent variables are not observed directly in the data, but are modeled so that their settings
produce the data through independent processes. In an appropriately designed model, these
processes could be interpreted as separate biological systems of interactions inuencing the
overall proteomic prole. The latent variables might indicate the condition of each process,
whether it is in a normal or dysfunctional state. If the model ts the data well, we can then
look at the components of the individual processes to speculate why these components aect
the outcome of a disease. There may be multiple ways to organize the features of a proteomic
prole into biological processes. One option is to use correlations learned from the feature
selection process. Another option is to label the features with their protein identities. If this
organization process is good, we might expect a better t of the model to the data.
5.2 RELATED WORK
5.2.1 Supporting Generalization Error Results
The permutation.based approach compares the error achieved on the true data to errors on
randomly labeled data. It tries to show that the result for the true data is dierent from
results on the random data, and thus it is unlikely the consequence of a random process.
Note that the permutation-based method is dierent and thus complementary to standard
hypothesis testing methods that try to determine condence intervals on estimates of the
target statistics. We also note that one may apply standard hypothesis testing methods
to check if the target statistic for our classication model is statistically signicantly dif-
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ferent from either the fully random, trivial or any other classication model. However, the
permutation framework always looks at the combination of the data label generation and
classication processes and thus establishes the dierence in between the performance on the
true and random data. Classication error is a composite evaluation metric. Other types
of performance measures for which condence intervals have been studied so far include
signicance of SN at a xed SP [119], AUC [120] and the ROC curve itself [121]. Here we
briey explain these options. Which performance measure to assess may vary according to
strategy. Bootstrap-estimated or analytically determined condence intervals around SN at
a specied SP [119] requires that a desired SP be known, and this depends on its intent;
for example a screening test should have very high SP to avoid resulting in too many false
positives when applied to a population. Even here, however, "very high" and "too many"
are rather context dependent, and should not be considered in a silo by ignoring existing
or other proposed diagnostic tests. Acceptable FP values depend to a degree on the SP of
existing practices, and to an extent on the prevalence of the disease. Any screen can be
considered to change the prevalence of disease in the "potential patient" population, and
therefore follow-up with panels of minimally invasive markers, or multivariate studies of
numerous risk factors (demographic, familial, vaccination, smoking history), and longterm
monitoring, might make such screening worthwhile. High-throughput proteomics highlights
the need for dynamic clinical diagnostics.
The various approaches suggested by Linnet were extended and revised with a suggestion
by [122] to adopt the bootstrap condence interval method [123]. A working paper by [124]
explores related approaches. One strategy is to perform bootstrapping [123] and calculate
a 1- condence interval around a measure of interest. Bootstrapping is a subsampling
scheme in which N data sets are created by subsampling the features of the original data
set, with replacement. Each of the N data sets is analyzed. Condence intervals around
some measure of interest (T ) can be calculated or consensus information can be gathered;
in either case, variability in an estimate T is used a measure of robustness of T . Various
implementations of the bootstrap are available; the least biased appears to be bias-corrected
accelerated version [123].
A second strategy is to calculate condence intervals around the AUC measure. Boot-
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strapping [123] is sometimes used to estimate AUC condence intervals. Relying on con-
dence in the AUC can be problematic because it reports on the entire ROC, and, in practice,
only part of the ROC is considered relevant for a particular application (e.g., high SP re-
quired by screening tests. A literature on assessing the signicance of partial ROC curves
has been developed [125, 126]; a recent study [127] compared the features and performance
of eight programs for ROC analysis. A third strategy is to calculate bootstrap condence
bands around the ROC curve itself [121]. Under this approach, bootstrapping is explored
and bands are created using any of a variety of "sweeping" methods that explore the ROC
curve in one (SN) or two (SN and 1-SP) dimensions.
5.2.2 Addressing concerns of Reproducibility
Earlier MS proteomic proling studies stimulated signicant enthusiasm [7], discussion [8],
and controversy [128] in the general scientic community and among proteomics researchers.
Potential confounding and bias in study design and analysis in initial studies [27], were rec-
ognized early on and have been addressed in subsequent research (See [129]) for an overview).
Issues related to confounding and bias in study design and data analysis can be approached
using appropriate principles of clinical epidemiology and laboratory research, together with
careful experimental design and methods for data preprocessing and analysis.
Predictive modeling relies on the detection of potential biomarkers which may explain
disease through previously understudied combinations of reproducible molecular measure-
ments. The reproducibility of these surrogate biomarker patterns often comes into question;
a pattern is not guaranteed to be replicated exactly within the same or other data generation
session, or at a dierent laboratory. This results from the intrinsic variation introduced into
the data by factors including, but not limited to, the biological nature of the samples and
limitations of the MS technology.
Typical proteomic proling studies attempted to minimize the eect of this variation by
generating data in a single session. Classication results on these data sets were encouraging,
but dealt only with the data variation within a single session. These data sets were produced
in the 'ideal' environment where only a single instrument in a single laboratory produces
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all of the available data at the same time. As a result, potential factors of inter-session
and inter-site biases were ignored. Skepticism arose as to whether spectra generated during
multiple sessions separated by variable intervals of time, or by a dierent laboratory, will be
useful for predictive modeling applications. Promising inter-site reproducibility results were
reported by [130,131]. Inter-session reproducibility, however, remains a relatively open area
of research.
5.2.3 Protein-Feature Association
Mass spectrometry (MS) proteomic proling enables a parallel measurement of hundreds
of proteins present in a variety of biospecimens. This technology has shown many very
promising results in dierentiating diseased and control samples in a variety of studies [132{
135]. The studies typically report classication statistics achieved by a predictive model,
such as accuracy, sensitivity, specicity or area under the ROC curve. As a supplement,
features constituting the discriminatory patterns are given as a list of mass-to-charge (m/z )
ratios. Unfortunately, these features were only rarely matched to proteins, which weakened
the overall results and spurred some controversy surrounding the interpretation of these
analyses [8]). Knowing the identities of ion species critical for the group dierences could
lead to understanding the biological relevance of the result and would make the results more
acceptable.
An early approach to feature labeling in TOF-MS data relied solely on information about
mass of the protein species, more specically the m/z ratio of peaks in MS signals [136].
However, many dierent molecules can appear at the same location, and choosing among
them often results in an incorrect or nonsensical identication. Improved mass spectrometry
techniques dependent on sample fractionation enabled better separation of molecules along
the m/z axis by separating them along another dimension, usually elution time. These MS
proling approaches typically use Tandem Mass Spectrometry as opposed to TOF-MS to
recover amino acid compositions of molecules. Despite the additional information, feature
labeling is imperfect and faces several challenges; since this thesis has only TOF-MS data
available, those methods for Tandem MS/MS are beyond the scope of this thesis. For a
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review of these methods and their limitations, see [137,138].
5.2.4 Incorporating Prior Information
In an eort to incorporate more prior knowledge into the learning process, [139] created a data
integration framework using Bayesian networks. The authors proposed that dierent data
sets would necessarily require dierent networks to accurately represent biological processes,
since dierent data sources will have dierent intentions on which processes to measure. In
this work, separate data sources were linked together by various Bayesian network structures,
although the performance of structured vs naive networks did not seem to dier much. Each
data source was modeled as being conditioned on by the functional relationship of a gene pair.
The correlations between expression measurements (as in microarray data) were discretized
and converted into true/false values. The network then predicts the type of functional
relationship responsible for the data. It is largely up to the learning algorithm to utilize
the "prior knowledge", which comes in the form of additional data types such as wet-lab
conformational assays or genetic associations.
Prior knowledge is also concentrated in publicly available sources, such as the Kyoto
Encyclopedia of Genes and Genomes (KEGG, [140]). A paper by [141] sought to use KEGG
as a way to validate prediction of gene pair interactions. The authors use a Bayesian scoring
metric which uses KEGG information as a benchmark. Interacting gene pairs are found to
be linked in various types of data. The scoring metric assigns higher scores to data which
display a greater frequency of links as found in the benchmark pathway information. Each
separate data source provides a score for a gene pair. The authors found it dicult to create
a Bayesian approach to estimate the contribution of each data source, since the data sources
have varying relative independence. As a solution, scores for a gene pair are reweighted
by rank-ordering the scores and dividing by a parameter chosen to optimize accuracy and
coverage of the integrated score on the benchmark. Accuracy was calculated by comparing
to gold-standard small-scale gene interaction assays. The work demonstrated that even weak
evidence from multiple sources can be combined for strong overall evidence for gene linkage
prediction. Furthermore, clustering genes in the resulting network resulted in highly coherent
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clusters in terms of function. The authors suggest the approach can be extended to human
genes and will improve as the amount of collected data increases. Functional analysis of the
clusters must still be done by hand.
Another eort to integrate prior knowledge was undertaken in [142]. Annotated gene ex-
pression datasets in the Gene Expression Omnibus (GEO, [143]) were mapped to concepts in
the Unied Medical Language System (UMLS, [144]). Datasets were partitioned by concept
into those mapped to that concept, and those not mapped. Genes in these datasets are then
tested for signicant dierences between the groups. The score of statistical signicance is
subjected to a random permutation test by permuting the assignments of datasets to con-
cepts. As a result, genes are annotated with phenotypic concepts from the UMLS, which
creates a phenome-genome network derived only from expression data. Validation was done
two ways: by assuring a strict statistical signicance threshold and by obtaining the same
gene-concept links in with homologous genes in other organisms. The latter method can
be restrictive since many conditions are not studied on homologous organisms. However,
thresholding by statistical signicance produced many manually veried relations.
5.3 METHODS
5.3.1 Permutation-Achieved Classication Error (PACE)
The objective of optimizing a classication score itself is largely uncontrolled in most ge-
nomic and proteomic high-throughput analysis studies. Researchers do not, for example,
typically attempt to determine and therefore do not report the statistical signicance of
the sensitivity of a test, in spite of the existence of a number of approaches for performing
such assessments. Here we introduce a permutation method for assessing signicance on the
achieved classication error (ACE) of a constructed prediction model.
Permutation test methods work by comparing the statistic of interest with the distribu-
tion of the statistic obtained under the null (random) condition. Our priority in predictive
models is to critically evaluate the observed classication performance. In terms of hy-
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pothesis testing the null hypothesis we want to reject is: The performance statistic of the
predictive model on the true data is consistent with the performance of the model on the data
with randomly assigned class labels.
Permutation-Achieved Classication Error (PACE, [145] is a statistical validation frame-
work for determining whether the eect of a predictive model is obtained by chance. For
this application, our statistic of interest is the achieved classication error (ACE) of the
predictive model. PACE evaluates a predictive model M by estimating the distribution of
ACE TACE underM . The procedure is represented in algorithm 4 . The number of permuta-
tions is arbitrary; we use 1000 by default. Each time M is evaluated on a dataset, the ACE
is estimated through cross-validation over multiple train/test splits to reduce the eect of
subsampling bias. If the true ACE of M falls on the tail of T beyond the threshold specied
by , the null hypothesis is rejected. This indicates that the predictive ability of M is less
likely to be by chance. This property gives additional assurance that M is valid model.
input : Predictive model M , signicance threshold , number of permutations B
output: Success of hypothesis test
Compute ACE T of model M on original data
for b 1 to B do
Permute the group labels in the data
Compute the ACE Tb for model M on the modied data
end
Calculate the p{value of T with respect to the distribution dened by permutations b
as: p = NTbT=B, where NTbT is the number of permutations for which the test
statistic Tb is better than T under the true labeling
if p <  then
Reject null hypothesis, validation succeeds on M at condence level 
else Accept null hypothesis, validation fails on M at condence level 
end
Algorithm 4: PACE Algorithm
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5.3.2 Measures of Reproducibility
PACE evaluates a model holistically. The permutation-based framework can be specialized
to the feature level to measure the stability of information found in the data. From an eval-
uation standpoint, these analyses are particularly useful when dealing with data produced
throughout multiple sessions. An ideal model should locate generalizable, robust features
to use for the discrimination process. The same feature set across datasets for the same
(or possibly for similar) diseases should remain strong if they are valid. To this end, a set
of reproducibility metrics is presented to measure the reproducibility of information across
data [39, 146]. These techniques also attempt to quantify how much inter-session variabil-
ity plays a role in the performance of predictive modeling. Specically, these techniques
demonstrate 1) the presence of intersession noise, 2) the similarity of proles from dierent
sessions, 3) the reproducibility of aggregate patterns and 4) the generalizability of a model's
performance when using inter-session data. The individual techniques are described in more
detail below. A feature set which displays strong reproducibility characteristics across multi-
ple data sessions is likely to benet an accompanying predictive model, which can be further
evaluated with the PACE framework described above.
 It is possible to examine the dierences in signals from the same sample across multiple
sessions. A signal dierence score is dened to measure the discrepancies between signals
from the same sample. The hypothesis tested is whether the signal dierence score for
proles from the same sample is signicantly better than proles from other samples.
This would indicate that identical samples processed in multiple sessions experience
more similarity to themselves than to other samples in the session, supporting the usage
of proles from multiple session for analysis purposes.
 The second proposed test asks whether discriminative information is aected by inters-
ession noise. This issue is analyzed on the feature signal and multivariate levels, using
dierential expression and classier accuracy metrics, respectively. The eect of inters-
ession noise on these statistics is determined by comparing them on single-session and
randomized multi-session data sets.
 The nal proposed tests evaluate the predictive performance of multivariate models on
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future sessions. One test evaluates by how much the performance of classication mod-
els deteriorates on future sessions with respect to their 'ideal' single-session performance.
The other test asks if performance of a multivariate model on future sessions can be
improved if the model is trained on mixed-session data. The hypothesis is that if inters-
ession variability exists, it can be learned through multi-session data, potentially leading
to accuracy gains over models trained on single sessions.
The specic methods to test these objectives are outlined below.
5.3.2.1 Reproducibility of prole signals No two MS proles are exactly the same.
Proles may dier due to instrument noise, dierences in sample preparation procedures,
etc. Dierences in proles for the same sample are visible even if two prole replicates are
generated in the same session, and even if they are placed on the same chip. The intra-session
prole variation is well known and existing methods are robust enough to cope with it. The
dierences in proles for the same sample across multiple data generation session are much
less understood. The dierences in the sample preparation at dierent times, instrument
settings may eect the resulting proles and contribute to possible inter-session biases and
variability.
Figure 22 displays four MS proles from the same sample that were generated in four
dierent sessions. Although the shape of the prole may look similar, dierences in relative
intensities of peaks are apparent. Are these dierences signicant? Are these variations too
strong to overcome so that the proles from the same sample are useless and easy to confuse
with proles generated for other samples? To answer these questions we need to dene a
similarity (or distance) metric that helps us assess the dierences among proles. We would
like MS proles from the same sample to dier less across sessions than proles from other
samples. To achieve this goal we measure the similarity among a set S of k spectra using
the average Euclidean distance dE between all pairs of spectra:
dE(S) =
1
k(k 1)
2
X
81p<qk
vuut dX
i=1
(pi   qi)2 (5.1)
where p and q represent a pair of spectra from the subset of k replicate spectra generated
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Figure 22: MS proles for a single sample across 4 dierent sessions. Changes are apparent
in relative intensities of peaks.
from the same sample source. Intuitively, the signal dierence score measures the sum of
areas between all possible superimposed pairs of k spectra; smaller values indicate better
similarity.
We used the above signal dierence metric rst, to evaluate the similarity of spectral
measurements from the same sample across multiple sessions and then, to determine that
the dierences from random collections of spectra from other patients are very dierent and
thus proles that originate from the same sample are hard to confuse with other proles.
A random permutation test [118] was used to test the dierences and their signicance.
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We rst estimated a distribution of signal dierence scores for randomly grouped spectra.
Random groupings were generated by shuing the sample identities assigned to spectra in
each session. The signal dierence score was recalculated for each random prole grouping,
and the process was repeated 1000 times to estimate the distribution of signal dierence
scores for randomly grouped spectra. Next, the signal dierence score for proles belonging
to the correct samples was calculated. If the score is statistically signicantly dierent with
respect to the estimated distribution, we have greater condence that signals from the same
sample are similar to each other beyond random eects. This increases our condence that
proles generated from multiple sessions are potentially useful for analysis.
5.3.2.2 Reproducibility of Discriminatory Signals Evaluating prole similarity
across sessions helps assure us of the basic consistency (reproducibility) of spectra with
respect to samples their represent. However, the dierences in proles across multiple sessions
are apparent (see Figure 22). This leads to a concern that information potentially useful
for disease detection purposes may be lost or at least signicantly compromised if data from
multiple sessions were used in the analysis. To assess the eect of the potential information
loss we compare data mixed from multiple sessions to data generated from individual sessions
and their discriminatory power.
The information that helps us discriminate between healthy (case) and diseased (control)
proles can be drawn from a single feature (peak) of the prole, or from a combination of
multiple features. We measure the quality of discriminative information for a single feature
(peak) by its dierential expression score. The score quanties the dierence observed in
a prole feature between case and control groups. In this paper, we use the Fisher-like
score, computed as j(+) ( )
(+)+( ) j, where  and  represent the sample mean and variance of the
feature, respectively. The signs (+) and ( ) denote case and control samples, respectively.
We note that dierential expression can be measured using many other criteria [25] which
would work just as well.
Testing peaks' discriminatory information loss: To determine if the dierential expression
information is lost across multiple sessions we assumed that feature's dierential expression
follows a distribution across sessions. The distribution can be empirically estimated by ran-
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domly choosing each sample's spectrum from its replicate set. We generate 1000 randomized
datasets and calculate a feature's dierential expression score under each dataset to recover
its empirical distribution.
If the proles generated in a single session retain more discriminatory information, we
expect their dierential scores to be higher on average than the mixed-session distribution.
We can test this by comparing the dierences in between the mean score for the mixed-
session distribution and the score for the single-session. We have four dierent sessions per
sample and multiple spectra peaks. We use 100 peak regions, evaluate their single-session
scores and compare their peak scores to the distributions generated for mixed session data.
This process generates a distribution of score dierences. If the single session spectra are
'better' we expect them to be dier on average from 0. This dierence and its signicance
can be assessed using standard one-sided hypothesis testing framework.
Testing multivariate information loss: The reproducibility of dierential information in
individual features may be indicative of the reproducibility of discriminative information
given by combinations of these features. However, this is not guaranteed. Are the feature
combinations dierently represented across sessions? If we mix data from dierent sessions,
what is the eect on the discriminative pattern and the resulting predictive model? To
answer these questions, we examine if the performance of a predictive model deteriorates on
data mixed from several sessions, as opposed to data from the same data-generation session.
Performance of a predictive model is typically measured using accuracy (percentage of
correct predictions), sensitivity and specicity, or area under the ROC curve statistics. In this
work, we evaluate predictive models using their test set accuracy. Similarly, there are many
classication models one may try to learn multivariate patterns. We use the linear Support
Vector Machine model [72,91] to learn the relationship between diagnostic features and state
of disease. This method has been used previously in many cancer studies [25,38,147] and is
particularly favored for its 'regularized' feature selection.
To assess the reproducibility of multivariate classication patterns across sessions, we
generate 1000 random datasets such that each patient (sample) receives one of the proles
from its replicate set. Our goal is to analyze dierences in the performance of classiers on:
(a) models trained and tested on proles from multiple sessions, versus (b) models trained
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and tested on proles from the same session. To measure test accuracies of models we rst
decide which patients (samples) will be used for training and testing purposes. Forty-six
patients (samples) are split via random subsampling [148] so that 30% of the samples are in
the test set. The spectra obtained for the remaining samples are used to train the predictive
model. The split is always the same for both single-session and multi-session models. Test set
accuracies of 1000 random models dene a distribution of accuracy scores for multi-session
data. This distribution can be compared to accuracy results for models trained and tested on
four single sessions. However, four single sessions entries are not sucient to make any strong
conclusion. In addition, there is a chance a single train and test split may be biased. To
eliminate these problems, we repeat the analysis for multiple (30) train{test splits. This lets
us calculate 120 accuracy scores for single session models (30 per one session) and compare
them to respective accuracy-score distributions dened by 1000 multi-session datasets. To
assess the benet or loss of multi-session data, we compare the mean of their accuracy-score
distribution to accuracies achieved by single-session models. To assess the global benet or
loss, we average the results over four dierent sessions.
5.3.2.3 Eect of multi-session data on generalization performance In the 'ideal'
analytical setup for proteomic proling studies, a predictive model is trained and evaluated
on data from the same session. It experiences only within-session noise and does not account
for potential inter-session noise, should it be re-used for future prediction of proles. How-
ever, in the practical setting of clinical screening, new samples may be processed on-the-y,
each at a dierent time and therefore experiencing unanticipated amounts of inter-session
variability. Concerns about this inter-session reproducibility is related primarily to concerns
over generalizability of predictive models that are extracted from past data sessions to pro-
les obtained in the future. We will analyze this aspect of the problem by learning predictive
models that are tested on proles from one target (test) session and trained on the proles
from the remaining three (training) sessions and by comparing them to the 'ideal' model
trained and tested on the proles from the same session.
We perform this analysis as follows. A target (test) session is chosen from the available
four sessions. The remaining three sessions are used to train a (future) predictive model.
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Next, samples are divided via the random subsampling approach to training and testing
samples, such that 30% of the samples are in the test sample set. The remaining samples are
represented in the training sample set. Next, we generate 1000 multi-session training datasets
by assigning each patient in the training sample set a prole from one of its training sessions
and learn the models for each dataset. The models are tested on the test session samples
and their accuracies dene the distribution of (future) test accuracy scores for mixed-session
data. The mean of the distribution is then compared to the accuracy achieved by the model
trained on the same session as the test session. To provide additional assurance we repeat
everything using 30 dierent train-test sample splits and average the results. This will let
us compare the average future performance of mixed-session models to the 'ideal' model for
one test session. The global performance can be assessed by averaging the results for four
test sessions.
In our rst comparison of (a) models trained on proles from the three training sessions,
versus (b) an 'ideal' model trained on proles from the same session as the testing set,
we expect the 'ideal' models to outperform the multi-session-trained models. Inter-session
variability is not present in the ideal model and is therefore expected to cause a loss of
performance. Our second aim is to compare models from group (a) versus (c) models trained
on proles from a single session other than the target session. The objective is to determine
if predictive models trained on multi-session data can learn to adapt to inter-session noise
and hence improve their performance when compared to models learned on single sessions.
We repeat the setup in the previous experiment to estimate the distribution of accuracy
scores for the 1000 models trained on multi-session data. Accuracy scores are also obtained
from models trained on one of the three single sessions. The dierence between the mean
accuracy of the multi-session models and single-session models are kept for a total of 3
dierences. This process is repeated 40 times for each of the four target sessions. We repeat
the hypothesis test to determine if the mean of these dierences diers signicantly from
0. In the case where multi-session models have the same generalization performance as
single-session models, the mean of this distribution should not dier signicantly from 0.
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5.3.3 Peak Labeling
A new computational approach for assigning protein labels to peaks in MS spectra is de-
scribed below. This method builds upon the information about the mass of a protein's
sequence and prior knowledge of the expected abundance of that protein in the biospecimen.
The method starts from a list of protein species that may show up in the prole, along
with their masses and expected relative abundances in the biospecimen. The method then
attempts to match the proteins to peaks observed in the prole while tting the recorded
mass and intensity characteristics of the peaks. Since the measurements in the MS prole
are noisy in both the mass and intensity dimension, it is not immediately clear what peaks
correspond to what protein species. To model this uncertainty we rely on a probabilistic
model that represents the distribution of measured masses and measured intensities for a
protein in the specimen.
The distinguishing characteristic of this peak-labeling approach is the inclusion of the
peak intensity aspect in the model. A previous approach to peak labeling relied solely on
information about mass of the protein species, more specically the m/z ratio of peaks in
MS signals [136]. However, many dierent molecules can appear at the same location, and
choosing among them often results in an incorrect or nonsensical identication. Our im-
provement is to incorporate information about the expected relative abundances of proteins
in the sample. Therefore, the intensity aspect attempts to match labels to peaks based
on the expected relative abundance of the label's peptide. For a reliable labeling, a label
must t the criteria of a good match to the location and intensity aspect of the peak signal
simultaneously.
We believe our current development eort is particularly important for high-throughput
whole-sample proteomic proling and its post-interpretive analysis. The term \whole-sample"
refers to methodologies which do not signicantly deplete or fractionate samples prior to their
MS analysis.
5.3.3.1 Probabilistic Model A mass spectrometry prole consists of a series of peak
measurements. Our method assigns protein labels to these peaks. Each label uniquely
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identies an ion species (charged molecule of a protein or peptide) believed to be responsible
for the peak. A probabilistic model and associated probabilistic score takes into account
expectations about where ion species may produce peaks in the MS spectrum, and how
intense they may be. The probabilistic score is optimized using a dynamic programming
algorithm.
MS proles occur as a series of measurements in two dimensions. The mass-to-charge
(m/z ) ratio reects the mass of the measured ion, and its corresponding intensity reects the
number of ions measured at that m/z. Measurements in a close neighborhood may aggregate
to peaks. These peaks may represent an ion species in the sample, or noise due to various
sources. Typical MS prole analyses focus only on peaks selected from the proles. Hence
our analysis focuses only on peak-based proles.
We dene an observed MS prole S by a set of peak measurements
S = f(x1; y1); (x2; y2); :::; (xn; yn)g
where xi denotes the m/z location of the i
th peak measurement, and yi its corresponding
intensity. The peak's m/z ratio reects the mass of the measured ion species creating that
peak. The peak's intensity reects the number of ions measured at a m/z ratio and measures
(indirectly) the concentration of the species.
Our goal is to annotate peaks in the MS proles with ion species labels. We approach
this task by associating peak measurements to labels. Let L = fl1; : : : ; ldg denote a set of
labels for ion species we believe may be present in the prole. Each label l can be associated
with either: a peak measurement m = (x; y) appearing at m/z location x and intensity y,
or the m = null value denoting a situation in which l does not get a peak. We refer to
the collection of these label-to-peak assignments as a label-induced prole and denote
it as SL = fm1;m2;    ;mdg. Figure 23 illustrates the idea, note that the label-induced
prole is only a subset of peaks of the original prole. Since MS proles are noisy, one set of
species labels may lead to more than just one prole SL. We therefore dene a probability
distribution P (SL) that reects how probable each of these proles is.
To model the relation between a label-induced prole and an observed prole, we assume
the observed prole S is generated from the labeled prole SL by adding additional peaks
to SL. These peaks may correspond to species not in L or to noisy measurements. Figure
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23 illustrates the relation between the two proles. We assume the probability P (SjSL) is
uniform for every prole S consistent with SL and 0 for every inconsistent prole. The two
proles S and SL are said to be consistent if every peak in SL is matched in terms of the
location and intensity.
5.3.3.2 Peak-labeling as an optimization problem Our goal is to nd the labeling
that gives the best label-to-spectrum t. In other words, we want to identify the best possible
label-induced prole SL as supported by the observed prole S. In terms of a probabilistic
model, the problem can be cast naturally as the problem of nding a label-induced prole
SL with the highest posterior probability:
SL =argmax
SL
P (SLjS) =argmax
SL
P (SjSL)P (SL)
P (S)
(5.2)
Since the denominator is common for all assignments, it is sucient to optimize its
numerator:
SL =argmax
SL
P (SjSL)P (SL) (5.3)
The rst term represents the conditional probability of observing a spectrum S given the ion
species in SL. The second term is the prior probability of SL. For the sake of simplicity, we
assume that P (SjSL) is approximately equal for all consistent matches of S and SL. In such
a case, the optimization reduces to the problem of nding the prole SL that is consistent
with S and that maximizes P (SL):
SL =argmax
SL
P (SL) such that SL is consistent with S (5.4)
A label-induced prole SL = fm1;m2;   mdg assigns peaks to labels in L. If no peak
is assigned to a label, a special 'null' value is used. Consequently, the model of the prior
distribution for SL, P (SL), can be dened in terms of an auxiliary label-induced-indicator
prole S^L = fu1; u2;   udg that determines whether or not each peak is assigned a label,
but does not give specics of peak measurements. Correspondingly, the values of a random
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Figure 23: An interpretation of the probabilistic model. Top: the label-induced prole
relates ion species labels with peak measurements (thick lines) in the prole. Some labels
are not assigned to any peak (B and D are therefore struck out). Bottom: the observed
mass spectrum S is given by the label-induced prole SL plus additional noise and unlabeled
measurements (thin lines). c2010 IEEE.
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variable ui are true or false for peak and 'null' outcomes respectively. Since the label-induced-
indicator prole is fully determined by SL and does not introduce any new information
1 we
can rewrite P (SL) as:
P (SL) = P (SL; S^L) = P (SLjS^L)P (S^L);
where P (S^L) is the probability of the labels in L being assigned to peaks or not and P (SLjS^L)
denes the probability distribution of peaks with certain location and intensity characteristics
for all non-null assignments.
We dene P (S^L) by assuming that the probability of an individual label receiving a peak
is independent of other peaks:
P (S^L) =
dY
i=1
p(ui) (5.5)
where p(ui) is the probability of seeing or not seeing a peak for an i
th label. This distribution
is dened in terms of a single parameter pi;0 that denotes the probability of the i
th ion species
failing to appear as a peak in the label-induced spectrum.
To dene P (SLjS^L) we propose and analyze two models that dier on the peak informa-
tion incorporated into the model. The rst model denes the distribution of label-induced
peaks only in terms of their location information and ignores peak intensity measurements.
The second model combines both the peak location and the peak intensity information to
dene the distribution.
5.3.3.3 Peak-location aspect First, let us consider a model for P (SLjS^L) that incor-
porates only information about location of ion species in L into the model. In this case, SL
can be redened as vector of the x components of fm1; : : : ;mdg. We denote this projection
as SxL.
Briey, if an ion species is present we expect it to be observed in the vicinity located
around its m/z ratio. In other words, the closer the peak is to its expected m/z ratio, the
better its peak-label t should be. We dene the probability of a label-induced spectrum as:
1The only reason to introduce the auxiliary prole is to simplify the denition of the distribution of SL
that uses random variables with a hybrid (null or peak measurement) outcomes.
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P (SxLjS^L) =
dY
i=1
P (xijS^L) (5.6)
where P (xijS^L) is dened as:
 P (xijS^L)  N(xiji; i) if the peak for the ith label is among the observed peaks, that
is, ui = true
 P (xi = nulljS^L) = 1 if the peak for the ith label is not among observed peaks, that is,
ui = false
 P (xijS^L) = 0 for all other cases.
The parameter i is the expected time-of-ight (TOF) position
2 of the ion species corre-
sponding to the ith label. The standard deviation i is set to reect the amount of mass
inaccuracy expected for the ith ion species.
Combining the model with the model for P (S^L) in equation 5.5, the probability of a
label-induced prole SL is:
P (SL) = P (S
x
LjS^L)P (S^L) =
dY
i=1
P (xijui)P (ui) (5.7)
where
P (xijui)P (ui) 
N(xiji; i)(1  pi;0) if ui = true
pi;0 if ui = false:
(5.8)
The advantage of the above model is that it decomposes along individual labels in L.
However, the decomposition comes with one limitation. It permits an out{of{order assign-
ment of labels to peak locations, that is, there is a non-zero probability that two labels with
expected m/z values i > j will switch their order in the label-induced prole. We do
not expect this situation to occur, although close paralogs may violate this order. To x
the problem we keep the above decomposable model, but always enforce the m/z locations
of peaks to be order-consistent with the expected masses of their labels. If paralogs with
very close masses are present in the label database, their order will depend on the expected
masses of their labels.
2The TOF is approximately equal to the square root of the ion's mass. Peak locations are converted to
TOF during calculations.
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The other advantage of the model is that parameters i, i and pi;0 restrict the range of
possible peak assignments to the ith label. Briey, the ith label can be assigned a peak with
location x only if
pi;0 < (1  pi;0) 1p
2i
exp

 (x  i)
2
2i

If this condition is not satised, the null assignment is preferred to a peak at x. This is
important since only peaks close to the expected m/z value should be considered as potential
matches for ith label.
5.3.3.4 Location-based peak-labeling algorithm The main advantage of our peak-
location model is that the optimization of SL can be carried out by a dynamic programming
procedure. The decomposability of the score and the fact that possible peak matches are
restricted by the parameters i, i and pi;0 lets us assign a peak to a label by only considering
peaks and labels in the close vicinity of its expected mass i. This is a favorable environment
for dynamic programming.
The proposed dynamic programming procedure works as follows. First, the set of labels
are sorted according to their expected mass. Then, each label is visited in ascending order
of its expected mass. The label can be associated with one of the peaks in the feasible range
of the represented ion species (dened by its pi;0 and i values), or with nothing (the 'null'
value). For each of these assignments, we calculate and keep its partial score and optimal
partial assignments to all previously scanned labels. If no peak is assigned to label i, pi;0 is
used. The process continues till all feasible peak-label pairs are examined and their scores
are assessed. The optimal peak-to-label pairing sequence is the output of the method.
5.3.3.5 Peak intensity aspect The optimization of the label-to-peak assignments above
was performed using the knowledge of the protein sequence and its mass. In addition, one
can obtain the information about the species expected concentrations in dierent types of
samples. The abundances of proteins and peptides in relation to each other can inform on
the proper assignments of labels to peak measurements in the prole.
We wish to incorporate information about protein and peptide relative abundance into
our peak-labeling procedure. We assume that measurements along either the location or
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Sort labels in ascending order based on expected mass.
for k  1 to d do
Compute a portion of SL by aligning labels la;    ; lb 2 L and peaks
mp;    ;mq 2 S which lie in a feasible window around label lk by maximizing
P (SL) through dynamic programming:
for i = 0 to b  1 do
score(i; 0)( pk;0  i
end
for j = 0 to q   1 do
score(0; j)( pk;0  j
end
for i = 1 to b do
for j = 1 to q do
P (SL(mk = xj))( score(i  1; j   1)  P (xjjuk)P (uk = true)
P (SL(mk = null))( score(i  1; j)  pk;0
P (SL(mk = null))( score(i; j   1)  pk;0
score(i; j)( max(P (SL(mk = xj)); P (SL(mk = null)))
end
end
end
return SL
Algorithm 5: Location-based peak labeling
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intensity axis happens through independent mechanisms, and that the noise models for
these mechanisms appear to be unrelated. This allows us to decompose the probability of
observing the spectrum under a given assignment as:
P (SL) = P (SLjS^L)P (S^L) = =P (SxLjS^L)P (SyLjS^L)P (S^L) (5.9)
We reuse the denition of the peak location aspect (from equation 5.6) for the rst factor.
The second factor in the probability denes the peak intensity aspect. Our assumption is
that relative abundance of the ion species in the sample is reected by their measured relative
intensities. Thus, the peak intensity aspect models the probability of peak intensities in SL
for all peak-to-label assignments. We dene the intensity aspect of SL as the vector of
y-components of fm1;    ;mdg and denote it as SyL. To model the relative abundance of
species that appear as peaks, we use the Dirichlet distribution:
P (SyLjS^L)  Dir(~yj1; : : : ; d) 
 (di=1i)Qd
i=1  (i)
dY
i=1
~yi 1i (5.10)
where ~y = (~y1; : : : ~yd), such that ~yi =
yiPd
j=1 yj
is the intensity value for the measurement
assigned to the ith label, renormalized according to intensities of other peak candidates in
L. The parameters of the distribution f1; : : : ; dg reect the expected concentrations of d
proteins and their variance.
The primary purpose of incorporating both intensity and abundance information is to
resolve possible misassignment of peaks to labels. Consider two peaks that are in the region
of the MS prole in which we expect a higher abundance protein to occur. Figure 24 displays
an assignment of peaks to the labels for protein A and B. While A appears as the only peak
in the region around its expected position A, there are many peaks around the expected
position B of protein B. Because of spectral misalignment, the peak caused by protein B
may not be the closest peak to its expected location B. However, we can correct for such
a problem by considering the relative abundance information. For example, if we expect
protein B to be about one fth more abundant as protein A, even if the peak with a higher
intensity is further from the expected mass, the label may be reassigned to account for a
proper t to expected concentration levels.
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Figure 24: An illustration of misassignment which is correctable by our procedure. Expected
positions of proteins are marked as , where the true identication of a peak is marked with
a capital letter. Abundance information can help to reach the correct assignment if we know
that protein B is one fth more abundant as protein A. c2010 IEEE.
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Note that the above Dirichlet distribution model factorizes over the individual intensities
if the normalizing constant
Pd
j=1 yj is known. In such a case, we would be able to couple
factors from the Dirichlet with factors in the peak position model (see previous section) and
optimize the two together locally within the dynamic programming scheme. Unfortunately,
the normalizing constant depends on peak-to-label assignments made over the complete
prole. This violates the assumption underlying the dynamic programming calculations, that
the probabilistic score can be calculated using only information from a partial assignment.
5.3.3.6 Enhanced peak-labeling algorithm To overcome this problem, we approxi-
mate the components used in the calculation of the normalization constant through a greedy
heuristic procedure. The procedure works as follows. First, the labels for ion species (pro-
teins) in L we expect to see in the prole are sorted according to their abundance. Following
this order, the label is assigned to the largest unlabeled peak in the region dened by its
expected mass i, i and pi;0. The fact that the largest peak is labeled corresponds to the
situation in which an ion species with the highest concentration claims the peak. The greedy
procedure does not optimize for combinations of assignments, but the hope is that it gives
a good initial assignment.
The heuristic assignment gives an initial set of peak-to-label assignments and it is used
to estimate the Dirichlet portion of the probabilistic score. Combining the location and
intensity aspects, the probabilistic score becomes:
P (SxLjS^L)P (SyLjS^L)P (S^L)    (
dX
i=1
i)
dY
i=1
~yi 1i P (xjS^L)
 (i)
(5.11)
Given the initial heuristic peak-to-label assignment, the optimization of m can be per-
formed using the same dynamic programming approach as outlined above. For each label, all
peak-to-label matches inside the feasible region of the current label are optimized and their
partial score is calculated. To obtain the Dirichlet portion of the score for each peak-to-label
match, the intensity components needed for its calculation are obtained from: (1) the partial
optimal assignment of peaks to labels already computed by the algorithm, or (2) the initial
heuristic peak-to-label assignment. Since some of the labels may be assigned the 'null' value,
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the intensity of the null-assigned peak is set to equal the level of noise observed within its
feasible region.
Because of the initial heuristic intensity assignment, the dynamic programming procedure
may not lead to the optimal assignment in the rst pass. To correct the heuristic assignment,
we run the algorithm multiple times so that a more rened initial intensity assignment is
used in the next step. The algorithm is run until no change in the global peak-to-label
assignment is observed.
5.3.3.7 Applying the Model The above model is a general framework for labeling
peaks. This accommodates for changes in the technology producing mass spectra, which
can dier greatly. In our experiments, we test our peak-labeling method on mass spectra
from both a simulated matrix-assisted and a surface-enhanced laser desorption/ionization
TOF spectrometer. Thus, we set the parameters of our method to appropriate settings for
time-of-ight mass spectrometry.
Measurements which contend for a label are obtained by selecting \peaks" from the
MS signals. While there are many ways to measure and select a \peak", we take the
following approach [25] : We begin with a set of available data D = S1; S2; :::; Sk, con-
sisting of k spectrum signals. In the rst step, a \mean" prole is created such that
Smean = (x1; (
P
k y1k)=k); (x2; (
P
k y2k)=k); :::; (xn; (
P
k ynk)=k). This achieves a smoothing
eect which ensures only highly expressed and reproducible peaks become prominent. Next,
the local maxima of the mean prole are selected. Finally, a signal-to-noise lter is applied
to remove those peaks that lie close to the baseline. This results in the selection of peak
locations that appear to be highly reproducible.
Peak intensity correction Care should be taken when assigning intensities to peak
measurements. The intensities reported should reect the number of measured molecules for
that peak to the best degree possible. If the intensities for all measurements are misrepre-
sented unintentionally, the assumed Dirichlet model may not t well, and few peaks will be
labeled. The necessities for corrections depends on the accuracy with which intensities are
reported by the MS technology. For example, our matrix-assisted laser desorption/ionization
(MALDI) TOF MS simulator produces wider, shorter peaks for larger mass molecules. The
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Sort labels in ascending order based on expected sample abundance.
Perform the initial heuristic alignment:
for i = 1 : : : d do
Select all unassigned measurements in S feasibly located around i.
Assign label li to the most intense of these peak measurements.
end
repeat
for k = 1 to d do
Compute a portion of SL by aligning labels la;    ; lb 2 L and peaks
mp;    ;mq 2 S which lie in a feasible window around label lk by maximizing
P (SL) through dynamic programming:
for i = 0 to b  1 do
score(i; 0)( pk;0  i
end
for j = 0 to q   1 do
score(0; j)( pk;0  j
end
for i = 1 to b do
for j = 1 to q do
P (SL(mk = mj))( score(i  1; j   1)   (
Pd
i=1 i)
~y
i 1
j P (xj jS^L)
 (i)
P (SL(mk = null))( score(i  1; j)  pk;0
P (SL(mk = null))( score(i; j   1)  pk;0
score(i; j)( max(P (SL(mk = mj)); P (SL(mk = null)))
end
end
end
until no change in SL
return SL
Algorithm 6: Peak-labeling with abundance information
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areas under these peaks may be quite large, but the critical points of these peaks are much
lower.
Since we use the height of the critical point of a peak as its intensity, a correction is
necessitated. We do this by rescaling the value yj at the peak's critical point. We assume that
peak measurement distributions follow a Gaussian distribution [1]. The standard deviation
of this distribution, j, is used as an estimate of the spread of a molecule's peak at m=z
position xj. We rescale the intensity yj of the peak by a factor of yj=cj ,where cj is the
value at the critical point of a normal distribution with mean 0 and standard deviation j.
This results in a better estimate of intensities, and therefore a better t to the empirical
abundance model used by the method.
Our procedure relies on a database of information about proteins which are expected or
may be found in a particular sample medium. While this data often comes from specialty
laboratories, eorts are underway to characterize popular sample types such as plasma [149],
urine [150] and saliva [151]. Using the available and appropriate references for the sample
medium in question, we select the most highly abundant proteins and collect information
about them. The result is a set of candidate labels for protein and peptide signatures in the
spectra.
We begin building the set of labels by connecting to databases such as ExPAsy3, UniProt4,
and the NCBI Entrez Protein database5. The amino acid sequences and molecular features
regarding the abundant peptide candidates found in the literature are retrieved. As an ex-
ample, gure 25 shows the relevant information obtained from Swiss-Prot about the Serum
Amyloid A (SAA) precursor protein, an abundant acute-phase reactant in human serum.
We use this information to compute the expected mass of a molecule of SAA. This is done
by adding the average isotopic masses of the amino acids in the given sequence, in addition
to the average isotopic mass of a single water molecule. A label with this expected mass is
added to the label database.
The location of a protein or peptide's signature along the x-axis depends on its TOF
through the mass spectrometer. This is approximately equal to the square root of the
3http://www.expasy.org/
4http://www.uniprot.org/
5http://www.ncbi.nlm.nih.gov/Entrez/
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Serum Amyloid A Precursor (SAA HUMAN)
MKLLTGLVFC SLVLGVSSRS FFSFLGEAFD GARDMWRAYS DMREANYIGS DKYFHARGNY
DAAKRGPGGV WAAEAISDAR ENIQRFFGHG AEDSLADQAA NEWGRSGKDP NHFRPAGLPE KY
key from to length
SIGNAL 1 18 18 Signal peptide
MOD RES 101 101 1 N4,N4-dimethylasparagine (Probable).
Figure 25: Summary of information taken from the Swiss-Prot database on the Serum Amy-
loid A Precursor protein (Accession SAA HUMAN). The amino acid sequence, as well as 2
potential post-translational modications and their positions of occurrence, are indicated.
c2010 IEEE.
expected mass of the corresponding molecule. In the case of multiply-charged ions of the
given molecule, the m=z position of the singly-charged molecule is divided by the number of
(positive) charges expected.
In addition, information is given about post-translational modications, which can change
the amino acid structure, and subsequently the mass, of the molecule. These include phe-
nomena such as glycosylation and phosphorylation. Potential, probable, and conrmed sites
for post-translational modications are documented in the most popular protein and peptide
databases. In our example, SAA can undergo signal peptide cleavage, as well as a dimethy-
lation at residue 101. For each possible modication, the average weight of the modifying
molecule is added or subtracted as necessary to that of the original, unmodied molecule.
In the case of multiply-charged ions, the expected mass is divided by the amount of charges.
A new label with the modied mass is added to the label database. We avoid considering all
combinations of modications by incorporating only a single modication per label. Figure
26 displays the resulting label list after processing SAA and its modications.
5.3.3.8 Protein abundance It is unrealistic to believe that every ion species with a
specic molecular weight will be detected by the MS technology in use at its expected m/z
location. Moreover, multiple proteins or peptides can share a similar expected m/z position.
We augment our labeling procedure by including information about the relative abundance
of proteins or peptides in the sample. This is expected to be reected in the spectra by the
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Ion Species Expected Mass/Charge Ratio (Daltons)
Serum Amyloid A 13532.02104
SP-cleaved Serum Amyloid A 11682.70064
Dimethylated, Serum Amyloid A 13560.07484
Serum Amyloid A +2H 6766.01052
Figure 26: List of candidate protein labels resulting from information collected about Serum
Amyloid A. The list includes the original precursor ion, post-signal-peptide cleavage, post-
dimethylation and post-double charge forms with their estimated mass/charge ratios. c2010
IEEE.
intensity of the signal along the y-axis.
In an 'ideal' measurement process, the relative abundances of molecules in the biospec-
imen should be evident in the intensities of peaks they produce in the spectrum [152]. For
example, consider a pair of peaks, with the rst peak being twice as intense as the second.
In the best case, the rst peak would be more likely generated by a molecule which was
twice as abundant in the biospecimen as the second peak's molecule. However, many factors
indicate that abundances of molecules in the biospecimen are not truly reected by intensi-
ties in resulting mass spectra [153]. Instead, the intensity of a protein or peptide's signature
along the y-axis depends on the amount of molecules successfully ionized and detected by
the spectrometer.
Accurately quantifying the amount of each molecule measured in proteomic studies is
a complex and ongoing eld of research. The emerging methods for protein quantitation
use stable isotope labeling [154] to dierentiate between the proteins in two sets of sample
pools. One sample pool is marked with a heavier molecular tag and the dierence is noted
in a shift of peaks along the x-axis equal to the weight of the tag. More recently, computa-
tional approaches have been developed for determining the relationship between the quantity
of molecules in a sample and the amount of signal generated by their presence [153, 155].
These methods generate prior expectations of how well a protein or peptide can be detected
based on its composition. Although these methods do not perfectly quantify the amounts
of proteins measured, their computational nature negates the cost of chemical reagents. A
key notion of these methods is that component peptides of proteins each have dierent de-
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tectabilities. This is important to know in standard protein identication, which fragments
proteins into their component peptides. In our alternative approach of peak labeling, pro-
teins are generally left intact. Thus their detectability is likely an aggregate function of
its component peptides. The determination of this function is not straightforward, but our
model incorporates this function as a parameter . The abundance variation parameter  is
intended to represent the relationship between the content of a given ion species in a sample,
and the mass spectrometer's observation of that ion species in terms of relative intensity.
Accurately expressing this relationship is an ongoing process. In light of the this uncertainty,
we make a number of limiting assumptions which facilitate the operation of our procedure.
We assume all molecules have an equal chance to ionize, and that their relative abun-
dances should be ideally reected through any measurement technique at any level. Proteins
and peptides may exhibit ionization diculty, which results in a weak or failed attempt to
quantify molecules that are present in the mixture. Previous work has addressed some of
the causes for this diculty by determining the eect of a peptide's physical and chemical
properties on its chance to be observed [153,155]. Incorporating this information into a ner
estimate for  is beyond the scope of this paper.
Second, we assume that proteins or peptides which experience modications occur in
the same abundance as their original, unmodied form. We make this assumption because
there is little publicly available empirical evidence indicating how often modications occur
under various experimental settings. An extension of this work, in which the occurrence of
modications is estimated based on function of the protein or peptide, is under way.
Third, we assume that the abundances of proteins or peptides should be ideally reected
through any measurement technique. Any measurement technique has the possibility of
favoring a particular class of molecules. We make this assumption to avoid generating our
expectations of abundance based on biased measurements. We wish to avoid particularities
about specic measurement technologies, each of which can be sensitive towards a particular
class of molecules.
Following these assumptions, it is only necessary to collect the relative abundances of
proteins from literature. For example, [149] gives a list of expected concentrations of these
proteins in human plasma. We use this information to obtain the expected relative abun-
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dance of the species in the sample and incorporate them to the probabilistic model. In the
absence of concentration bounds, we can estimate the concentration of a molecule as equal
to the weight of the sample divided by the mass of the molecule. This gives an upper bound
on the abundance of the molecule.
Figures 31 and 32 show that the values parameters take on greatly inuence the per-
formance of the labeling method. Spectra produced by dierent machinery or experimental
design will likely require dierent parameters for a labeling to be successful. Whenever pos-
sible, values for parameters should be chosen carefully with prior knowledge. In the absence
of prior knowledge, a parameter search can be done by measuring the success of the labeling
procedure on spectra from a known protein mixture, while varying the values of parameters.
Each peak position in the analyzed spectra may be assigned its own location variation
parameter, i. This parameter should be set to reect the reported mass accuracy at the m/z
position of the ith peak for the MS instrument used to produce the data. For the Ciphergen
PBSIIc MS instrument, this value was 0.2% of the expected mass. For the simulated data,
the mass accuracy was unknown, but constant across all peaks. Thus, all i parameters had
the same value, and multiple evaluations were performed while varying this value.
Each peak position in the analyzed spectra may also be assigned its own intensity vari-
ation parameter, i. This parameter should be set to reect the expected variation in the
intensity of the ith peak for the MS instrument used to produce the data. In both the simu-
lated and real data, there was no way to accurately measure the variation in intensity, as the
amount of ions presented for measurement is never absolutely known. In our experiments,
we set i to be equal to the expected relative concentration of the i
th molecule in the sample.
These parameters are scaled so that the standard deviation of each variable is 10% of their
expected values. Although we did not vary these parameters during our experiments, this
can be done in an attempt to achieve a better labeling.
Each peak position in the analyzed spectra may also be assigned its own reliability pa-
rameter, pi;0. This parameter should be set to reect the expectation that the i
th molecule
generates a detectable peak in the MS signal. In experiments where anity surfaces selec-
tively bind molecules for analysis, molecules which should not bind should have their pi;0
parameter set to reect the probability with which they will remain in the analysis. In both
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our simulated and real experiments, we set these parameters to a single value p0. In the
simulated experiments, this parameter was varied slightly over a range of values. With the
SELDI-TOF data, p0 was set to 0.05 to reect a 5% chance that molecules in the peak
database do not register as peaks in the MS signal. This value was determined by assuming
a 1% chance of a peak not appearing on either tail of the distribution, and 3% to reect
imperfections in the peak detection procedure.
5.4 EXPERIMENTS AND RESULTS
The following sections deploy the methods proposed above, which aid the interpretation of
MS proteomic data analysis results in varying ways. The amount of work into each method
necessarily varies. PACE is a general technique which could be applied to any dataset. The
next section demonstrates its application towards validating the strength of the classiers
learned on the 3 Vanderbilt Lung SPORE datasets in Chapters 3 and 4. However, for the
peak labeling method, very little data exists which serves as a gold standard. Additionally,
few datasets exist where the samples are generated in multiple sessions, so it is dicult to
do a thorough validation of the reproducibility measures. Nevertheless, some results on the
multisession UPCI Lung Cancer dataset are presented below, as well as peak-labeling using
SELDI technology to identify calibrant proteins in human serum.
5.4.1 Case Study: Application of the PACE Technique to Lung SPORE datasets
Up until this point, we have performed many experiments resulting in good predictive models
on the Vanderbilt Lung SPORE datasets. We can use the PACE technique to determine
whether or not these results occur simply by chance. Instead of ACE, let our permutation test
statistic instead be the average AUC of a predictive model on the SAP-processed Vanderbilt
Lung SPORE datasets. The predictive model will be the same as that reported in Table 3,
a `1-norm regularized linear SVM. The labels are permuted 1000 times for every one of the
40 train/test splits.
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Figure 27 shows the estimated permutation distributions for the Vanderbilt IMAC, WCX
and MALDI Lung SPORE datasets, from left to right, respectively. The AUC achieved by
our predictive model under the true labeling is marked with a small red cross. Note that
the cross lies well outside the distribution, visually conrming signicance. Statistically, this
result is signicant at the  = 0:001 threshold, meaning it would be very dicult to accept
the null hypothesis that the results achieved in Chapter 3 were obtained by chance alone.
This gives us assurance that our predictive model is valid.
5.4.2 Case Study: Application of Reproducibility Measures to Lung Cancer
Serum Spectra
5.4.2.1 Signal reproducibility We rst examined whether proteomic spectra are re-
producible across multiple sessions. We used the random regrouping test described in Section
5.3.2.1 to evaluate whether the signals from the same sample were more similar than signals
from randomly chosen sample sets. Since we expect to nd dierences between case and
control samples, this score was evaluated separately on respective subgroups of case and
control spectra.
The histogram in gure 28 (left) indicates the average signal dierence score for the 21
cancer patients across all 4 sessions. A distribution of 1000 averages of 21 signal dierence
scores for randomly selected quadruplets of spectra is plotted as a reference. The score for
the replicate spectra falls outside of the score distribution for randomly grouped spectra.
A similar phenomenon occurs with the control samples. Furthermore, we can assess the
reproducibility of signal dierence over a small region of the prole. The right panel of
gure 28 displays the distribution of signal dierence scores for the peak region at 8228 Da.
There is less dierence in the peak among proles from the same sample than from proles
randomly assigned to a sample. There is a statistically signicant dierence between the
signal dierence scores obtained from true and random replicates, at both the global and
local (peak) signal level. This assures us that proles from the same sample do not exhibit so
much dierence that they can be easily confused with proles from a dierent sample. This
encouraging result emphasizes the reproducibility of proteomic proles at the signal level.
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5.4.2.2 Reproducibility of discriminative features We use the randomization frame-
work from section 5.3.2.2 to determine whether dierential expression scores obtained from
mixed session data dier on average from the dierential expression mined from single session
datasets. These dierences may assess the benet or loss due to mixed-session analysis.
Figure 29 (left) displays the empirical distribution of dierential expression scores for
multi-session data of one prominent peak in the spectra. The distribution was obtained
from 1000 random datasets such that each patient was randomly assigned a prole from one
of the four sessions. The four marks indicate the dierential expression scores obtained for
proles in four individual sessions.
We next determined the signicance of these dierences. To determine the amount of
noise experienced over a range of features, we similarly analyzed the top 100 dierentially
expressed peak regions in the proles. The mean was calculated for every feature's dierential
expression score distribution, as well as the score of the feature in the four single sessions.
These four scores were subtracted from the mean and kept for each feature, resulting in a
distribution of 400 dierences. Figure 29 (middle) displays this distribution. If single session
scores were biased (that is, better scores are produced by the single session analysis) we
would expect to see the mean of this distribution to dier signicantly from 0. In other
words, we would expect to reject (at some signicance level) the null hypothesis: the mean
of dierences is  0. Indeed, the mean of the distribution of dierences was  0:0351, giving
a p-value of 5:588  10 8 for the one-sided t-test, which leads to the rejection of the null
hypothesis. Hence the amount of dierential expression in single sessions appears to be
better on average than in mixed-sessions. This shows that inter-session variability aects
the measured dierential information.
We expect this negative result to aect the performance (accuracy) of predictive models
trained on multi-session data. The question is how big the eect really is. Earlier research
studies considered it most ideal to learn from and evaluate their predictive models on data
from a single session. We therefore compare the dierences in accuracy between models
trained on multi-session data versus models trained on single-session data.
Following the methods in section 5.3.2.2, we analyzed the accuracy of multi-session mod-
els versus single-session predictive models. Figure 29 (right) displays the distribution of
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dierences between mean accuracies of multi-session and single-session predictive models. If
better accuracies are achieved by predictive models for single-session data, we would expect
to see the mean of this distribution to be below 0. Indeed, the mean of the distribution of
dierences was  0:0267 which once again indicates a loss that can be explained by additional
inter-session variability. To conrm the dierence we used a repeated resampling experiment
proposed by [156], estimating the 95% condence interval around the mean of dierences to
be  0:0267 0:0001. This experiment conrmed that this dierence is indeed signicant.
On average, there is about a 2.7% drop in accuracy when using multi-session data,
demonstrating a relatively small (average) loss of reproducibility of multivariate discrim-
inative patterns across multiple sessions. One should understand that this is an average
assessment; the performance of an individual classier may vary from session to session and
also depends on how proles from multiple sessions are mixed.
5.4.2.3 Generalization Performance Finally, we want to determine the eect the
multi-session training has on predictive models which must generalize well to future, unseen
proles and sessions. The previous result demonstrates that intersession noise exists, but
does not seem to greatly aect the performance of predictive models on average. However,
the analysis used each session and did not try to assess the performance on future sessions.
We use the methods in section 5.3.2.3 to analyze whether training predictive models on multi-
session data generalizes well to proles in future sessions and compare the performance of
these models to 'ideal' predictive models trained and tested on single session data.
Figure 30 (left) displays a distribution of accuracy dierences between the average of 1000
predictive models built from random multi-session training data and models trained on data
that came from the session on which the model was tested. The mean of the distribution is
 0:0231 which quanties an overall average generalization accuracy loss one may expect to
see by training the model on the mixed session data as opposed to the accuracy of the 'ideal'
model. We analyzed the dierence using an additional resampling test [156] to compute the
95% condence interval of the mean. The result of the mean falling within  0:02860:0001
conrmed the dierence is statistically signicantly dierent. However, in terms of absolute
numbers the accuracy loss with respect to the ideal model is not bad.
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In a practical setting such as clinical screening, the training data will certainly not come
from the same session as the testing session. This eliminates the possibility of having an
'ideal' predictive model. We repeated the previous experiment by examining the dierences
between the multi-session models and models trained on proles from a single session other
than the target session. The dierence from the previous experiment is that the single-
session models lose the advantage of the 'ideal' environment. Inter-session noise must now
be accommodated by both the multi-session and single-session-trained models.
Figure 30 (right) displays a distribution of accuracy dierences between the average of
1000 predictive models trained on multi-session data and models trained on the remaining
single sessions. The mean and 95% condence interval of this distribution falls above 0
(= 0:0289  0:0001), indicating a benet of training on multi-session data. The condence
interval is again computed using the repeated resampling test [156], which conrmed the
dierence to be statistically signicantly dierent. This result illustrates how training on
multi-session data can allow the model to adapt to inter-session noise. The better a predictive
model can adapt to inter-session noise, the more reproducible the performance will be on
future data.
5.4.3 Case Study: Application of Peak Labeling
Experiments with our peak-labeling method were conducted in two phases. First, we tested
the method on data simulated from a virtual MALDI-TOF mass spectrometer [1]. Second,
we have made preliminary validation of the procedure on real biological data for human
sera. Information about 94 high-abundance proteins (their expected mass and abundance)
in serum was collected from online protein databases and from the literature [149,157]. The
resulting collection was used as the label database throughout our experiments.
5.4.3.1 Phase 1: Labeling simulated data A set of 100 simulated spectra was gener-
ated with 16 controlled spiked-in peptides. The relative concentrations of these peptides were
chosen arbitrarily and retained as information to be used by the identication procedure.
Our task is to label peaks in the spectra correctly (true positive), while avoiding labeling
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peaks which may appear as a result of noise (false positive). While Receiver Operator Char-
acteristic (ROC) curves can be used to measure this tradeo, the skew in number of true
positives (16) versus number of potential false positives (> 300) can lead to a misrepresen-
tation of performance. Instead, we evaluate our peak labeling method using precision-recall
(PR) curves [158], which are used in Information Retrieval tasks where a skew exists in the
numbers of true positives and potential false positives. In our task, precision refers to the
fraction of label-assigned peaks which are matched to the correct label, while recall refers
to the fraction of the 16 labels which were correctly assigned to a peak. Each of the 100
spectra were labeled, and performance statistics were averaged over the dataset.
We have tested two versions of our peak-labeling method: a baseline version that relies
only on the expected mass of the species and our improved version that combines the knowl-
edge of the expected mass together with their abundance information. The objective was to
show that the inclusion of the abundance information improves the identication accuracy
of the procedure.
We evaluated both our baseline method and the abundance-enhanced method over a
broad range of detection conditions. These were controlled by varying the location variation
parameter, , and the reliability parameter, p0. In the baseline method, we observed a
dramatic eect of varying p0, which uses only peak location information. A higher value of
p0 heavily discourages a label if the location of a peak is far from the expected mass of a
molecule. This results in a conservative labeling beyond p0  0:5. The probability of peaks
not occurring begins to outweigh all but the closest location-based matches. Thus, few if
any peak-to-label matches are made beyond this point, resulting in recall and precision close
to 0. As the location variation parameter  grows, there is a slight gain in recall at a cost
of precision. By providing a larger window for consideration of peak labels, the method can
freely choose labels which may have been further away from their expected mass locations.
However, if a close location match has already been found, increasing the window size does
not help our method choose the correct label. Thus, the improvement in performance is very
minimal when varying .
We sought improvements in precision and recall from the abundance-enhanced method.
For our experiments, we set the relative abundance variation parameters to reect the con-
161
centration used as input to the simulator. Peptides not involved in the process were set
to have an abundance attributed to \noise". This was calculated as 1/100 of the smallest
spiked-in peptide abundance. The remaining parameters  and p0 were varied as before.
In comparison to the previous case, which used only location information, the abundance-
enhanced method showed a large improvement in precision. Figure 31 compares the variation
in precision and recall for both the baseline and abundance-enhanced methods when varying
p0 and xing  = 0:05.
The importance of p0 in the relative abundance-enhanced method is downplayed due to
the need to t labels to appropriately sized peaks. Only a handful of labels will ever match
a peak by both location and relative abundance. A correct match is either hit-or-miss, and
only a value of p0 = 1 causes the recall and precision to drop to 0. The result is relatively
stable behavior of precision and recall as p0 is varied. As seen in the previous case, varying
 results in an improvement of recall in exchange for lost precision. However, the precision
obtained at most parameter settings are much better than under any parameter conguration
examined using the previous method. This results in much better parameter congurations
than can be achieved without including abundance information. The abundance-enhanced
method can therefore outperform the method using only peak information.
To quantify the improvement of the method, we use the F -measure [159], the harmonic
mean of precision and recall. The maximum F -measure obtained by the method using only
peak information was 0.5226, versus 0.6667 when including relative abundance information.
As an additional performance metric, the area under the method's PR curves (AUC) can
be measured [158]. Figure 32 compares the PR curves for both versions of the labeling
method. The PR curve for the peak-location method is completely dominated by the PR
curve for the abundance-enhanced method. The AUC for the peak location method is 0.5782,
while the abundance-enhanced method achieves an AUC of 0.7387. These results show the
contribution of relative abundance information greatly improves the method.
5.4.3.2 Phase 2: Labeling spiked-in human serum We next applied the abundance-
augmented procedure to labeling of whole-sample human serum proles with and without an
added protein calibration mixture. All mass spectra were produced using a Ciphergen PBS
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IIc SELDI-TOF mass spectrometer (Ciphergen Biosystems, Inc). Figure 33 displays average
spectra of the calibration mixture (top), human serum sample (center), and combination of
the \spiked-in" calibrant and serum sample (bottom). The calibrant contains an equimolar
concentration of horse proteins equine cytochrome C and equine myoglobin. We estimate
that serum proteins occur in 250-1000 fold excess of the calibrant. The peaks from the
calibrant are absent in the serum prole due to their non-human nature. They are, however,
visible in the calibrant/serum mix.
Our objective was to correctly label peaks of equine cytochrome C and equine myoglobin
in the human serum-calibrant mixture, while avoiding these labels when the calibrant is
not present in the serum. The label database of 94 highly abundant serum proteins was
augmented with information about equine cytochrome C (GenBank accession P00004) and
equine myoglobin (GenBank accession P68082). Parameters of the procedure were set as
follows. The location variation parameter  was set according to the reported mass accuracy
of the Ciphergen PBS IIc instrumentation (0.2% of the molecular mass [27]). The relative
abundance variation parameters 1 : : : d used for the abundance component were set using
the expected concentrations of the proteins represented in the label database, such that the
expected value is equal to the expected concentration and standard deviation of each variable
is 10% of its expected value. The reliability parameter p0 was set to 0.05 to reect a 5%
chance that a molecule does not create a peak.
The peak-labeling procedure was rst applied to the \spiked-in" spectra. Figure 34
displays the successful labeling of equine myoglobin, as well as the distinction between similar
compounds from dierent organisms. The assignment of equine myoglobin is made possible
through information about its abundance and location, which properly distinguishes it from
other labels. Figure 35 displays the proper identication of equine cytochrome c among
other regional peaks. In this mixture of peaks, one is detected at the expected location of
equine cytochrome C. Since the peaks in the area have similar abundance, the procedure uses
locational information to inuence the nal labeling. The label displays that the cytochrome
C molecule (11702 Da) exhibits an added acetyl group (42 Da) and heme group (616 Da),
bringing the total weight to 12360 Da.
In the second experiment, we applied the procedure to spectra containing only human
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serum. Knowing that the calibrant is not present, we could a priori exclude the mixture
components from the set of protein labels. However, to test the robustness of the procedure,
we assumed the calibrant components are present at the same concentrations as in the spiked-
in spectra. Figures 36 and 37 display the result of the labeling procedure on the serum-only
prole. The procedure does not label any peak as equine myoglobin or equine cytochrome C,
even though the opportunities exist; a peak is detected in the vicinity of equine myoglobin's
expected mass. However, the probability of assignment to the \null" value outweighs the
probability of assigning it to a protein label. In particular, the intensity observed is too
low to t the expected concentration well enough to outweigh assigning the peak to the
\null" value. In the case of cytochrome C, no peak is detected in the vicinity of the target.
Surrounding peaks which fall into the feasible region are assigned to the \null" value, due
to a lack of labels which can t these peaks.
It is certain that these peaks are correctly identied. Few peaks are expected to appear
in the calibrant serum. Due to their nonhuman nature, they appear at places which do
not seem reproducible in the serum-only analysis. This is clearly observed through addition
of the calibrant to whole serum. Finally, the noticeable appearance of the peaks in the
\spiked-in" serum lead to the possibility of a highly-abundant peptide. Although there are
competing proteins for the spiked-in peaks besides equine cytochrome C and myoglobin, our
probabilistic model is able to match them correctly. These results are promising and support
further exploration.
In both experiments, we were aware of which proteins needed to be labeled, and whether
the labeling was correct. The selection of parameters varies the performance of the method
greatly, and in this case we are able to choose the parameters which yield the best perfor-
mance. In new data, where the true peak identities are not known, it is unclear how to
choose the parameters to achieve the best result. While the location variation parameter
 can be set to the expected mass accuracy of the particular instrument, the optimal or
close-to-the-optimal setting of the reliability parameter p0 remains an open question. If a
calibration serum is processed along with the data, a parameter search can be performed to
optimize the method to the data produced by the machinery. The parameter which results
in the best labeling of the calibration serum can be used in further analysis of data coming
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from the same experimental setup.
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Figure 27: PACE distributions for Vanderbilt Lung SPORE data. Left panel: IMAC. Center
panel: WCX. Right panel: MALDI. All three results under the true labeling (red cross) are
signicant at  = 0:001 with respect to the null hypothesis distributions.
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Figure 28: Distributions of signal dierence scores for random groupings of proles for
case samples. The left panel displays signal dierence scores taken over the entire range
of the signal, while the right panel displays signal dierence for a single feature at 8228
Da. The signal dierence score for the true replicate spectra is plotted as a dot along
the x-axis. The signal dierence among the true replicates is much less than any observed
signal dierence among randomly grouped proles. This indicates that the observed greater
similarity between replications of the same sample is much less likely to be due to random
eects.
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Figure 29: Left panel: Distribution of dierential expression scores under random regroup-
ings of proles for the peak region at 12.938 kDa. The dierential expression score for the
peak in each of the 4 individual sessions is plotted as a dot along the x-axis. Middle panel:
distribution of dierences between the mean of mixed-session Fisher score distributions and
single session Fisher scores for 100 peak regions. The distribution has a mean of -0.0351
and p-value of 5:588  10 8 for the null hypothesis: the mean is equal to 0. Right panel:
distribution of dierences between the mean accuracies of models trained on multi-session
data and accuracies of models trained on single-session data. The mean of this distribution
falls below 0 ( = -0.0267), indicating an on-average benet of training from single-session
data.
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Figure 30: Left panel: distribution of accuracy dierences between predictive models trained
on multi-session data and models ideally trained on data from the same single session as the
target test session. The mean below 0 (= -0.0286) indicates an advantage of the ideally
trained single-session models. Right panel: distribution of accuracy dierences between the
same predictive models trained on multi-session data and models trained on single-session
data from sessions other than the target testing set. The mean above 0 (= 0.0289) indicates
an advantage of training on multi-session data. This illustrates the ability of predictive
models trained on multi-session data to adapt to inter-session noise.
169
0 0.2 0.4 0.6 0.8 1
0
0.2
0.4
0.6
0.8
1
R
ec
al
l
p0
 
 
0 0.2 0.4 0.6 0.8 1
0
0.2
0.4
0.6
0.8
1
Pr
ec
is
io
n
p0
 
 
Location Only
Abundance + Location
Location Only
Abundance + Location
Figure 31: Performance variation at  = 0:05 for the baseline peak-location method and the
relative abundance-enhanced method. Recall (top) and precision (bottom) are plotted as
a function of the reliability parameter p0. As p0 increases, both precision and recall of the
peak-location method shrink as the requirement for close location-based matches becomes
more strict. However, the importance of this parameter is noticeably downplayed in the
relative abundance-enhanced method. Since fewer possibilities exist for the method to nd
peaks which are both appropriately positioned and sized, labelings and their performance and
recall remain relatively stable. A signicant gain in precision can be seen in the abundance-
enhanced method, indicating fewer false positive peak-to-label matches. c2010 IEEE.
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Figure 32: Comparison of Precision-Recall curves for both peak-labeling methods. The
abundance-enhanced labeling method (thick solid line) improves over the method which
uses only peak location information (thin dashed line). The areas under these curves were
measured as 0.7387 for the abundance-enhanced method, versus 0.5782 for the basic peak
location method. c2010 IEEE.
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Figure 33: Calibrant spiked into whole serum sample. Top: Calibrant mixture shot alone.
Center: Whole serum sample shot alone. Bottom: Whole serum sample spiked with cali-
brant. The spiked-in peaks are marked, and correspond to cytochrome C (12.360 kDa) and
myoglobin (16.591 kDa) from the calibrant (also marked). c2010 IEEE.
172
1.6947 1.7131 1.7373
x 104
0
1
2
3
4
5
6
7
8
9
10
11
Annotated reproducible peaks across entire dataset
m/z ratio (Da)
In
te
ns
ity
Methylcobalamin +2H
Myoglobin.
Equine Myoglobin.
Figure 34: labeled peaks of serum-calibrant mixture in the range of [16500 17500] Da. The
spiked-in peak at 16947 Da is correctly labeled as equine myoglobin. The second peak labeled
myoglobin at 17131 Da corresponds to human myoglobin, which has a similar mass weight
(17184 Da). The unlabeled peak positions could not be condently assigned a label. c2010
IEEE.
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Figure 35: labeled peaks of serum-calibrant mixture in the range of [12000 13000] Da. The
spiked-in peak at 12359 Da is correctly labeled as equine cytochrome C. The unlabeled peak
positions could not be condently assigned a label. c2010 IEEE.
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Figure 36: labeled peaks of whole human serum in the range of [16500 17500] Da. The peak
at 17128 Da labeled myoglobin corresponds to human myoglobin, which has a similar mass
weight (17184 Da). The unlabeled peak positions could not be condently assigned a label.
Although a peak is available at the expected mass weight of equine myoglobin (16947 Da),
the intensity is too low to allow a condent decision. c2010 IEEE.
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Figure 37: labeled peaks of whole human serum in the range of [12000 13000] Da. The
unlabeled peak positions could not be condently assigned a label. Although many peaks
appear within the feasible range of equine cytochrome C (12360 Da), none are labeled as
such due to extreme dierences in location. c2010 IEEE.
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6.0 CONCLUSIONS
The ability to quickly, cheaply and noninvasively assess the health of a person is of great
clinical importance. Mass spectrometry protein proling is a method which shows promise
in these directions. Discriminative signals can be found in order to predict healthy samples
from a variety of complex diseases. Mass spectrometry, along with existing and emerging
high-throughput technologies, faces a number of challenges which necessitate techniques that
enable useful analysis and understanding of the data. Overall, the methods presented in this
thesis contribute to a framework which improves the analysis of mass spectrometry protein
proling. The primary contributions of this thesis are briey summarized below.
 Automatic Selection of Preprocessing Methods | Chapter 3 introduced and evaluated
our novel approach to preprocessing MS protein prole data: the Standard Automatic
Preprocessing procedure (SAP). To my knowledge, SAP is the rst system which at-
tempts to optimize the preprocessing of TOF-MS protein prole data by choosing among
multiple preprocessing methods for each stage of preprocessing. SAP is competitive with
a heavily-customized baseline preprocessing procedure we developed. When the baseline
procedure has a negative impact on downstream predictive model performance, SAP is
able to outperform the baseline procedure. The SAP procedure also demonstrates some
unique characteristics which may allow it to inform a user on what preprocessing meth-
ods are best suited to a particular data source. For example, in the context of variance
stabilization, SAP prefers to apply the Log-transformation to MALDI data, while the
Cube-Root transformation is preferred by the SELDI data sources.
 Parallel decorrelation feature selection | Section 4.3.1 introduced the novel Parallel
MAC Decorrelating feature selection method. In our experiments, we saw that the
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MS protein proling data sources are normally biased by an extremely high amount of
correlations. These correlates need to be addressed directly by the feature selection or
predictive modeling process, or through a combination of both. Our experiments showed
that, on average, feature selection methods which take these correlations into account
result in a better predictive model performance than methods which rank features in a
multivariate or univariate way.
 Evaluation of kernel-learning approaches | Section 4.4.2 evaluated three kernel-learning
approaches to determine whether or not kernel learning would impart a benet to SVM-
based predictive models versus the standard linear kernel. The experiments suggest that
kernel learning is not preferable to a linear kernel with `-1 regularization. Despite this,
the calibrated probabilities of the hyperkernel are quite good, and future work could
potentially tap this advantage.
 Pathway kernel | Section 4.3.6 describes the Pathway kernel, a kernel function which
attempts to capture information about regulatory biological processes observable in MS
protein proles. The TOF-MS data source is not the best suited for use with the approach
described for computing the kernel in Section 4.3.6. This is largely due to error in the
translation process from gene interaction networks to feature mappings in the proteomic
proles. Newer technology with better annotations, and additional resources like EPO-
KB [160] can help to reduce the amount of error in this translation process.
 A method for assessing the statistical signicance of a predictive model's performance |
Many high-throughput data sources suer from too many dimensions and too few sam-
ples. MS protein proling data are no dierent. The risk of achieving a good predictive
performance just by chance increases especially with smaller numbers of samples, which
is unavoidable especially with rare diseases. Section 5.4.1 demonstrates Permutation-
Achieved Classication Error (PACE), a novel method for assessing the statistical sig-
nicance of a predictive model's performance. PACE can be used to test whether a
predictive model's power is more likely to be due to spurious patterns in the data. The
experiments show that our predictive models frequently nd discriminative information
that is very unlikely to be due to random chance, suggesting that genuine surrogate
biomarkers can be recovered from protein proling data.
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 Measures of reproducibility | The sensitivity of many high-throughput data sources,
including MS protein proling, can detect minute dierences in replications of the same
sample. Since proteins can change over time, a sample recovered from storage may
generate a dierent protein prole. Section 5.3.2 introduced several measures of repro-
ducibility which help the interpretive analysis of MS prole data generated over multiple
time sessions, and possibly on dierent laboratory equipment. The experiments show
that protein proles retain their individuality over multiple sessions despite the eect of
noise over time. We also showed that including proles from multiple data generation
sessions can improve the generalizability of predictive models on future proles.
 Algorithms for peak labeling of molecular species in TOF-MS data | Section 5.4.3 in-
troduced novel algorithms for labeling prole peak features with biological peptide iden-
tiers. In experiments, we showed that a probabilistic model taking advantage of prior
knowledge about protein abundance has enhanced precision and recall for labeling peaks
in simulated data. The enhanced probabilistic model was also successful in selectively
labeling calibrant peaks when spiked into a normal human serum sample.
 A simulator for MS protein prole data | Appendix A details a revision of a previously
described physical model of a TOF Mass Spectrometer [1]. The revision includes in-
structions for how to simulate realistic TOF-MS spectra, given a list of UniProt peptide
accession numbers. The simulator model's parameters are adjustable to reect a variety
of machinery types.
6.1 IMPACT ON BIOINFORMATICS DATA ANALYSIS
Many high-throughput data sources are very similar to MS protein prole data. Genomic
and metabolomic data merely change the type of biological element being measured by the
instrument. Variants of TOF-MS are currently being used to generate metabolomic data.
Therefore, many of the techniques presented in this thesis can be applied to other types of
bioinformatics data. In the following sections, I suggest some applications of these techniques
outside of protein proling to demonstrate their wider applicability.
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6.1.1 Preprocessing of other \omic" datasets
Microarray data typically undergoes preprocessing much in the same vein as described in
Chapter 3 for protein prole data. Stages of microarray preprocessing include background
correction, normalization and summarization, which are analogs of MS protein prole pre-
processing's baseline correction, normalization and smoothing stages. It has been shown in
previous research that the choice of the most appropriate preprocessing methods is largely
platform dependent [161,162] and not easy to automate [163]. As new technologies emerge,
signicant eort is made to characterize noise sources and determine the optimal preprocess-
ing procedures for each individual technology [163{165].
Repurposing the SAP preprocessing framework for microarray data preprocessing could
assist the state-of-the-art eorts to automate and recommend appropriate preprocessing
procedures. Large databases of microarray data from a variety of technologies exist in
databases like the Stanford Microarray Database (SMD, [166]) or Gene Expression Omnibus
(GEO, [143]). This data could be fed to SAP in an eort to learn preferences for preprocessing
methods in relation to the originating data platform. In turn, eorts to characterize noise
sources in microarray and metabolomic data can help rene the local stagewise scores of
SAP to further improve the selection process.
Beyond \omic" data, image analysis is another subeld of biomedical informatics which
requires signicant data preprocessing. Since image data can be relatively large to store and
transmit, lossless compression of the data is often required. Despite the compression, data
must continue to be useful for clinical diagnosis. This tradeo has been previously noted and
studied [167], and presents yet another opportunity for the SAP framework to be applied.
Global and local scores would balance the tradeo between diagnostic information loss and
storage size.
6.1.2 Feature Selection and Predictive Modeling Preferences
Feature selection remains an important topic for all high-throughput data sources, as the
dimensionality of data will continue to increase with improving technology. At the time
of this article, mass spectrometers like the Linear Trap Quadrupole-Orbitrap hybrid mass
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spectrometer (Thermo Electron, Bremen, Germany) exist which can identify molecules at 2
parts per million [168]. Further improvements are being made to mass spectrometers, and
the increasing resolution corresponds to higher data dimensionality. As isotopic distributions
of molecules begin to be elucidated, the number of correlated features in the data will also
increase. Correlation-aware techniques will be of utmost importance in order to perform
good feature selection on these future data.
The experiments in feature selection and predictive modeling, presented in Chapter 4,
have intuitive but important results. First, if our goal is to have the best classier per-
formance, ranking features univariately is often not the best way to do feature selection.
Predictive models perform much better when their predictive features are considered in con-
junction with other, or previously selected, features. Next, a simple predictive model, like
the linear SVM, can frequently outperform predictive models based on more complicated
kernels. The savings over computing a more complicated kernel, in terms of computational
complexity, can be extremely benecial. The choice of regularization penalty is also impor-
tant. It has been previously proven that `1 regularization is eective even when the training
samples are outnumbered by exponentially many irrelevant features [169]. The results in
this thesis are consistent with this result.
6.1.3 Reproducibility of Results
All \omic" data sources are bound to suer from reproducibility issues. Even those \omic"
data sources which may appear in the future will face questions about reproducibility. A
biological sample will degrade over time, no matter how strict and considerate the storage and
processing protocols are. The reproducibility measures and evaluation framework presented
in Chapter 5 are general enough to be adapted to any technology. This enables any \omic"
technology user to evaluate for themselves whether that technology can generate reproducible
and reliable data. This is a critical step for addressing the concerns about the applicability
of a certain technology in a practical setting.
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6.1.4 Next-Generation Genomic Sequencing
The advent of \next-generation sequencing" enables the rapid sequencing of genomes on a
cellular basis. This allows the genomes of tumor tissue cells to be compared to genomes
of cells from the tissue adjacent to, and distal from, the tumor. An emerging challenge
in this new area of bioinformatics is the discovery of driver versus passenger mutations,
both of which appear to be discriminative mutations between tumor and healthy tissue.
However, the driver mutations are thought to be causally implicated in tumor progression,
while passenger mutations are a result of chance or inconsequential errors during the cell
division process. Being able to classify these two types of mutations is therefore valuable for
driving further research.
The pathway kernel used in this thesis was an attempt to map genomic features to
protein prole information. Although it was not successful in this application, the general
technique could be applied to the analysis of driver/passenger mutation classication. Stan-
dard mutation classication approaches typically involve phenotypic, sequence-based and
structure-based features [170,171] of the resulting mutation, which are then fed to a predic-
tive model like the SVM. Eorts to attach these features to downstream interacting gene
\modules" is underway [172]. The modules dier primarily from classic pathways in that
modules represent a group, of which genes may not have a direct interaction. This gives us
the advantage of describing a driver mutation as being one that is present in any gene of a
module, and then interacting genes of the mutated gene may exhibit a disregulated pathway.
The obvious next step is to ask how these gene modules are aecting oncogenesis through
protein expression. In this application, the pathway kernel could be built around these new
gene modules and their resulting mutated proteins, instead of the gene pathways used in our
experiments.
As these driver mutations are thought to be among the rst somatic changes in the
development of cancer, it may be useful to evaluate mutated gene module pathways to
classify early-stage cancer proles versus normal proles. To identify the modules which
are more likely to represent passenger mutations, the pathway kernel can be applied to
classify later-stage cancers versus healthy tissue. A comparison of the most relevant features
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for both of these analyses would be very revealing. Ideally, pathways and modules which
predict cancer will dier between the two studies. Those pathways or modules eective for
the early-versus-normal study, but less eective for the late-versus-normal study, could be
more likely inuenced by driver mutations. Pathways or modules which only appear relevant
for the late-versus-normal study are probably more likely due to passenger mutations. In the
worst case, this technique could narrow down the vast number of mutations which require
driver/passenger classication.
6.2 OPEN QUESTIONS AND FUTURE WORK
The methods and results presented here raise a number of interesting open problems in
proteomic proling analysis. Several directions, as discussed below, could be undertaken in
order to improve these methods further.
6.2.1 Tradeo of the local and global scores in SAP
It is still unclear how to proportion the SP-curve's weight to the global DE score versus the
local stagewise scores of each stage. In some cases, for example, the Heteroscedacity Reten-
tion score described in Section 3.2.1, it would be possible to estimate a weight by evaluating
several weight combinations and determine the average benet to multiple datasets under
that weighting scheme. This could help to become a qualitative measure for the stagewise
score; as the weight estimation begins to lean more on the global metric, it probably means
that the local metric for that stage requires revision.
6.2.2 Class-sensitive Automatic Preprocessing
An improvement of Standard Automatic Preprocessing, which I call Class-sensitive Auto-
matic Preprocessing, takes the ideas in SAP one level further. Each stage denes a pair of
stagewise scores, one for features expected to be discriminative, and another for those which
are superuous. The goal in each stage is to optimize the DE score and normal stagewise
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score only with respect to the discriminative features, while at the same time allowing the
non-discriminative features to also select their own preprocessing method. This allows dis-
criminative features to be preferentially treated and may improve the overall quality of the
signal resulting from preprocessing.
6.2.3 Method Parameterization Search for SAP
The amount of methods available to SAP for this paper were small, because each method
operated using default parameters. Ideally, SAP treats dierently parameterized methods
(for example, a smoothing procedure with sliding window size of 24 features, instead of 12)
as competitors for a given stage. An automated grid search over a parameter space for
preprocessing methods might lead to better performance in some stages of preprocessing.
6.2.4 Combining feature selection with kernel learning
One of the better performing methods in this chapter is the linear SVMwith `1-regularization,
combined with the parallel decorrelation algorithm. It remains to be seen whether any of the
kernel-learning methods can be improved upon if they go through feature selection. We saw
that the hyperkernel approach is able to give well-calibrated probabilities despite not being
accurate. It would be interesting to see whether we could improve the classication accu-
racy by performing feature selection, but retain the benet of better calibrated probability
estimates.
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APPENDIX A
SIMULATION OF TOF-MS DATA
The model proposed by Coombes et al. [1] describes a mathematical model for the simulation
of TOF-MS proteomic proles. It is available for the S-Plus programming environment from
the authors' website (http://bioinformatics.mdanderson.org/cromwell.html). The input to
the system is a set of parameters which govern the behavior of physical properties of molecules
and how they are propagated and detected by the mass spectrometer. Molecular weights can
be fed to the simulator to produce their resulting mass spectra. I was unable to reproduce
realistic spectra using this package directly, but using the derivations and methods below, I
was able to make an improvement on the simulator which does produce realistic spectra.
A.1 PARAMETERS OF THE MODEL
Figure 38 displays a general schematic of a mass spectrometer simulated by this model.
Let the parameters of the data simulator, as described by Coombes et al. in [1], be dened
as follows: L is the length of the drift tube. D1 is the distance from the sample plate
to the electric eld, which is bounded at the front by the focusing grid. D2 is the width
of the electric eld, which is bounded on the far end by the accelerating grid. The laser,
upon striking the sample, imparts a velocity v0 on a molecule from the distribution N(; ).
Energized ions drift for delay time  before reaching the electric eld. Voltage V1 is then
applied to the sample plate, causing ions to be propelled into the electric eld. The electric
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Figure 38: A general diagram of a mass spectrometer simulated by the Coombes et al. model.
(SP): sample plate, (FG): focusing grid, (AG): accelerating grid, (DE): detector plate.
eld is charged with voltage V , which further increases the acceleration of ions. These ions
continue onward until they reach the detector. The amount of time during which the detector
is able to measure incoming particles (i.e. the resolution) is given as  .
The default values of the parameters of the model, under both the implementation in [1]
and the implementation used in this thesis are given in Table 20.
A.2 DERIVATION OF TIME-OF-FLIGHT VALUES
Using the Time-of-Flight equations derived in [1], I was not able to reproduce protein pro-
les which looked realistic compared to genuine TOF-MS data from the available biological
datasets used in this work. I do believe the description in [1] is sound, but I am unable
to nd the error myself, due to a lack of understanding of the physical laws used for their
derivation. Instead, I derived the equations for particles using the most fundamental laws
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Table 20: Simulator Parameters and Default Settings
Parameter Coombes et al. This work
D1 17e
 3 17e 3
D2 8e
 3 8e 3
L 1 1
V 20000 20000
V1 2000 2000
 600e 9 600e 9
 4e 9 4e 9
 350 350
 50 50
of classical physics. To my knowledge, the derivation below is a correct procedure for esti-
mating Time-of-Flight (TOF) values for molecules present in the sample. Please excuse my
incredibly simplied explanation, for the eld of physics is not my area of expertise, and if
I make errors in assumption or otherwise, then I hope to facilitate their discovery by the
more advanced reader. I use the SI units of measurement, where possible, in the following
derivation.
Electric elds are measured in units of volts (V , electric potential) per meter (m, distance)
or newtons (F , force) per coulomb (electric charge). Let E represent an electric eld and
z = 1:602e19 represent the elementary charge of one electron in coulombs. Therefore,
E =
V
m
=
F
z
(A.1)
From Newton's Second Law of Motion, net force on a particle is equal to the mass (g,
grams, to prevent confusion with meters) of the particle times its acceleration a:
F = ga (A.2)
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Rewriting Equation A.2 results in the following:
F = zE
F =
zV
m
(A.3)
And therefore, the acceleration of a particle in a particular electric eld will be given as:
a =
F
g
a =
zV
mg
(A.4)
Our goal is to calculate the time it takes for an ion to travel from the sample plate to the
detector. The linear distance d traveled by a particle with initial velocity v, under uniform,
constant acceleration a, is given as:
d = vt  1
2
at2 (A.5)
This equation can be rewritten in terms of time by applying the quadratic formula.
t =
 v pv2   2a(d)
a
(A.6)
While negative terms can result from this equation, we are not interested in negative
times (these ions would not reach the detector).
We split up the calculation of the TOF values into three stages. First, there is the time
for the focusing phase, tf , which occurs from the ion's location in the plume, x0 to the
position of the focusing grid of the electric eld, D1. Next, for the accelerating phase, ta, we
consider the time taken from entering the electric eld at D1 and leaving the electric eld
at D2. Finally, the drift time td is calculated as the time taken to travel from D2 to the
detector, a distance of L.
The initial velocity v0 imparted on an ion is given stochastically by the distribution
N(; ) every time an ion requires its TOF value calculated. The three ight times are
calculated using Equation A.2 as follows:
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tf =
 v0 +
p
v20   2af (D1   x0)
af
where af =
zV1
D1g
(A.7)
The velocity of the ion at the end of the focusing phase, vt, will be equal to vt = tfaf+v0.
ta =
 vf +
q
v2f   2af (D1   x0)
af
where aa =
zV
D2g
(A.8)
The velocity of the ion at the end of the acceleration phase, va, will be equal to va =
ta  aa + vt.
In the drift phase, acceleration is assumed to be 0 (constant velocity). Therefore, to
prevent numerical error from dividing by 0, we use the relationship between distance, velocity
and time to compute td. Recalling that distance = rate * time:
td =
L
va
(A.9)
Finally, Time-of-Flight is calculated as + tf + ta+ td. This procedure results in realistic
TOF-MS spectra.
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A.3 USING THE SIMULATOR TO GENERATE SPECTRA
My simulator takes as input, values for the parameters listed in Table 20, and a list of peptide
accession numbers corresponding to peptides which should appear in the mass spectra.
First, a sample amount S is dened in kilograms. This will be the total amount of
sample analyzed. I do not know what a reasonable setting is for this parameter. For most
experiments, I set S = 4e 16kg.
Next, each separate molecular species (peptide) to be analyzed in the sample is dened
by its primary amino acid peptide sequence. In my experiments, the primary sequence is
obtained from the UniProt database [10]. The expected mass of the peptide is computed as
the sum of the average isotopic masses of the amino acids in the given sequence, in addition
to the average isotopic mass of a single water molecule. Post-translational modications
can also aect the peptide's sequence, and these are taken into account when calculating
the peptide mass. Signal peptides from complete protein sequences are removed, and when
documented in the UniProt entry, the mass of a post-translational modifying molecule is
added to the peptide's expected mass.
Each molecular species is assigned a relative proportion, which indicates how abundant
that molecular species is relative to other molecular species. Following this, I calculate
the number of possible molecules pm which can t in the sample. This is calculated by
pm = S=mi, where mi is the mass of molecular species i. The simulator is used to calculate
TOF values using the equations above for each of the pm molecules. A quadratic relationship
is expected between TOF values and m/z, such that the TOF value squared approximates
the m/z value to a constant factor [173]. Let the ith row of matrix of A be ]1; TOFi; TOF
2
i ]
for all ions to be simulated in the spectra. Let bi = mi. The coecients x for a least-squares
solution to the system of equations Ax = b are computed. Finally, TOF values are binned
according to the resolution  of the mass spectrometer. These TOF values are then converted
to m/z values by multiplication with the coecients x learned above. Naturally, the number
of TOF values entering that bin reect the intensity measured at that particular m/z value.
The result is a spectrum consisting of detected m/z values and the amount of molecules
detected in that time bin, which corresponds to relative abundance.
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APPENDIX B
TABLES OF MATHEMATICAL FORMULAE
Table 23: Dataset Characterization Measures
Geometric mean = 1
d
Pd
i=1
hQn
j=1 xi;j
i1=n
Harmonic mean = 1
d
Pd
i=1
nPn
i=j(1=Xi)
Trim mean =
1
d
Pd
i=1(iwith 20% highest and lowest percentiles removed fromxi)
Standard Deviation = 1
d
Pd
i=1

1
n 1Pnj=1(xi;j  1n Pxi;j)

Range = 1
d
Pd
i=1(max(xi) min(xi))
Median = 1
d
Pd
i=1median(xi)
Interquartile Range = 1
d
Pd
i=1 75
th percentile of xi - 25
th percentile of xi)
Maximum / Minimum Eigenvalue = Computed from sample covariance matrix
Skewness = 1
d
Pd
i=1
Ej(xi;j i)3
3i
Kurtosis = 1
d
Pd
i=1
Ej(xi;j i)4
4i
Correlation Coecient = Avg correlation coecient btwn all pairs
Z-score = 1
d
Pd
i=1
1
n
Pn
j=1
xi;j i
i
Euclidean Distance = Avg dist. btwn all pairs (See table 21)
Mahalanobis Distance = Avg dist. btwn all pairs (See table 21)
Cityblock Distance =Avg dist. btwn all pairs (See table 21)
Chi-Squared PDF =x
(v 2)=2e x=2
2v=2 (v=2)
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Table 23: (continued)
Chi-Squared CDF =
R x
0
t(v 2)=2e t=2
2v=2 (v=2)
dt
Normal PDF = 1

p
2
e (x )
2
=22
Normal CDF = 1

p
2
R x
  inf e
 (x )2=22dt
Binomial PDF =
 
n
x

pxq(n x)I0;1;:::;n(x)
Discrete Uniform CDF = oor(x)
N
I0;1;:::;n(x)
Exponential PDF = 1
u
ex=u
F PDF =
 
h
(1+2)
2
i
 ( 12 ) (
2
2 )

1
2
 1
2 x
1 2
2h
1+

v1
v2

x
i 1+2
2
Gamma PDF = 1
ba (a)
xa 1ex=b
Geometric CDF =
Poor(x)
i=0 rq
i
Hypergeometric CDF =
Px
i=0
(Ki )(
M K
N i )
(MN)
Lognormal PDF = 1
x
p
2
e (ln(x) )
2
22
Poisson PDF = 
x
x!
e I0;1;:::;n(x)
Rayleigh PDF = bx=2e( x
2=2b2)
Student's t PDF =  ((v+1)=2)
 (v=2)
1p
v
1
(1+(x2=v))(v+1)=2
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Table 21: Examples of distance metrics for clustering.
Metric Formula
Euclidean distance d(r; s) = (xr   xs)(xr   xs)0
Standardized Euclidean distance d(r; s) = (xr   xs)trace() 1(xr   xs)0
Mahalanobis distance d(r; s) = (xr   xs) 1(xr   xs)0
City Block metric d(r; s) =
Pn
j=1 jxrj   xsjj
Minkowski metric d(r; s) = p
rPn
j=1 jxrj   xsjjp

Cosine distance d(r; s) =

1  xrx0sp
x0rxr
p
x0sxs)

Correlation distance d(r; s) = 1  (xr xr)(xs xs)0p
(xr xr)(xr xr)0
p
(xs xs)(xs xs)0
Hamming distance d(r; s) =
#(xrj 6=xsj)
n
Jaccard distance d(r; s) =
#[(xrj 6=xsj)^((xrj 6=0)_(xsj 6=0))]
#[(xrj 6=0)_(xsj 6=0)]
x and x0 denote a column vector and its transpose respectively.
xr and xs indicate the r
th and sth samples in the data set, respectively.
xrj indicates the j
th feature of the rth sample in the data set.
xr indicates the mean of all features in the r
th sample in the data set.
 is the sample covariance matrix.
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Table 22: Formulae for popular lter scores
Filter Name Formula
Fisher Score score(i) = (+(i)  (i))
2
(+(i))2+( (i))2
Student t{test score(i) = (+(i)   (i))=
q
2+
n+
+
2 
n 
Mutual Information score(X) =
P
x
P
y p(X = x; Y = y)  log p(X=x;Y=y)p(X=x)(Y=y)
(Chi{Square)2 score(X) =
P
x
P
y
(p(X=x;Y=y) p(X=x)p(Y=y))2
p(X=x)p(Y=y)
AUC score(i) =
R
ROC Curve for feature i
J{measure score(X) =Px p(X = xjY = 0)  p(X = xjY = 1)  log p(X=xjY=0)p(X=xjY=1)
J5 Score score(i) = +(i)  (i)1
m
Pm
j=1 j+(j)  (j)j
The standard SAM technique is meant to be used in a permutation setting, however, the
scoring criteria can still be used for ltering methods.
score(i) = +(i)  (i)
s(i)+s0
The correcting constants s(i) and s0 are computed as follows:
s(i) =
r
(1=n+)+(1=n )
(n1+n2 2)
hPn+
j=1(xj(i)  +(i))2 +
Pn 
j=1(xj(i)   (i))2
i
s0 = 1 for purposes of simplicity.
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APPENDIX C
LISTS OF TOP TWENTY PATHWAYS USED BY PATHWAY KERNEL
PER DATASET
Table 24: Lists of 20 most relevant MSigDB Pathway
Identiers per dataset
COPD
DCPATHWAY
module 287
GTGGGTGK UNKNOWN
CARM ERPATHWAY
V$ZID 01
V$PITX2 Q2
module 49
AMINO ACID AND DERIVATIVE METABOLIC PROCESS
GH GHRHR KO 6HRS DN
MESODERM DEVELOPMENT
TGCCTTA,MIR-124A
CCTGAGT,MIR-510
HSA00480 GLUTATHIONE METABOLISM
HSA00604 GLYCOSPHINGOLIPID BIOSYNTHESIS GANGLIOSERIES
RESPONSE TO WOUNDING
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Table 24: (continued)
Dataset MSigDB Pathway Identier
UVB NHEK1 UP
V$AP2REP 01
HDACI COLON BUT16HRS DN
RNA CATABOLIC PROCESS
MORF PPP2R5B
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Table 24: (continued)
Dataset MSigDB Pathway Identier
Hepatitis C
HSA00340 HISTIDINE METABOLISM
V$ATF1 Q6
VESICLE MEDIATED TRANSPORT
RUTELLA HEPATGFSNDCS UP
ZHAN PCS MULTIPLE MYELOMA SPKD
PYRUVATE METABOLISM
V$AFP1 Q6
ESR FIBROBLAST UP
RRCCGTTA UNKNOWN
PROTEIN AMINO ACID DEPHOSPHORYLATION
V$AR 01
V$OCT1 B
PROTEIN TYROSINE PHOSPHATASE ACTIVITY
V$HMEF2 Q6
V$AREB6 04
module 543
GOLGI ASSOCIATED VESICLE
CELL PROJECTION
UV ESR OLD UNREG
module 125
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Table 24: (continued)
Dataset MSigDB Pathway Identier
ILD
LYTIC VACUOLE
VACUOLE
V$AP2REP 01
module 15
chr9q
CCTGCTG,MIR-214
INTRACELLULAR PROTEIN TRANSPORT
REGULATION OF PROGRAMMED CELL DEATH
HSA00641 3 CHLOROACRYLIC ACID DEGRADATION
V$CREBP1 01
module 155
AGUIRRE PANCREAS CHR1
RESPONSE TO ORGANIC SUBSTANCE
SA BONE MORPHOGENETIC
FLECHNER KIDNEY TRANSPLANT WELL UP
CTACTGT,MIR-199A
BECKER ESTROGEN RESPONSIVE SUBSET 2
LEE CIP DN
MORF ERCC2
NI2 MOUSE UP
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Table 24: (continued)
Dataset MSigDB Pathway Identier
Diabetes
GTGCCAT,MIR-183
RIBOSOMAL SUBUNIT
chr14q11
V$TBP 01
MITOCHONDRIAL MATRIX
MEMBRANE FRACTION
chr10q24
CATTGTYY V$SOX9 B1
CALCIUM ION BINDING
module 98
ION BINDING
module 124
GNF2 CDH11
TATAAA V$TATA 01
module 5
KANG TERT DN
BRCA BRCA1 POS
MGGAAGTG V$GABP B
PEART HISTONE DN
MORF TTN
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Table 24: (continued)
Dataset MSigDB Pathway Identier
Melanoma I
V$WHN B
module 229
HDACI COLON BUT12HRS DN
CTCTATG,MIR-368
V$MYOD Q6 01
CORTICAL ACTIN CYTOSKELETON
ATGCTGG,MIR-338
CELLULAR RESPONSE TO STIMULUS
chr15q23
MEMBRANE
CORTICAL CYTOSKELETON
N GLYCAN DEGRADATION
MORF EIF3S2
module 212
CALCIUM REGULATION IN CARDIAC CELLS
V$ELK1 01
MEMBRANE PART
LEE TCELLS2 UP
WELCSH BRCA DN
V$ETS2 B
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Table 24: (continued)
Dataset MSigDB Pathway Identier
Breast Cancer
chr12q
CELL PROJECTION BIOGENESIS
chr10q25
STEROID HORMONE RECEPTOR SIGNALING PATHWAY
GNF2 NPM1
CELL CORTEX
BHATTACHARYA ESC UP
chr1q23
GNF2 SPI1
HSA00521 STREPTOMYCIN BIOSYNTHESIS
chr5p15
ZHAN PCS MULTIPLE MYELOMA SPKD
TUBE MORPHOGENESIS
module 533
chr2q35
ZHAN MM CD138 CD2 VS REST
CONDENSED CHROMOSOME
PEART HISTONE UP
CELL DIVISION
module 61
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Table 24: (continued)
Dataset MSigDB Pathway Identier
Pancreatic Cancer I
module 545
OLD FIBRO UP
ADIP DIFF CLUSTER3
STEMPATHWAY
TCAPOPTOSISPATHWAY
LEE MYC TGFA DN
GGCNNMSMYNTTG UNKNOWN
HYPOPHYSECTOMY RAT UP
LEE CIP DN
MEMBRANE BOUND VESICLE
LU IL4BCELL
MORF IL4
V$MEF2 03
LYMPHOCYTE DIFFERENTIATION
module 259
WELCSH BRCA DN
POD1 KO MOST DN
NUCLEOLAR PART
REGULATION OF PH
chr4p14
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Table 24: (continued)
Dataset MSigDB Pathway Identier
Pancreatic Cancer II
chr4q23
TCA
KREBS TCA CYCLE
NEGATIVE REGULATION OF MAP KINASE ACTIVITY
GGCNNMSMYNTTG UNKNOWN
THELPERPATHWAY
STEMPATHWAY
CAR IGFBP1
GLYCEROPHOSPHOLIPID METABOLIC PROCESS
V$AHR Q5
RYTGCNNRGNAAC V$MIF1 01
chr2q23
TCAPOPTOSISPATHWAY
ATCMNTCCGY UNKNOWN
GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS
MORF PTPRR
WALLACE JAK2 DIFF
ACTACCT,MIR-196A,MIR-196B
V$HIF1 Q3
module 166
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Table 24: (continued)
Dataset MSigDB Pathway Identier
Prostate Cancer
DNA PACKAGING
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY
module 41
V$PAX4 01
V$NKX22 01
module 5
CAGGTA V$AREB6 01
CTTTGA V$LEF1 Q2
V$PAX4 03
TGGAAA V$NFAT Q4 01
TRANSITION METAL ION BINDING
CYTOPLASMIC PART
V$OCT1 07
V$DR4 Q2
SYSTEM PROCESS
NEUROLOGICAL SYSTEM PROCESS
WGTTNNNNNAAA UNKNOWN
PLASMA MEMBRANE
STRESS ARSENIC SPECIFIC UP
NUCLEOBASE NUCLEOSIDE NUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS
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Table 24: (continued)
Dataset MSigDB Pathway Identier
Scleroderma
TTCYNRGAA V$STAT5B 01
V$AP1 Q6 01
RESPONSE TO ABIOTIC STIMULUS
V$NRF2 Q4
V$MYOD Q6
TGANTCA V$AP1 C
YCATTAA UNKNOWN
V$YY1 Q6
module 118
module 24
module 334
V$NFE2 01
V$HFH4 01
CTTTAAR UNKNOWN
module 23
RESPONSE TO CHEMICAL STIMULUS
V$GR 01
module 330
CELLULAR HOMEOSTASIS
V$ER Q6 01
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Table 24: (continued)
Dataset MSigDB Pathway Identier
UPCI Lung Cancer
module 349
KANNAN P53 UP
TPA SKIN UP
LAMB CYCLIN D1 UP
MORF PPP1CC
LEE CIP UP
SHIPP FL VS DLBCL DN
LIZUKA L1 GR G1
module 166
GAMETE GENERATION
chr13q33
INOSITOL PHOSPHATE METABOLISM
chr18q21
PANTOTHENATE AND COA BIOSYNTHESIS
module 540
NKTPATHWAY
METHOTREXATE PROBCELL UP
V$TAXCREB 01
NAKAJIMA MCSMBP MAST
module 107
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Table 24: (continued)
Dataset MSigDB Pathway Identier
Vanderbilt Lung IMAC
HOFMANN MDS CD34 LOW AND HIGH RISK
module 286
module 429
UREA CYCLE AND METABOLISM OF AMINO GROUPS
DEVELOPMENTAL MATURATION
ZUCCHI EPITHELIAL UP
HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS
IDX TSA UP CLUSTER2
module 440
chr6q14
NO2IL12PATHWAY
UBIQUITIN LIGASE COMPLEX
module 424
RECEPTOR SIGNALING PROTEIN ACTIVITY
SARSPATHWAY
CANTHARIDIN DN
IRITANI ADPROX DN
DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
FLECHNER KIDNEY TRANSPLANT REJECTION PBL DN
IDX TSA UP CLUSTER4
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Table 24: (continued)
Dataset MSigDB Pathway Identier
Vanderbilt Lung WCX
METPATHWAY
GTPASE REGULATOR ACTIVITY
AACTGAC,MIR-223
CCR3PATHWAY
chr2q37
PROTEASOMEPATHWAY
P53 SIGNALING
GNF2 G22P1
BRENTANI SIGNALING
TGAGATT,MIR-216
PROTEASOME
GOLUB ALL VS AML UP
chr2p22
TGACATY UNKNOWN
GCM PSME1
HSA00670 ONE CARBON POOL BY FOLATE
RECEPTOR ACTIVITY
MORF CASP2
RNA METABOLIC PROCESS
AGGGCAG,MIR-18A
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Table 24: (continued)
Dataset MSigDB Pathway Identier
Vanderbilt MALDI
module 279
ATATGCA,MIR-448
V$OCT Q6
module 334
RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY
TTTNNANAGCYR UNKNOWN
V$MEF2 02
KRCTCNNNNMANAGC UNKNOWN
STEMCELL COMMON DN
V$IRF1 Q6
AGED MOUSE RETINA ANY UP
module 183
PARK RARALPHA MOD
module 345
module 182
V$COUP DR1 Q6
PROTEIN KINASE BINDING
HOFFMANN BIVSBII BI TABLE2
ATCTTGC,MIR-31
ACAACCT,MIR-453
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APPENDIX D
STANDARD OPERATING PROCEDURES FOR BASELINE
PREPROCESSING
For the sake of reproduction, our standard operationg procedure for performing baseline
preprocessing is given below.
D.1 BASELINE PREPROCESSING
By default, the order of preprocessing steps continues as follows:
 Variance stabilization.
 Baseline correction.
 Prole normalization.
 Smoothing
 Alignment
D.1.0.1 Variance Stabilization Higher intensities typify higher-variance measures in
TOF-MS datasets. We decouple the dependency of variance of measurements upon their
intensity by applying the cube-root transformation to all prole readings (Hauskrecht et al.,
2005).
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 Change the intensity of every prole measurement to be the cube root of that measure-
ment.
D.1.0.2 Baseline correction To ensure that intensities are measured with a baseline
of 0, instrument noise is removed by a sliding-window method:
 Calculate a minimum over local window of width 200 data points to determine the
baseline shift constant for the window's middle position.
 Subtract the constant from the intensity reading.
 Slide the window forward
 Continue to compare new baseline correction techniques.
D.1.0.3 Prole normalization Prole normalization is performed by TIC correction
on a limited range.
 Sum intensities between the m/z range of 1500 and 16500 Daltons.
 Divide each intensity in the prole by this amount.
 Continue to compare new baseline correction techniques.
D.1.0.4 Smoothing Smoothing is accomplished by rounding intensities to t a Gaussian
shape.
 For each intensity i in prole p do:
{ Fit i to a Gaussian distribution based on its 10 immediate neighbors on either side.
The Gaussian distribution has standard deviation equal to 2.
{ Move to the next intensity.
 Continue to compare the eects of smoothing.
D.1.0.5 Alignment
 Calculate the mean prole by averaging all samples in the study
 Identify peaks in the mean prole using Procedure Peak-Identication
 For all proles p do:
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{ Identify peaks of the prole p
{ Use dynamic time-warping procedure to adjust the m/z values associated with the
prole p so they align with the peak in the mean prole
 Continue to compare alternative alignment strategies.
D.1.0.6 Handling technical replicates If more than one technical replicate exists for
a sample, the replicates are averaged together to produce a single proteomic prole per
patient.
 Average spectra that correspond to the same sample.
 Measure the eect of averaging on COV in search of variance ination (undesirable
outcome)
D.1.1 Standardized Peak Identication (Data Characterization)
D.1.1.1 Data characterization
 Ensure the following for each prole p:
{ Each prole consists of n intensity measurements
{ Each intensity measurement is assigned an m/z value.
{ Individual peaks or peak complexes may be analyzed.
 Each prole contains a class label corresponding to its disease state (typically 1 for case,
and 0 for control).
 Consider various binarization approaches prior to modeling.
 Continue to consider additional (multivariate) data characterizations.
D.1.1.2 Peak identication
 Average all proles in the dataset.
 Using a sliding window of width 12 (measurements), search for local maxima in this
averaged prole.
 Local maxima are marked as peak positions.
 Transfer the positions of marked peaks to the original proles.
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 Continue to compare additional peak detection algorithms.
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